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Insensitivity to chemotherapy is an ongoing issue in cancer treatment, one that 
appears to be highly dependent on patient-specific variations. It has been shown clinically 
that while a subset of patients will successfully respond to a particular chemotherapeutic 
regimen, there exists another subset of patients who when exposed to the same course of 
therapy will remain resistant to treatment or exhibit signs of relapse after treatment has 
been administered. This discrepancy raises interesting questions regarding the role that 
patient-specific variations play in controlling the efficacy of chemotherapy treatment 
regimens.  
Doxorubicin (Dox) is a common chemotherapeutic agent used in the treatment of 
a variety of solid tumors and leukemias. Even after the extensive and long-standing 
clinical utilization of Dox, a consensus on the drug‟s method of action has yet to be 
reached, thereby suggesting that multiple mechanisms of action may in fact be at work. 
The diversity of Dox‟s method(s) of action becomes all the more pertinent considering 
that resistance to Dox treatment is a major issue in cancer chemotherapy, oftentimes 
leading to patient relapse. To gain a deeper understanding of the processes that influence 
Dox resistance, therefore, we must first understand the mechanisms that underlie and 
contribute to Dox‟s toxicity. To this end, the metabolic reactions that activate Dox have 
been implicated as major determinants of Dox cytoxicity and as possible factors that 
control Dox resistance in cancer cells. 
There are several lines of evidence that redox-dependent metabolism plays a large 
role in Dox toxicity. The Dox bioactivation network is comprised of a system of 
reduction/oxidation (redox) reactions that lead to the formation of toxic Dox metabolites 
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and reactive oxygen species (ROS). Moreover, multi-drug resistant acute lymphoblastic 
leukemia cells derived from relapsed patients have elevated levels of the antioxidant 
glutathione and show insensitivity to Dox treatment. The redox dependence of Dox 
bioactivation, the understanding that Dox treatment generates ROS, and the evidence that 
Dox resistant cells exhibit increased antioxidant capacity, suggest the possibility that 
redox pathways modulate the efficacy of Dox treatment in cancer cells. The overall 
objectives of the proposed dissertation, therefore, were to investigate how the redox 
properties of the Dox bioactivation network influence Dox toxicity in acute 
lymphoblastic leukemia cells, and to provide evidence that cell-specific variations in the 
intracellular levels of these redox components influences the degree to which Dox 
treatment will induce cancer cell death.  
The central hypothesis of this dissertation is that the Dox bioactivation network is 
regulated by intracellular levels of antioxidant components and metabolites that work 
collectively to generate toxic Dox metabolites or to generate intracellular oxidant signals. 
More specifically, it is hypothesized that while the generation of toxic Dox metabolites 
will ultimately promote Dox-induced cell death, the generation of intracellular oxidant 
signals can either promote cell death or cell viability, depending on the intracellular 
context in which the oxidant signals are generated. To test this hypothesis, a three step 
approach was utilized. First, a computational network model of cytosolic Dox 
bioactivation was developed based upon patient-derived cell line differences in metabolic 
enzyme levels. Second, a systems-based model of intracellular ROS consumption in 
lymphocytes was constructed. Third, the consequence of Dox-induced ROS on the 
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potentially oncogenic nuclear factor kappa B (NF-κB) signal transduction pathway was 
analyzed.  
The significant findings of this study are that the redox reactions involved in Dox 
metabolism are dual-natured, containing a toxicity-generating module characterized by 
nicotinamide adenine dinucleotide phosphate (NADPH)-dependent Dox reductive 
conversion, as well as an ROS signal-generating module characterized by NADPH- and 
oxygen-dependent Dox redox cycling. This study reveals that balance between the 
coupled redox reactions that comprise the toxicity- and ROS signal-generating modules 
of Dox bioactivation determines the sensitivity-phenotype of leukemia cells. This study 
provides evidence that phenotypic changes in the Dox-sensitivity of leukemia cells can be 
induced by the successful modulation of the Dox bioactivation network through the 
pharmacological inhibition of NADPH in a concentration- and cell type-dependent 
manner.  
In addition, this study highlights the importance of the intracellular redox network 
in controlling chemotherapy-induced ROS. The unequal distribution in antioxidant 
burden across the various intracellular antioxidant enzymes suggests a significant role for 
NADPH supply, as controlled by the enzyme glucose-6-phosphate dehydrogenase 
(G6PD), to the intracellular ROS buffering capacity of cells during instances of oxidative 
stress. Changes in G6PD activity were shown to promote protein-S-glutathionylation 
during oxidative stress conditions, thereby implicating G6PD in the modulation of redox-
sensitive signal transduction pathways.  
Furthermore, this study reveals that intracellular glutathione redox balance, a 
measure of the intracellular redox environment, can effectively regulate Dox-induced 
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NF-κB signal transduction in leukemia cells. The systematic modulation of intracellular 
glutathione redox balance in leukemia cells by N-acetylcysteine (NAC) revealed an 
important role for protein S-glutathionylation mechanisms in the control of NF-κB signal 
transduction induced by Dox treatment. These findings identify the glutathione redox 
network as a potential therapeutic target for the systematic modulation of Dox sensitivity 
in cancer cells and elucidate the complex role that antioxidants such as NAC can play in 
modulating the effectiveness of Dox chemotherapy treatment regimens.  
Lastly, this study highlights the need for and the capacity of computational 
models to accurately describe the complex redox-reactions that contribute to Dox 
metabolism in leukemia cells. This study is groundbreaking in its use of computational 
modeling to analyze reversible electron transfer events between proteins using mass-
action kinetics. The models developed in this study can accurately explain cytosolic 
doxorubicin bioactivation, intracellular hydrogen peroxide clearance, and kinase-specific 
S-glutathionylation, thereby showing that the use of comprehensive and/or relatively 
simple computational models can provide semi-quantitative predictions about the 
behavior of redox systems in mammalian cells as they relate to Dox-induced toxicity and 










 Dox, a chemotherapeutic anthracycline, is a well-known cytotoxic drug used in 
the treatment of a variety of solid tumors, leukemias, and lymphomas (Gewirtz, 1999). 
While Dox remains one of the most effective drugs to date for treating cancer, there is 
still some controversy surrounding its mechanism(s) of action (Asmis et al, 2005; 
Gewirtz, 1999; Gilleron et al, 2009; Kostrzewa-Nowak et al, 2005). Some studies suggest 
that Dox exerts its toxic effects via its ability to interfere with the biosynthesis of 
macromolecules, e.g. DNA (Calendi et al, 1965; Di Marco et al, 1965; Supino et al, 1977; 
Zunino et al, 1972). However, these effects only seem to be evident at high 
concentrations of Dox. Other studies implicate a major role for free radical generation. 
However, because most of these experiments were carried out in cell free systems using 
supraclinical drug concentrations, some level of doubt regarding the importance of free 
radical generation in Dox-induced toxicity still exists (Bates & Winterbourn, 1982; Eliot 
et al, 1984; Gutteridge & Quinlan, 1985; Muindi et al, 1984). Other proposed 
mechanisms for Dox-induced toxicity include DNA adduct formation and DNA 
crosslinking (Cullinane & Phillips, 1990; Cummings et al, 1991; Sinha & Chignell, 1979; 
Sinha et al, 1984), interference with DNA strand separation during replication (Bachur et 
al, 1992; Fornari et al, 1994; Montecucco et al, 1988), and interference with 
topoisomerase II (Tewey et al, 1984a; Tewey et al, 1984b). The lack of understanding 
regarding the way in which Dox exerts its antitumor effects is all the more concerning 
considering that Dox resistance in cancer cells is still an ongoing issue (Akman et al, 
1990; Bao et al, 2011; Doroshow et al, 1991; Kievit et al, 2011). Dox resistance in cancer 
cells has been correlated with a number of different phenomena ranging from aberrant 
phosphatase activity (Grunwald et al, 2002) and expression of oncogenic proteins like 
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MDM2 (Gu et al, 2002), to alterations in normal cell signaling (Zhou et al, 2003b) and 
cell cycle progression (Wang et al, 1999). Although the underlying mechanism of Dox 
resistance is not fully understood, researchers have determined several factors that 
influence Dox cytotoxicity, most notably the expression of membrane transporters P-
glycoprotein/MDR1 (Pgp) (Dhooge et al, 1999; Fisher & Sikic, 1995; Kostrzewa-Nowak 
et al, 2005; Ross, 2000) and the generation of ROS and free radicals via Dox redox 
cycling (Gewirtz, 1999). Because the modulation of Pgp activity in vivo (Dhooge et al, 
1999; Ross, 2000) and the use of antioxidants (Berggren et al, 2001a; Wang et al, 2004) 
have failed to demonstrate any long term disease-free survival, alternative mechanisms 
have been proposed to describe the antitumor effects of Dox and thereby offer plausible 
explanations for why some cancers are sensitive to Dox treatment while others are not. 
Dox Bioactivation and Drug Sensitivity 
 The reductive conversion of Dox has been implicated as a major determinant of 
Dox cytotoxicity and has been proposed as an underlying factor controlling drug 
resistance in cancer cells (Akman et al, 1990; Kostrzewa-Nowak et al, 2005b; Sinha & 
Chignell, 1979). Reductive conversion of Dox is characterized by the one-electron 
reduction of the quinone moiety of Dox, via NADPH and cytochrome P450 reductase 
(CPR), into a semiquinone radical (Kostrzewa-Nowak et al, 2005b; Menna et al, 2007).  
Once the semiquinone radical has been generated, it can exert direct toxic effects or be 
oxidized back to the quinone form (i.e. redox cycling) (Ramji et al, 2003). The 
combination of reductive conversion and redox cycling occurs simultaneously in 
mammalian cells; this overall process is termed bioactivation. It has been reported that 
the ability of Dox to undergo reductive conversion is dependent on the availability of 
molecular oxygen and NADPH, and the activities of several intracellular enzymes such 
as superoxide dismutase (SOD), glutathione peroxidases (GPx), NADPH oxidases 
(NOXs), and thioredoxin (Trx) (Akman et al, 1990; Doroshow et al, 1991; Gilleron et al, 
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2009; Kostrzewa-Nowak et al, 2005), components whose intracellular concentrations and 
activities may vary from one cancer type to the next, or from patient to patient. This 
variation may help explain some of the contradictory evidence in the literature that 
describes the proper intracellular environment or intervention strategy for effectively 
controlling Dox toxicity in vivo (Akman et al, 1990; Berggren et al, 2001a; Ramji et al, 
2003). For example, Dox-resistant MCF-7 breast cancer cells showed little change in 
SOD activity compared to their Dox-sensitive counterparts (Akman et al, 1990); 
however, in another study Dox-sensitive MCF cells were rescued via the introduction of 
SOD (Doroshow et al, 1991). Furthermore, despite the central role of CPR in the 
bioactivation process, the importance of this enzyme in modulating Dox toxicity has been 
called into question. It is widely accepted that CPR is the primary enzyme for catalyzing 
the reductive conversion of Dox in vivo (Bartoszek, 2002), yet overexpression of CPR 
does not result in enhanced Dox cytotoxicity (Ramji et al, 2003). 
Dox Bioactivation and the Intracellular Redox Environment 
 Because the overall network structure for cytosolic Dox bioactivation is believed 
to be conserved across different cell types (Bachur et al, 1979; Cummings et al, 1992; 
Sinha et al, 1989a), the contradictory behavior described above is most likely the result of 
differences in the intracellular levels of redox network components (both metabolites and 
proteins) between cells. In vitro studies carried out by Kostrzewa-Nowak et al.  support 
this hypothesis by showing that changes in NADPH concentration and SOD activity had 
a direct impact on degree of Dox reductive conversion (Kostrzewa-Nowak et al, 2005). 
This dependence of the drug on [NADPH] becomes very important in light of recent 
findings that frequently-occurring somatic mutations in gliomas and leukemias can result 
in a directional change from NADPH production to NADPH consumption by isocitrate 
dehydrogenases (IDH1/2) resulting in lower intracellular NADPH levels (Dang et al, 
2009; Ward et al, 2010). Additionally, several lines of evidence in the literature have 
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pointed to the involvement of NOX activity in Dox treatment (Gilleron et al, 2009a), 
providing added relevance to the intracellular levels of NADPH in Dox bioactivation. 
Thus, the redox context-dependence of Dox metabolism becomes central to accounting 
for patient variability to anthracycline regimens. Contradictory observations regarding the 
redox-mediated reactions involved in conferring Dox potency highlight the need for a 
more in-depth quantitative examination of how the behavior of the Dox bioactivation 
network is influenced by the initial levels of its system components, its component 
interactions, and the intracellular redox environment in which the network operates. 
Dox-Induced ROS and Signal Transduction 
 Reactive oxygen species are of great interest to researchers because they are 
readily diffusible (Antunes & Cadenas, 2000) and can act as signaling molecules due to 
their second messenger properties (Rhee, 2006). Because the metabolism of Dox results 
in the generation of ROS such as superoxide (O2
-
) and hydrogen peroxide (H2O2), Dox 
treatment has the potential to affect redox-sensitive intracellular signaling networks. One 
such redox-sensitive signaling network is that which controls the activation of the NF-κB 
transcription factor. NF-κB is a transcription factor that is known to play a regulatory role 
in cellular processes such as growth and proliferation (Bharti & Aggarwal, 2002). This 
ability of NF-κB to regulate cell growth and proliferation becomes all the more important 
when viewed in the context of cancer biology. Cancer is a hyper-proliferative disorder 
(Bharti & Aggarwal, 2002) and many malignancies are characterized by abnormalities 
and irregularities in NF-κB activation (Dolcet et al, 2005). NF-κB is a well-known redox-
sensitive protein and the NF-κB pathway is comprised of many redox sensitive steps 
(Hayashi et al, 1993; Herscovitch et al, 2008; Kamata et al, 2002; Matthews et al, 1992; 
Oliveira-Marques et al, 2009; Reynaert et al, 2006; Toledano & Leonard, 1991). For this 
reason, Dox-induced ROS has the potential to regulate NF-κB signal transduction in 
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cancer cells, and subsequently, NF-κB-dependent transcription of genes that control cell 
survival. 
Research Objectives and Specific Aims 
 The redox dependence of Dox bioactivation, the ability of Dox to generate ROS, 
and the ability of ROS to modulate signal transduction, provide substantial evidence to 
the possibility that redox pathways modulate the efficacy of Dox treatment in cancer 
cells. The overall objective of this research, therefore, was to investigate how the 
redox properties of the Dox bioactivation network influence Dox toxicity in acute 
lymphoblastic leukemia cells through the generation of toxic Dox metabolites and 
the induction of ROS. The central hypothesis behind this dissertation was that the Dox 
bioactivation pathway is regulated by intracellular levels of antioxidant components and 
metabolites that work collectively to generate toxic Dox metabolites or to generate 
intracellular ROS signals. More specifically, there was an interest in determining the 
molecular conditions that would lead to the preferential formation of toxic Dox 
metabolites at the expense of ROS generation, thereby promoting Dox-induced cell 
death. Lastly, because ROS can potentially affect redox-sensitive signaling pathways that 
regulate cell proliferation and growth, it was hypothesized that Dox-induced ROS could 
either promote cell death or cell viability, depending on the intracellular redox context in 
which the ROS signals are generated. To test these hypotheses, a three step approach was 
utilized: 
 
 Specific Aim 1: Develop a systems-based model of intracellular Dox 
bioactivation to examine the role of redox reactions in controlling the formation of 
toxic Dox metabolites and Dox-induced ROS. The working rationale for this aim was 
that intracellular levels of redox proteins and metabolites control the extent to which Dox 
reductive conversion occurs in a cancer cell, and ultimately, the sensitivity of the cancer 
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cell to Dox treatment. An in vitro computational model of cytosolic Dox bioactivation 
was developed and validated with previously determined experimental data of in vitro 
Dox bioactivation (Kostrzewa-Nowak et al, 2005). Previous research had identified most 
of the components that comprise the Dox bioactivation network; however, adaptation of 
the network to changes in Dox treatment or to patient-specific changes in network 
components is much less understood. To investigate the in vivo control properties of the 
coupled redox reactions that comprise the Dox bioactivation network, the metabolic 
differences between two patient-derived acute lymphoblastic leukemia (ALL) cell lines 
exhibiting varied Dox sensitivities were analyzed. Cell line-specific computational 
models were developed and validated to predict Dox bioactivation in the ALL cell lines 
at different Dox concentrations. Pharmacological inhibitors were administered, 
simultaneously with Dox, to tease out the rate-limiting properties of the oxygen-
dependent redox cycling and NADPH-dependent reductive conversion of Dox. Using 
these methods, the intracellular conditions necessary to promote Dox reductive 
conversion or Dox-induced ROS formation in ALL cells were determined. 
 
Specific Aim 2: Develop a comprehensive network model of cellular ROS 
buffering to predict changes to the intracellular redox environment that occur as a 
result of oxidative stress. The working rationale for this aim was that intracellular levels 
of redox enzymes control the homeostatic redox potential of the glutathione and 
thioredoxin redox couples in a manner that affects the overall ROS buffering capacity of 
individual cells. To elucidate the mechanism by which mammalian cells control 
intracellular H2O2 accumulation during periods of H2O2-induced oxidative stress, a 
computational model was generated. This quantitative model integrated all pertinent 
components of cellular redox buffering during transient oxidative stress; the model took 
into account not only the key components of the intracellular redox buffering system, but 
also the hierarchical interdependence of each component on the other. The network 
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model incorporated the activity of intracellular protein thiols in ROS buffering and 
highlighted the importance of protein disulfide formation and protein S-glutathionylation 
in the cell‟s ability to cope with transient and sustained conditions of oxidative stress. 
The use of computational modeling to study peroxide buffering allowed for a detailed 
investigation of the molecular dynamics of a cell undergoing oxidative stress, one that 
has not yet been established experimentally. 
 
Specific Aim 3: Characterize the importance of the intracellular redox 
environment in controlling the degree to which Dox-induced ROS modulates a 
redox-sensitive signal transduction pathway. The working hypothesis for this aim was 
that the intracellular redox environment, as defined by the intracellular level of the major 
antioxidant glutathione (GSH), determines the ability of Dox-induced ROS to modulate a 
redox-sensitive signal transduction pathway. NF-κB is a transcription factor believed to 
be a key regulator of the initiation and progression of many human cancers (Dolcet et al, 
2005). A specific look at the effect of Dox-induced ROS on the NF-κB signal 
transduction pathway was conducted and the role of the glutathione/glutathione disulfide 
(GSH/GSSG) redox balance in controlling Dox-induced NF-κB activity in ALL cells was 
investigated. The examination of Dox-induced NF-κB activation between two ALL cell 
lines with dissimilar antioxidant capacities, and the use of the antioxidant N-
acetylcysteine (NAC) to systematically alter intracellular GSH/GSSG redox potential 
during Dox treatment, clearly illustrated how intracellular glutathione redox balance can 
regulate Dox-induced NF-κB signal transduction to potentiate the sensitivity of ALL cells 










 In the United States, acute lymphoblastic leukemia (ALL) is the most common 
form of cancer among children (Bleyer, 1990). While the incidence of childhood 
leukemia has increased over the past 20 years, the survival rate for children diagnosed 
with this disease is very promising and resides at approximately 70% (Bleyer, 1990). 
There are many reasons for this high survival rate but the use of risk-adapted therapy to 
tailor the intensity of treatment to each patient‟s risk of relapse is being heralded as the 
basis for this success (Yeoh et al, 2002). Although the survival rate of childhood 
leukemia is high, the highly refractory nature of this cancer should not be overlooked 
(Kearns et al, 2001; Yeoh et al, 2002). Patients who, for unknown reasons, do not 
respond to therapy have a very low prognostic outcome. Currently, the identification of 
prognostically important leukemia subtypes is imprecise, labor intensive (Yeoh et al, 
2002), and is focused on biomarker identification rather than underlying mechanisms of 
cancer relapse. There is an obvious need, therefore, for novel methodologies and 
platforms with which to accurately and efficiently characterize the heterogeneity of ALL 
subtypes and their ability to respond to chemotherapy. Developing more accessible 
methods with which to stratify ALL subtypes, methods that rely on protein expression 
and dynamic intracellular signaling networks, for instance, could result in the 
development of more efficacious approaches to individualized treatment. 
 The first step in transitioning from a generalized approach to cancer treatment to a 
more personalized one is a fundamental understanding of the way in which 
chemotherapeutic agents achieve their cytotoxicity and an appreciation of how patient-
specific variation could affect the efficiency of said mechanism. Currently, the majority 
of chemotherapeutic drugs are designed to disrupt cytoskeletal dynamics, essential signal 
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transduction pathways, or DNA replication (Moreno-Sanchez et al, 2010). Most 
chemotherapeutic agents lack target-specificity and tend to affect or inhibit the normal 
function of non-transformed cells (Asmis et al, 2005; Gilleron et al, 2009). Dox, for 
example, is known to have significant and unwanted cardiotoxic effects as a result of its 
ability to disrupt the mitochondrial respiratory chain and induce oxidative stress 
(Gewirtz, 1999; Gilleron et al, 2009).  
 The aim of this work was to improve understanding of the redox-dependent 
methods by which Dox achieves its cytotoxic actions in cancer cells. Understanding how 
redox reactions affect Dox bioactivation and how the intracellular redox environment 
dictates the effect of Dox-induced ROS on redox-sensitive signal transduction pathways 
provides a framework for the use of patient-specific redox components as predictive 
markers of patient-sensitivity to Dox treatment. With this knowledge, efficacious 
pharmacological intervention strategies may be developed for a more controlled 
manipulation of Dox metabolism to either promote cell viability, as would be desired 
when protecting non-transformed cells from unwanted Dox toxicity, or to potentiate Dox-







3.1. Redox Metabolism in Cell Biology 
 
3.1.1 Reactive Oxygen Species: Intracellular Sources  
 Cellular respiration is a process by which cells convert biochemical energy from 
food into adenosine triphosphate (ATP), the main energy currency of the cell. Aerobic 
respiration is a special type of cellular respiration in that it requires molecular oxygen 
(O2) in order for the biochemical conversion process to take place. Mammalian cells 
primarily utilize aerobic respiration to sustain their energy requirements and a side effect 
of this process is the generation of ROS (Finkel & Holbrook, 2000). ROS is a term that 









) as well as nonradical oxidizing agents (hydrogen peroxide, H2O2; nitric oxide, NO) 
which are formed as a bi-product of aerobic respiration (Nordberg & Arnér, 2001). 
Althogh ROS have been implicated in a variety of human diseases (Halliwell, 1991), they 
are also produced as a result of normal metabolism and play a crucial and beneficial role 
in intracellular signal transduction, activation of transcription factors, and immune 
defense. There are a variety of different intracellular ROS molecules; the most common 
ROS found in mammalian cells are superoxide, hydrogen peroxide, and hydroxyl radical 
(Nordberg & Arnér, 2001). In Figure 3-1, a schematic representation of the step-wise 
reduction of molecular oxygen to produce these three common ROS molecules is shown. 
 The common ROS molecules will be discussed in brief to provide a general 
overview of their intracellular sources. This discussion will begin with the superoxide 
anion. Although superoxide is considered to be a free radical species, its reactivity with 
intracellular components is surprisingly limited (Halliwell, 1991; Nordberg & Arnér, 
2001). For this reason, O2
•- 
is considered a very poor signaling molecule (D'Autreaux & 
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Toledano, 2007). Certain compartments within the mammalian cell that are rich in 
molecular oxygen and electrons, for example, the inner mitochondrial membrane space, 
can effectively support the spontaneous production of superoxide. However, because O2
•-
 
is somewhat ineffective at permeating through lipid membranes (D'Autreaux & 
Toledano, 2007), most of the superoxide produced in the mitochondria is contained 




Figure 3-1. Reduction of molecular oxygen to produce ROS. The step-wise reduction 
of molecular oxygen highlighting the one-electron transfer reactions that produce the 
common intracellular ROS molecules superoxide (O2
•-
), hydrogen peroxide (H2O2), and 
hydroxyl radical (OH
•
). Image adapted from the reaction mechanism described by 
(Nordberg & Arnér, 2001). 
 
 
 Though the majority of endogenous O2
•-
 stems from processes that take place 
within the mitochondrion, the mammalian cell contains specialized enzymes that are 
capable of generating superoxide independent of mitochondrial involvement (Petry et al, 
2010). Superoxide can be produced endogenously by the cyclooxygenase enzyme, the 
lipoxygenase enzyme, or by flavoenzymes (D'Autreaux & Toledano, 2007; Halliwell, 
1991; Nordberg & Arnér, 2001). Xanthine oxidase (XO) and NADPH oxidases (NOXs) 
are well studied superoxide producing flavoenzymes found in mammalian cells 
(Kuppusamy & Zweier, 1989; Petry et al, 2010). Xanthine oxidase, also known as 
xanthine oxidoreductase, can be found in most mammalian tissues, but is largely 
concentrated in epithelial and endothelial cells (Bayir, 2005). In humans, unstimulated 
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cells have a relatively low basal expression of XO, yet upon cellular activation by 
cytokines, the transcription of XO is rapidly upregulated and its activity increased (Bayir, 
2005). Changes in the oxygen content of the intracellular or extracellular environment, 
e.g. hypoxia or hyperoxia, can also alter the transcriptional regulation of XO and 
therefore, the intracellular accumulation of O2
•-
 (Bayir, 2005; Berry & Hare).  
 NADPH oxidases are another category of flavoenzymes that are capable of 
producing O2
•-
. NOXs are membrane-bound enzymes that catalyze the one electron 
reduction of molecular oxygen to O2
•-
 using the electron donor, NADPH (Petry et al, 
2010). The NOX family is comprised of 7 distinct enzymes and 6 distinct subunits that 
form the catalytic core of the NOX enzyme system: NOXs 1-5 and DUOXs 1-2 represent 








, NOXO1, and 
NOXA1 represent the 6 NOX subunits (Bedard & Krause, 2007). While each of the 7 
distinct NOX enzymes shares a similar structural domain, they can differ in their cellular 
location and their need for additional subunits to achieve maximal activation. NOX2, for 
instance, is a NOX isoform that is found primarily on the plasma membrane of 







 (Petry et al, 2010). Alternatively, NOX1, which is 
believed to associate with plasma membrane caveolae and the nuclear membrane of some 
cells (Hilenski et al, 2004; Miller et al, 2007),  is thought to require the subunits NOXO1 
and NOXA1 for cell type- and stimulus-dependent maximal activation (Banfi et al, 
2003). There are, however, certain NOXs that are believed to be subunit-independent in 
their activation. NOX4 is an NADPH oxidase that does not seem to require additional 
subunits for its activation; regulation of NOX4 activity is achieved primarily through 
regulation of its transcription (Kawahara et al, 2007; Serrander et al, 2007). 
 Another common ROS found in mammalian cells is hydrogen peroxide. Although 
H2O2 is not a free radical, its reactivity with intracellular thiols is significant (D'Autreaux 
& Toledano, 2007). This characteristic, paired with its relatively long half-life, makes 
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H2O2 is a good signaling molecule (Antunes & Cadenas, 2000; Liu et al, 2005). Much 
like superoxide, hydrogen peroxide is produced primarily by metabolic reactions that take 
place in the mitochondria (Balaban et al, 2005; Beckman & Ames, 1998; Boveris & 
Chance, 1973). Within the mitochondria, the electron transport chain generates O2
•-
 
through the one-electron reduction of O2
 
(Fig. 3-1). Because O2
•-
 can be toxic to cells 
(Marnett, 2000; Mates et al, 1999), it is rapidly detoxified by the mitochondrial enzyme 
manganese superoxide dismutase (MnSOD) to produce H2O2 (Nordberg & Arnér, 2001). 
Non-mitochondrial generation of O2
•-
, through the actions of flavin-containing enzymes 
such as xanthine oxidase and NADPH oxidases, can also result in H2O2 generation. 
Copper and zinc superoxide dismutases (Gray & Carmichael, 1992), located in the 
cytosol of mammalian cells, are responsible for detoxifying cytotosolic O2
•-
, producing 
H2O2 as a product (Nordberg & Arnér, 2001). The spontaneous dismutation of O2
•-
 can 
also occur, independently of enzyme action, and this spontaneous dismutation is 
responsible for some of the intracellular H2O2 that is evident in cells.  
 The mammalian cell contains specialized organelles that are capable of producing 
hydrogen peroxide independently of superoxide generation (Fritz et al, 2007). One such 
organelle is the peroxisome. Peroxisomes are organelles that play a role in lipid 
biosynthesis as well as in lipid catabolism and fatty acid breakdown (Angermüller et al, 
2009). The breakdown of fatty acids involves the transfer of hydrogen from the fatty acid 
substrate onto molecular oxygen, a process that results in the production of H2O2 
(Angermüller et al, 2009). Several notable enzyme-catalyzed processes are thought to be 
responsible for the generation of H2O2 within the peroxisome: the enzyme catalyzed 
breakdown of uric acid by urate oxidase, the enzyme catalyzed breakdown of xanthine by 
xanthine oxidase, and the enzyme catalyzed breakdown of fatty acids by acyl-CoA 
oxidase (Angermüller et al). 
 Hydroxyl radical is third and final ROS molecule that will be discussed in detail. 
The hydroxyl radical is an extremely reactive radical capable of interacting with a variety 
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of biomolecules (Betteridge, 2000; Halliwell, 1991). The hydroxyl radical is formed by 
the metal ion-catalyzed Fenton reaction of H2O2 (Nordberg & Arnér, 2001). In the Fenton 
reaction, the transition metal ions of copper (Cu
+
) and iron (Fe
2+
), complexed with 





3-1) (Nordberg & Arnér, 2001). Moreover, because O2
•-





, through its reaction with intracellular proteins like ferritin and 
some dehydrogenases (Harris et al, 1994), superoxide and transition metals play an 
important role in the intracellular formation of hydroxyl radicals. The reaction in which 
O2
•-
 generates transition metals via its reaction with intracellular proteins is called the in 
vivo Haber-Weiss reaction (Fridovich, 1997).  
 
3.1.2 Reactive Oxygen Species: Physiological Functions  
 ROS have many diverse physiological functions within the mammalian cell; the 
two main functions are phagocyte-dependent defense against infection and redox-
regulated signal transduction (Nordberg & Arnér, 2001; Valko et al, 2007). Phagocytes 
are white blood cells that aid the immune system by ingesting harmful foreign particles, 
bacteria or dead cells (Steevels & Meyaard, 2011). This phagocytotic process is aided by 
ROS because most bacteria and foreign microbes are extremely sensitive to ROS 
exposure. Superoxide is produced within the phagocyte by NADPH oxidase complexes 
(Babior, 1999; Nauseef, 1999). Superoxide dismutase (SOD) within the phagocyte is able 
to convert O2
•-
 into hydrogen peroxide, which when produced, can be further converted 
into hypochlorous acid (HOCl). The redox enzyme myeloperoxidase is the enzyme 
responsible for the conversion of H2O2 into HOCl (Rossi et al, 1985). Hypochlorous acid 
can subsequently lead to the production of hydroxyl radical (Valko et al, 2007). 
Hypochlorous acid and hydroxyl radical are the primary ROS molecules that carryout the 
antimicrobial effects of ROS within the phagosomes and, as a result, they play an 
important role in the mammalian defense against infection. 
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 In addition to defense against infection, ROS play an important role in cellular 
signal transduction. Signal transduction is defined as the process by which cells 
communicate with one another and with their extracellular environment (Poli et al, 2004). 
Signal transduction processes, which are triggered by changes in the extracellular or 
intracellular environment, ultimately lead to the induction of gene expression which 
induces various cellular processes such as growth, proliferation or even apoptosis 
(Thannickal & Fanburg, 2000). ROS can regulate signal transduction because they have 
the ability to modify redox sensitive proteins (Valko et al, 2007). ROS has been shown to 
affect the structure and thereby the function and activity of many redox sensitive proteins, 
such as growth factor receptors (Neufeld et al, 1999), protein kinases (Mulder, 2000), and 
transcription factors (Oliveira-Marques et al, 2009). The oxidation of redox sensitive 
proteins by ROS can lead to structural changes within the protein, which can promote 
either protein activation or protein inactivation. This capacity of ROS to modify protein 
activity is believed to be one reason why many cell types exhibit a small oxidative burst 
of ROS upon stimulation by extracellular cytokines, growth factors, or hormones 
(Thannickal & Fanburg, 2000). Additionally, the ability of ROS to modify protein 
activity helps to explain why the mammalian cell maintains its various intracellular 
compartments at distinct homeostatic redox potentials (Kemp et al, 2008).  
 Inspection of the signaling cascade responsible for activating the NF-κB 
transcription factor, in particular, reveals the extent to which ROS can regulate a 
particular signal transduction pathway. NF-κB is a transcription factor that is involved in 
everything from cell proliferation and growth to immune response and inflammation 
(Ghosh et al, 1998). Although most transcription factors have their effect in the nucleus, 
the activation of the NF-κB transcription factor begins in the cytosol with the degradation 
of its inhibitor protein IκB (Ghosh et al, 1998). The degradation of IκB has been shown 
to be induced by oxidative conditions and is thought to be inhibited by antioxidant action 
(Dalton et al, 1999; Nakamura et al, 1997). Ironically, S-glutathionylation, an ROS-
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dependent protein modification that can serve to inactivate certain redox-sensitive 
proteins (de Oliveira-Marques et al, 2007; Oliveira-Marques et al, 2009), has been shown 
to affect IκB; S-glutathionylation of IκB is thought to result in its inhibition (Kil et al, 
2008). The kinase responsible for IκB degradation, inhibitory κB kinase (IKK) is also 
sensitive to protein S-glutathionylation (de Oliveira-Marques et al, 2007; Oliveira-
Marques et al, 2009). Previous research has shown that oxidative stress can induce the S-
glutathionylation of IKK-β on Cys179 which leads to its inactivation (Korn et al, 2001). 
The NF-κB molecule itself, irrespective of its protein regulators, has also been shown to 
be redox-sensitive. The p50 subunit of the NF-κB molecule is susceptible to oxidation 
(Hayashi et al, 1993; Matthews et al, 1992). This oxidation of the p50 subunit appears to 
promote NF-κB activation as it is the oxidized form of the NF-κB transcription factor that 
preferentially translocates to the nucleus (Oliveira-Marques et al, 2009). However, once 
in the nucleus, it is the reduced form of NF-κB that successfully binds to DNA to 
promote the transcription of a variety of genes (Kabe et al, 2005). Moreover, recent 
evidence seems to suggest that this same p50 subunit could be a potential target of 
protein S-glutathionylation (Pineda-Molina et al, 2001), a modification that would inhibit 
the DNA-binding activity of the NF-κB transcription factor. These findings provide 
several examples of how ROS and the intracellular redox environment can effectively 
regulate intracellular signal transduction. 
 
3.1.3 Reactive Oxygen Species: Oxidative Stress and Disease Induction 
 Oxidative stress is a condition characterized by an imbalance between the 
concentration of ROS within a system and the system‟s ability to consume ROS or repair 
damage caused by ROS. ROS are likely to cause cellular damage because of their high 
reactivity with all the major groups of biomolecules within the cell: proteins, lipids and 
DNA (Nordberg & Arnér, 2001). For this reason, an accumulation of ROS within the cell 
can be extremely toxic. Reactions of ROS with intracellular proteins can lead to the 
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oxidation of amino acid side chains, a process that can result in protein-disulfide 
formation (Gilbert, 1990; Jones, 2008) and protein S-glutathionylation (Gallogly & 
Mieyal, 2007). Oxidation of proteins by ROS can also lead to peptide bond cleavage as 
well as protein-protein cross-link formation (Stadtman & Berlett, 1998). These ROS-
induced post-translational modifications can cause the detrimental inhibition of enzyme 
activity and the denaturing and malfunctioning of proteins (Butterfield et al, 1998; 
Stadtman & Berlett, 1998). Several diseases, such as Alzheimer‟s (Carney et al, 1994), 
rheumatoid arthritis (Chapman et al, 1989), and muscular dystrophy (Murphy & Kehrer, 
1989), have been associated with ROS-induced protein modifications. 
 Lipids are another class of biomolecules which are readily susceptible to ROS-
mediated damage. The most common form of ROS-induced damage experienced by 
lipids is lipid peroxidation (Steinberg, 1997; Yla-Herttuala, 1999).  Lipids are made up of 
fatty acids and unsaturated fatty acids are very susceptible to oxidation by free radical 
species. Free radical oxidation of lipids usually results in oxidative side reactions that 
potentiate the degree of oxidative damage experienced by the cell (Molavi & Mehta, 
2004; Stadtman & Berlett, 1998). Lipid oxidation has the potential to disrupt the 
organization of the lipid bilayer which could alter the permeability of the lipid membrane 
to important metabolites and minerals.  Because the controlled transport of minerals such 
as potassium and calcium are important to normal heart function, and because the 
formation of artherosclerotic plaques involves the oxidation of low-density lipoproteins, 
lipid oxidation has been implicated in cardiovascular disease (Halliwell, 1991; Valko et 
al, 2007). Cardiomyocyte hypertrophy, a condition characterized by abnormal cardiac 
cell growth, can lead to congestive heart failure and other cardiovascular diseases 
(Molkentin & Dorn, 2001); this process is believed to be mediated by ROS-induced lipid 
oxidation (Murdoch et al, 2006).  
 The final class of biomolecules that is susceptible to ROS-mediated damage is 
nucleic acids. Because deoxyribonucleic acid (Bednarski et al) plays an important role in 
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cellular replication, damage to DNA can be extremely detrimental to the cell. ROS has 
the capacity to both cleave and cross-link DNA molecules. Both of these processes will 
ultimately affect the fidelity with which DNA is replicated. A typical mammalian cell has 
the machinery to repair DNA damage that is caused by ROS; however, when this 
machinery is overwhelmed, mutations in DNA can result from erroneous base pairing 
(Valko et al, 2007). The accumulation of DNA mutations is believed to be one of the 
main causes of cancer because it can result in aberrant signal transduction, gene 
transcription, and all around genomic instability (Marnett, 2000; Valko et al, 2006). 
Correspondingly, there appears to be a high incidence of cancer in individuals who are 
exposed to high levels of oxidative stress (Marnett, 2000; Mates et al, 1999).  
 
3.1.4 Antioxidant Enzymes  
 Both radical and non-radical ROS have the potential to cause cellular damage. As 
a result, mammalian cells have developed a host of antioxidant enzymes that are capable 
of preventing and repairing ROS-mediated damage. These enzymatic antioxidants 
include, but are not limited to, superoxide dismutases, catalase, glutathione peroxidases, 
and peroxiredoxins (Prx). Superoxide dismutases were the first antioxidant enzymes to be 
discovered (Bannister, 1988). Prior to discussing the specific antioxidant enzyme systems 
that help maintain normal oxidant levels within the mammalian cell, the NADPH/NADP
+
 
redox couple will be discussed in brief.  
 NADP
+
 is the oxidized form of NADPH, the molecule that provides reducing 
equivalents for a variety of intracellular reactions. Some of these reactions include the 
anabolic biosynthesis reactions that produce lipids and nucleic acids (Ying, 2008), the 
redox-dependent reactions that produce and consume ROS (Bedard & Krause, 2007; 
Nordberg & Arnér, 2001), and the metabolic reactions that activate xenobiotic drugs such 
as Dox (Kostrzewa-Nowak et al, 2005). The primary source of NADPH in mammalian 
cells is the pentose phosphate pathway (Ying, 2008). Most mammalian cells have a 
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homeostatic balance of NADPH/NADP
+ 
that is maintained within the cell at any given 
time. Unwanted deviations from this homeostatic potential can have detrimental effects 
on many cellular processes and is associated with several disease states (Ying, 2008).  
 As mentioned previously, SOD is responsible for catalyzing the dismutation of 
O2
•-
 into H2O2. In mammals, SOD can be categorized into two metal-containing SOD 
isoenzymes: mitochondrial Mn-SOD and cytosolic/extracellular Cu,Zn-SOD (Bannister 
et al, 1987). Although most mammalian cells contain both SOD isoenzymes, the 
mitochondrial Mn-SOD appears to be more essential than its Cu,Zn-SOD counterpart, as 
revealed by knockout experiments in mice (Melov et al, 1998).   
 Catalases are another class of antioxidant enzymes found in mammalian cells. 
These heme-containing enzymes are found primarily in peroxisomes, where they catalyze 
the dismutation of hydrogen peroxide into water and molecular oxygen (Aebi, 1984). 
Catalase has also been shown to play a role in phenol and alcohol detoxification via its 
ability to catalyze the reaction of these species with H2O2 (Nordberg & Arnér, 2001). 
Other antioxidant roles for catalase include its ability to minimize cellular damage due to 
the hydroxyl radicals (OH
•
) that are formed via the metal-catalysed Fenton reactions 
(Nordberg & Arnér, 2001), and its ability to stabilize reduced NADPH, thus allowing the 
metabolite to effectively carry out its role in supporting many of the intracellular 
antioxidant enzyme systems (Kirkman & Gaetani, 1984; Kirkman et al, 1999). 
 Glutathione peroxidases (GPx) are one of the major classes of antioxidant 
enzymes that depend on NADPH to carry out their antioxidant actions. Glutathione 
peroxidases are selenocysteine containing enzymes that catalyze the removal of hydrogen 
peroxide, and other alcohol peroxides, within the mammalian cell (Ursini et al, 1995). 
There are four classes of GPx in mammals, namely GPx1 – GPx4 (de Haan et al, 1998; 
Mates et al, 1999). GPx1 and GPx4 are located primarily in the cytosol of mammalian 
cells; however, recent study has uncovered a specialized role for GPx4 in spermatid 
development and chromosomal arrangement (Ursini et al, 1999). GPx2 and GPx3 are 
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found primarily in gastrointestinal cells and kidney cells, respectively (Dreher et al, 1997; 
Mates et al, 1999).  The mechanism by which GPx reduces hydroperoxides appears to be 
conserved across GPx family members (Epp et al, 1983). Upon oxidation of GPx, the 
selenoate (Se
-
) containing active site is transformed to a selenenic acid (SeOH). This 
selenenic acid is susceptible to reaction with reduced glutathione (GSH). This reaction 
forms the Se-SG glutathione adduct, which, upon the addition of a secondary GSH 
molecule, regenerates the original selenolate active site with the forming glutathione 
disulfide (GSSG) as a bi-product. Glutathione peroxidases play a substantial part in 
defending the mammalian cell against H2O2-accumulation during instances of oxidative 
stress (Adimora et al, 2010). 
 Peroxiredoxins (Prx), also known as thioredoxin peroxidases, are a class of 
mammalian antioxidant enzymes that are directly responsible for reducing 
hydroperoxides, e.g., hydrogen peroxides (Shuvaeva et al, 2009).  Prx are divided into 
three classes: typical 2-Cys Prx, atypical 2-Cys Prx, and 1-Cys Prx (Chae et al, 1999). 
Both the typical and the atypical 2-Cys Prx molecules contain two cysteine subunits: a 
peroxidatic cysteine subunit, which is responsible for the catalytic peroxidase action of 
the Prx molecule, and a resolving cysteine subunit (Shuvaeva et al, 2009). The 1-Cys Prx 
enzyme contains a peroxidatic cysteine subunit with no resolving cysteine to accompany 
it (Chae et al, 1999). While the different classes of Prx enzymes share the same catalytic 
mechanism of oxidation, the mechanism by which the oxidatively-inactivated enzymes 
return to their active form differs between classes. Upon oxidation by a peroxide 
substrate such as H2O2, the peroxidatic cysteine, which is the redox-active cysteine (Cys-
SH) located in the active site of the Prx molecule, is transformed to a sulfenic acid (Cys-
OH); this oxidation process is conserved across all three Prx enzyme classes (Shuvaeva et 
al, 2009). For the 2-Cys Prx enzymes, the second step of the catalytic cycle involves the 
attack of the peroxidatic sulfenic acid by the resolving cysteine to form an inter-subunit 
disulfide bond, as is the case with the typical 2-Cys Prx, or an intra-chain disulfide bond, 
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as is the case with the atypical 2-Cys Prx (Chae et al, 1999). In both cases, these disulfide 
bonds are reduced to their original active cysteine forms by the actions of antioxidant 
enzymes that specialize in disulfide bond reduction such as the thioredoxins and the 
glutaredoxins (Chae et al, 1999). Because the 1-Cys Prx conserve only the peroxidatic 
cysteines, there is no disulfide bond formation, and the peroxidatic sulfenic acid must be 
reduced back to its active cysteine form be a reductant molecule such as glutathione 
(Shuvaeva et al, 2009).   
  
3.1.5 The Glutathione Antioxidant System 
 Glutathione (GSH) is a tripeptide that contains a sulfhydryl group. This amino 
acid derivative serves several important functions within the mammalian antioxidant 
system. Glutathione is considered to be the most abundant intracellular thiol-based 
antioxidant found in mammalian cells, and therefore considered by some as the cell‟s first 
line of defense against oxidative stress. It cycles between two forms: the reduced thiol 
form, GSH, and the oxidized form, GSSG, characterized by the disulfide linkage of two 
GSH tripeptides (Schafer & Buettner, 2001). Because of its relatively high intracellular 
level (1 – 10 mM) (Schafer & Buettner, 2001), GSH serves as a sulfhydryl buffer, 
protecting cells from oxidative damage by reacting with potentially damaging free 
radicals (Gallogly & Mieyal, 2007; Schafer & Buettner, 2001). When the sulfur atom in 
GSH reacts with a free radical it produces a GSH thiyl radical (GS
•
) (Gallogly & Mieyal, 
2007). Two GSH thiyl radicals can in turn react to produce one GSSG molecule. To be 
effective as a buffer, therefore, the concentration of reduced GSH must be maintained at a 
substantially high level compared to the concentration of oxidized GSSG; the ratio of 
GSH to GSSG in most cells is greater than 500:1 (Schafer & Buettner, 2001). GSSG is 
reduced by the NADPH-dependent flavoenzyme glutathione reductase (GR), and this 
enzyme is critical to the maintenance of a proper glutathione redox potential in 






Figure 3-2. Generalized schematic of the mammalian glutathione antioxidant 
system. Hydrogen peroxide is reduced by the glutathione peroxidase (GPx)-catalyzed 
oxidation of two molecules of glutathione (GSH) to form glutathione disulfide (GSSG). 
GSSG is subsequently reduced by the enzymatic actions of glutathione reductase (GR) 
which depend on the reducing equivalents provided by NADPH. H2O2 promotes the 
oxidation of protein monothiols (R-SH) to protein sulfenic acids (R-SOH); the addition of 
a glutathione molecule to the protein sulfenic acid generates an S-glutathionylated protein 
(R-SSG). S-glutathionylated proteins are reduced by glutaredoxins (Grx) via the 
oxidation of two molecules of glutathione to glutathione disulfide. 
 
 Reduced GSH is also an effective sulfhydryl buffer against non-radical ROS. 
GSH conjugation reactions, catalyzed by glutathione S-transferases (Armstrong, 1997), 
help protect intracellular protein monothiols from permanent oxidative damage (Schafer 
& Buettner, 2001) by facilitating the formation of protein mixed disulfides (Pr-SSG). 
Because the formation of protein mixed disulfides can affect the activity of certain 
proteins, GSH is believed to play a direct role in redox-dependent cell signaling (Gallogly 
& Mieyal, 2007; Ghezzi, 2005). As discussed earlier, GSH is an integral contributor to 
the actions of the GPx and Prx enzyme systems. When GPx reacts with H2O2 it becomes 
oxidized and oxidized GPx relies on subsequent reactions with GSH to return to its active 
reduced state (Ursini et al, 1995).  Moreover, reduced thiols such as GSH are believed to 
play a direct role in the reduction of the peroxidatic sulfenic acids that are formed upon 
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the reaction of 1-Cys peroxiredoxins with hydroperoxides (Chae et al, 1999; Shuvaeva et 
al, 2009).  
 Glutaredoxins (Grx) are a class of proteins whose function is directly related to 
GSH (Holmgren, 1976). Four different mammalian Grx proteins have been identified and 
are categorized into two subgroups: classical dithiol Grxs (Grx1 and Grx2) and classical 
monothiol Grxs (Grx3 and Grx5) (Holmgren, 1976; Lillig et al, 2008). Grx1 and Grx3 are 
found primarily in the cytosol of mammalian cells. Grx2 is comprised of three different 
isoforms which can exist either in the mitochondria, the cytosol, or the nucleus of 
mammalian cells; however, Grx5 is primarily found in the mitochondria of mammalian 
cells (Lillig et al, 2008). Glutaredoxins play a role in cellular antioxidant defense by 
reducing GSH-mixed disulfides and some oxidized protein-disulfide species (Fig. 3-2) 
(Holmgren, 1976; Lillig et al, 2008; Peltoniemi et al, 2006). In reducing oxidized proteins 
and GSH-mixed disulfides, Grx itself becomes oxidized and therefore inactivated. To 
return to its reduced and activated state, Grx proteins depend on reducing equivalents 
from GSH. The use of GSH as a cofactor in the Grx-catalyzed intracellular enzymatic 
reactions results in the production of oxidized GSSG. Oxidized GSSG is then reduced by 
the actions of GR, as described previously (Holmgren, 1976). The Grx proteins, together 
with GSH and GR, make up the intracellular glutathione antioxidant system.  
 It is important to note that the activity of the glutathione antioxidant system (Fig. 
3-2), as defined by the GSH redox potentials, can vary from one cellular compartment to 
the next (Kemp et al, 2008; Schafer & Buettner, 2001). The levels of reduced GSH in the 
cytosol and the mitochondria are significantly higher than those in the endoplasmic 
reticulum (Hwang et al, 1992). Moreover, although these intracellular compartments may 
be functionally separated, resulting in compartment-specific redox environments, 
regulated transport of GSH and GSSG between these compartments is maintained (Kemp 




3.1.6 The Thioredoxin Antioxidant System 
 The thioredoxin antioxidant system is made up of two antioxidant enzymes 
working in conjunction with one another: thioredoxin (Trx) and thioredoxin reductase 
(TR) (Nordberg & Arnér, 2001). Thioredoxins are proteins with oxidoreductase activities 
that are capable of reducing oxidized proteins via cysteine thiol-disulfide exchange 
(Holmgren, 1985). When cysteine containing proteins are oxidized by ROS, they have 
the potential to form protein disulfide bonds; Trx proteins contain a dithiol active site 
which can be utilized to reduce disulfide-bonded proteins (Holmgren, 1989). Upon 
reduction of the oxidized protein, the active site of the Trx molecule is transformed from 
a dithiol state to a disulfide state, thereby inactivating the Trx protein (Fig. 3-3) 
(Holmgren, 1977). To return to its active dithiol state, Trx depends on the catalytic 
actions of thioredoxin reductases, which get their reducing equivalents from NADPH 
(Holmgren, 1977). The manner in which GR reduces oxidized GSSG is very similar to 
the manner in which TR reduces oxidized Trx. There are two isoforms of TR in the 
mammalian cell: TR1, which is primarily cytosolic, and TR2, which is primarily 










Figure 3-3. Generalized schematic of the mammalian thioredoxin antioxidant 
system. Hydrogen peroxide is removed by the actions of peroxiredoxins (Prx), which 
when inactivated by oxidation depend on thioredoxin for their reduction. H2O2 also 
promotes the oxidation of protein dithiols (R-(SH)2) to protein disulfides (R-SS); protein 
disulfides are reduced back to protein dithiols by thioredoxins which in turn are 
enzymatically reduced by thioredoxin reductases (TR) using NADPH as reducing 
equivalents.  
 
 There are three known classes of mammalian Trx. The classical Trx-1 protein 
localizes primarily in the cytosol of mammalian cells (Holmgren & Lu, 2010) while the 
Trx-2 isoform of Trx localizes to the mitochondria. The third Trx protein, SpTrx, is a Trx 
variant that is primarily expressed in mammalian spermatozoa (Miranda-Vizuete et al, 
2001). Many intracellular proteins depend on Trx for reduction upon their oxidation, 
most notable of which are the Prx enzymes discussed previously (Rhee et al, 2001). In 
addition to this well characterized Trx-dependent enzyme, many other intracellular 
proteins rely on Trx for their reduction, including several transcription factors. The NF-
κB transcription factor is an example of a transcription factor whose activity can be 
modulated by Trx (Schenk et al, 1994). NF-κB activation is inhibited by Trx in the 
cytosol, whereas in the nucleus, Trx has been shown to activate the DNA-binding of NF-
κB (Wei et al, 2000).  
 The balance between reduced and oxidized Trx is represented by the thioredoxin 
redox potential (Watson et al, 2003). Much like the GSH antioxidant system, the activity 
26 
 
of the thioredoxin antioxidant system (Fig. 3-3), as defined by the Trx redox potential, 
can vary from one cellular compartment to the next. The Trx redox potential in the 
cytosol is more reducing that that of the nucleus, which is in turn more reducing that that 
of the mitochondria (Kemp et al, 2008). The controlled transport of reduced and oxidized 
Trx between these intracellular compartments serves to maintain their distinct Trx redox 
potentials, thereby providing a mechanism for redox-regulated control of signal 
transduction between compartments (Halvey et al, 2005; Jones et al, 2004; Kabe et al, 
2005). 
 
3.2. Redox Chemistry and Anthracycline Drug Toxicity 
 
 
 For over 40 years, anthracycline antibiotics, also known as anthraquinones, have 
been used to treat a variety of cancers. Microorganisms served as the original source of 
these molecules (Kovacic & Osuna, 2000) and since then, much attention has been given 
to the mechanistic understanding of their clinical efficacy against neoplastic growth. The 
most common anthracycline antibiotics currently in use are Dox (Adriamycin) (Fig. 3-4) 
and daunorubicin (Daunomycin) (Gewirtz, 1999; Kovacic & Osuna, 2000). While the 
remainder of this discussion will focus on the Dox anthracycline, most of the conclusions 
drawn can be applied to other members of the anthracycline family (Abdella & Fisher, 
1985).  This section will address the redox chemistry of anthracyclines and highlight 
some of the potential mechanisms of anthracycline toxicity that are attributed to redox-
mediated processes.  
 
3.2.1 Redox Chemistry of Anthracyclines  
 Anthracyclines are molecules that belong to the quinone family of chemicals, 
more specifically, the quinone methide (QM) family of chemicals (Abdella & Fisher, 
1985).  The structure of Dox is shown in Figure 3-4. Most anthracyclines share the same 
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quinone methide backbone (QMB) that is exhibited by Dox, however, changes to the 
functional group (FG) and side group (Asmis et al) of these molecules separate one 
anthracycline antibiotic from the other. Anthracyclines are prone to redox modifications, 
due to the relative reactivity of their respective functional groups (Abdella & Fisher, 
1985). The first chemical modification that will be discussed concerns the reactions that 
lead to semiquinone and hydroquinone formation. Quinones, semiquinones, and 
hydroquinones differ primarily in the strength of their functional groups to act as leaving 
groups. In chemistry, leaving groups are defined as molecular fragments that depart from 
their parent compound upon heterolytic bond cleavage (Broeckaert et al, 2008). Potential 




Figure 3-4. Chemical Structure of Dox (Adriamycin). The chemical structure of Dox 
is offered, highlighting the quinone methide backbone (QMB), the quinone functional 
group (QFG), the L-daunosamine functional group (FG), and the Dox-specific OH side 
group (Asmis et al).  
 
 
 Quinones can be transformed into highly reactive semiquinones upon the addition 













semiquinone molecule is a radical, it has a relatively short lifetime; the semiquinone 
radical is prone to oxidation by O2 under aerobic conditions, and its subsequent reaction 
with O2 promotes the loss of the carbon-7 glycosidic functional group (Abdella & Fisher, 
1985). The resulting aglycon radical is capable of reducing molecular oxygen, abstracting 
hydrogen atoms, or labeling susceptible nucleophiles, many of which exist in the 
intracellular milieu (Bachur et al, 1979; Pan et al, 1981; Sinha & Gregory, 1981). 
Alternatively, quinones can be transformed into highly reactive hydroquinones by the 
two-electron reduction of the quinone functional group (Fisher et al, 1983). However, 
because hydroquinones are also extremely susceptible to oxidation by O2, the 
hydroquinone structure is not long-lived in aerobic environments; the rapid loss of the 
glycosidic carbon-7 functional group results in the formation of a non-radical quinone 
methide product (Fisher et al, 1983). The quinone methide that results from the two-
electron reduction of anthracyclines is potentially electrophilic and can take part in the 
covalent labeling of nucleophilic biomolecules (Lin et al, 1980; Moore, 1977; Moore & 
Czerniak, 1981).   
 Both the one-electron and two-electron pathways of quinone reduction are 
believed to be the primary mechanisms by which flavin-containing intracellular enzymes 
promote the in vivo macromolecular degradation of xenobiotic compounds such as Dox 
(Bartoszek, 2002; Fisher et al, 1983; Kostrzewa-Nowak et al, 2005). Moreover, the 
actions of these enzymes promote an intracellular chemical process called redox cycling 
(Fig. 3-5). Dox and other related anthracyclines can undergo redox cycling in the 
presence of molecular oxygen. Redox cycling is characterized by the reductive activation 
of the anthracycline molecule to a semiquinone or hydroquinone, via the one- or two-
electron mechanisms previously described (Fisher et al, 1983), followed by the non-
enzymatic reoxidation of the semiquinone or hydroquinone compound by molecular 






Figure 3-5. Redox Cycling of Dox. Quinone Dox is enzymatically reduced to its 
semiquinone form by the oxidoreductase cytochrome P450 Reductase (CPR). 
Semiquinone Dox is rapidly reoxidized to the quinone form by its non-enzymatic reaction 
with molecular oxygen to form superoxide. Superoxide is subsequently converted to 
hydrogen peroxide by the actions of the superoxide dismutase enzymes (SOD).  
  
One-electron reduction of quinone anthracyclines is an enzymatic process achieved in 
biological systems by a range of cellular oxidoreductases, most notably NADH 
dehydrogenase, NADPH cytochrome P450 reductase (CPR) (Kostrzewa-Nowak et al, 
2005), xanthine oxidase (Mordente et al, 2001; Pawlowska et al, 2003), and nitric oxide 
synthase (Garner et al, 1999; Vasquez-Vivar et al, 1997). The subsequent non-enzymatic 
oxidation of the semiquinone or hydroquinone radical by molecular oxygen promotes the 




, and H2O2 (Fisher et al, 1983; Kovacic & Osuna, 
2000). 
 
3.2.2 Proposed Role of Enzymatic Reduction in Dox Cellular Toxicity 
 The exact mechanism by which Dox exerts its cytotoxic actions is yet unknown. 
However, a number of different mechanisms have been proposed, and one of these 
proposed mechanisms is directly related to the enzymatic reduction of anthracyclines by 
intracellular oxidoreductases. The one- and two-electron reductions of quinone 
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anthracyclines leads to the formation of highly reactive semiquinone and hydroquinone 
intermediates (Abdella & Fisher, 1985; Fisher et al, 1983). These intermediates are 
regarded as highly electrophilic and can therefore covalently label nucleophilic molecules 
such as DNA (Lin et al, 1980; Moore, 1977; Moore & Czerniak, 1981). The process by 
which activated Dox molecules interact with nucleophilic molecules such as DNA is 
termed bioreductive alkylation (Moore, 1977). There is an increasing body of evidence in 
the literature that suggests the bioreductive activation of anthracyclines like Dox 
significantly promote drug retention by facilitating the covalent binding of these drugs to 
cellular DNA (Cummings et al, 1992). Many cancer cells evade the toxic actions of Dox 
by actively pumping the drug outside of the cell (Bao et al, 2011), decreasing the 
intracellular drug retention time. By promoting covalent binding to DNA, the enzymatic 
reduction of anthracyclines like Dox provides a redox-mediated mechanism that is 
capable of circumventing multi-drug resistance associated with drug efflux (Kievit et al, 
2011).  Moreover, the covalent interaction of activated anthracyclines with DNA is 
believed to promote DNA crosslinking which is thought to contribute to drug-mediated 
cellular toxicity (Skladanowski & Konopa, 1994).  
 
3.2.3 Proposed Role of ROS in Dox Cellular Toxicity 
 Another proposed mechanism of Dox toxicity is one which is directly related to 
free radical generation. It has already been shown in the literature that Dox and other 
members of the anthracycline family are able to induce ROS production via their ability 
to be redox cycled (Fisher et al, 1983; Kovacic & Osuna, 2000). However, there appears 
to be some controversy in the literature regarding the extent to which this ROS 
contributes to anthracycline-induced cellular toxicity. In fact, although various forms of 
ROS have been detected by electron spin resonance, including superoxide, peroxides, and 
hydroxyl radicals, and evidence of lipid peroxidation has been seen in in vitro assays of 
Dox treatment (Kalyanaraman et al, 1980), the question remains as to whether the level 
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of ROS produced by clinically relevant Dox concentrations is high enough to induce 
ROS-mediated damage that contributes to cell death (Kovacic & Osuna, 2000). One 
argument against the role of free radicals in Dox-induced toxicity is that the hypoxic 
conditions of the tumor microenvironment (Guppy, 2002) do not contain enough oxygen 
to promote the oxygen-mediated redox cycling of Dox. However, to counter this 
argument, some researchers claim that the extremely rapid oxidation reaction that occurs 
between molecular oxygen and the semiquinone/hydroquinone form of Dox does not 
require large amounts of oxygen to take place; the extremely rapid nature of this reaction 
is therefore viewed as a clear indicator of the existence of in vivo Dox redox cycling and 
subsequent ROS generation (Taatjes et al, 1998). In fact, the generation of free radicals is 
accepted as the direct cause of cardiotoxicity that results from Dox treatment (Gewirtz, 
1999). Moreover, free radicals generated by Dox redox cycling, if generated in close 
proximity to essential biomolecules, such as DNA or membrane lipids, can rapidly induce 
DNA cleavage (Sinha & Gregory, 1981; Taatjes et al, 1998) and lipid peroxidation 
(Benchekroun & Robert, 1992), two processes that are known to contribute to cell death 
(Gewirtz, 1999).   
 
3.2.4 Proposed Role of Thiol Signaling in Dox Cellular Toxicity 
 ROS generated by Dox treatment can induce cellular toxicity by its direct 
interaction with biomolecules (Abdella & Fisher, 1985; Fisher et al, 1983; Kovacic & 
Osuna, 2000). However, because ROS can affect redox-sensitive signaling pathways, it is 
also likely that the ROS generated by Dox treatment could promote cellular toxicity by 
modulating redox-sensitive signaling pathways that are directly involved in cell survival. 
The NF-κB signaling pathway is well known as a redox-sensitive pathway that mediates 
cell survival (Oliveira-Marques et al, 2009). Several proteins in the NF-κB signal 
activation pathway are susceptible to ROS-mediated protein modifications. Berdnaski 
and colleagues have shown a direct link between NF-κB activity and Dox induced 
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apoptosis in osteosarcoma and breast cancer cell lines (Bednarski et al, 2009). The 
relationship between Dox-induced ROS and NF-κB activity was further clarified in a 
study by Lin et al. illustrating that inhibition of Dox-induced ROS leads to a correlated 
inhibition of NF-κB activity in neuroblastoma cells (Lin et al, 2007). 
 The GSH antioxidant system is the primary determinant of the cellular redox 
environment and alterations to the redox environment can lead to cell death. Protein S-
glutathionylation is a process that is regulated by the glutathione antioxidant system and 
ROS are known to promote S-glutathionylation of proteins via modulation of GSH, Grx, 
and GR (Gallogly & Mieyal, 2007; Ghezzi, 2005; Peltoniemi et al, 2006). Recent work 
by Asmis et al. illustrates the capacity of Dox to alter the glutathione antioxidant system 
in a way that promotes cell injury in human macrophages, independent of ROS formation 
(Asmis et al, 2005). The authors report that increased protein S-glutathionylation 
parallels the GSH oxidation and GSSG accumulation that is induced by Dox treatment 
(Asmis et al, 2005). The ability of Dox to modify the glutathione antioxidant system in a 
manner that mediates cellular injury, independent of ROS formation, suggests an 
alternate pathway of Dox-induced toxicity, one that is that is strongly coupled to 





THE DYNAMIC REGULATION OF DOX BIOACTIVATION 
Introduction 
The reductive conversion of Dox has been implicated as a major determinant of 
Dox cytotoxicity and has been proposed as an underlying factor controlling drug 
resistance in cancer cells (Akman et al, 1990; Kostrzewa-Nowak et al, 2005; Sinha & 
Chignell, 1979; Sinha et al, 1989b). Reductive conversion of Dox is characterized by the 
one-electron reduction of the quinone moiety of Dox, via NADPH and cytochrome P450 
reductase (CPR), into a semiquinone radical (Kostrzewa-Nowak et al, 2005; Menna et al, 
2007; Ravi & Das, 2004). Once the semiquinone radical has been generated, it can exert 
direct toxic effects or be oxidized back to the quinone form (i.e. redox cycling) (Ramji et 
al, 2003). The combination of bioreductive conversion and redox cycling occurs 
simultaneously in mammalian cells; this overall process is termed bioactivation. It has 
been reported that the ability of Dox to undergo reductive conversion is dependent on the 
availability of molecular oxygen and NADPH, and the activities of several intracellular 
enzymes such as superoxide dismutase (SOD), glutathione peroxidase, NADPH oxidases 
(NOXs), and thioredoxin (Akman et al, 1990; Berlin & Haseltine, 1981; Doroshow et al, 
1991; Gilleron et al, 2009; Kostrzewa-Nowak et al, 2005; Ravi & Das, 2004; Sinha et al, 
1989b), components whose intracellular concentrations and activities may vary from one 
cancer type to the next, or from patient to patient.  
 
*
Modified from Finn NA, Findley HW, Kemp ML “A switching mechanism in Dox bioactivation can be 




This variation may help explain some of the contradictory evidence in the literature that 
describes the proper intracellular environment or intervention strategy for effectively 
controlling Dox toxicity in vivo (Akman et al, 1990; Bartoszek & Wolf, 1992; Berggren 
et al, 2001; Doroshow et al, 1991; Kim et al, 2001; Ramji et al, 2003; Sinha et al, 1989b).  
Because the overall network structure for cytosolic Dox bioactivation is believed 
to be conserved across different cell types (Bachur et al, 1979; Cummings et al, 1992; 
Sinha et al, 1989b), differences in cellular Dox sensitivity may result from differences in 
the intracellular levels of the network components (both metabolites and proteins) that 
control Dox bioactivation. In vitro studies carried out by Kostrzewa-Nowak et al  support 
this hypothesis by showing that changes in NADPH concentration and SOD activity have 
a direct impact on the degree of Dox reductive conversion experienced by leukemia cells 
(Kostrzewa-Nowak et al, 2005a). This dependence of the drug on [NADPH] becomes 
very important in light of recent findings that frequently occurring somatic mutations in 
gliomas and leukemias can result in a directional change from NADPH production to 
NADPH consumption by isocitrate dehydrogenases (IDH1/2) resulting in lower 
intracellular NADPH levels (Dang et al, 2009; Ward et al, 2010). Additionally, there is 
evidence in the literature that Dox treatment stimulates NOX activity, providing added 
relevance to the intracellular levels of NADPH in Dox bioactivation (Gilleron et al, 
2009). Thus, the redox context-dependence of Dox metabolism becomes central to 
accounting for patient variability to anthracycline regimens.  
Contradictory observations regarding the redox-mediated reactions involved in 
conferring Dox potency highlight the need for a more in-depth quantitative examination 
of how the behavior of the Dox bioactivation network is influenced by the initial levels of 
its system components and its component interactions. The objectives of this study, 
therefore, were to (a) determine the intracellular factors that control Dox bioactivation for 
different Dox treatment conditions, (b) develop a mechanistic model of Dox bioactivation 
in leukemia cells that could be interrogated to predict resistance to Dox treatment prior to 
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clinical administration of the drug, and (c) test, through simulation, the possible 





Materials and Methods 
Computational modeling  
Ordinary differential equation models of in vitro and in vivo Dox bioactivation 
were developed based on the scheme proposed by Kostrzewa-Nowak et al (Kostrzewa-
Nowak et al, 2005). Here, the term in vitro refers to experiments conducted in solution, 
while the term in vivo refers to experiments conducted within living cells. The in vitro 
model, which describes Dox activation in the presence of NADPH and CPR, contains 6 
kinetic parameters and 9 ODEs (Table 4-2) that describe the changes in concentration of 
the 9 compounds (Table 4-1) that comprise the Dox bioactivation network (Dox, 
metabolites, redox enzymes and reactive oxygen species). The in vivo model, which 
describes Dox activation in the presence of NADPH, CPR, G6PD, SOD1, and NOX4 is 
an adaptation of the in vitro model and contains 10 kinetic parameters and 10 ODEs 
(Table 4-4). The in vitro and in vivo mathematical models developed in this study use 
mass action kinetics of individual redox reactions, in the absence of kinetic regulation, to 
describe the enzymatic and non-enzymatic reactions that result in the redox cycling and 
reductive conversion of Dox. The computational models were designed and numerically 
integrated using MATLAB R2008a (The Mathworks, Inc., Natick, MA, USA).  
 
Major Assumptions of the Computational Model  
To accurately describe the effect of NADPH concentration on the mode of Dox 
bioactivation that takes place, the NADPH molecule was allowed to react slowly with 
molecular oxygen in the in vitro model. Although this reaction is known to take place in 
vivo through the enzymatic actions of NADPH oxidases (Gilleron et al, 2009), due to the 
high concentration of NADPH contained in the reaction mixture, the non-enzymatic 
reaction of NADPH with molecular oxygen was assumed to be possible; this reaction was 
included at a low rate in the network model of in vitro Dox bioactivation and was found 
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to be essential to the accurate description of this process. For the in vivo kinetic model of 
Dox bioactivation, the reaction of NADPH with molecular oxygen was assumed to be 
primarily catalyzed by NADPH oxidases in a mass action-driven reaction that was 
dependent on Dox concentration, because it has been shown that Dox treatment can 
activate NOXs in a Dox concentration-dependent manner (Gilleron et al, 2009). For both 
the in vitro and in vivo models, Dox degradation was assumed to be negligible within the 
time period investigated in the study based on evidence provided in the literature (Ozols 
et al, 1979). 
 
Table 4-1: Initial concentration values of the nine components that comprise the in vitro 
Dox bioactivation model. 
 
Species Abbreviation Initial Condition (M) Reference 




(Kostrzewa-Nowak et al, 
2005) 
Oxidized CPR CPRox 0 Assumption 
Quinone Dox Doxq 1.0   10
-4 
(Kostrzewa-Nowak et al, 
2005) 
Semiquinone Dox Doxsq 0 (Kostrzewa-Nowak et al, 
2005) 
NADPH NADPH 1.0   10
-4









Molecular Oxygen O2 2.7   10
-4
















Table 4-2: Rate expressions and rate constants for the six ODEs that comprise the in 
vitro Dox bioactivation model. 
 
Rxn # Expression Parameter Reference 







R2 k2 ([CPRox]) ([NADPH]) k2 = k1 (Kostrzewa-Nowak et al, 
2005) 






(Kalyanaraman et al, 1980) 


























(Gray & Carmichael, 1992) 
 
The concentration of intracellular molecular oxygen used in the in vivo model was 
derived from literature reported values of oxygen consumption in the HL-60 human 
leukemia cell line (Xu et al, 2005). The rate of oxygen consumption in the HL-60 cell 
line was reported to be significantly lower than the rate of oxygen consumption in the 
non-transformed murine macrophage cell line J774A (James et al, 1998; Xu et al, 2005). 
The intracellular oxygen concentration measured for the J774A cell line, in conjunction 
with the reported oxygen consumption rates for the transformed HL-60 and non-
transformed J774A cell lines (James et al, 1998; Xu et al, 2005), were used to estimate 
the intracellular concentration of oxygen in the two ALL cell lines under investigation: 
the Dox resistant (EU1-Res) and the Dox sensitive (EU3-Sens). While this may be an 
inexact estimate of the actual concentration of oxygen in the cell lines being modeled, it 
does underscore the limited oxygen environment under which cancer cells proliferate 
(Vaupel et al, 1998).  
Dox transport across the cell membrane, as modeled in the in vivo models of Dox 
bioactivation, was described by a concentration gradient multiplied by the permeability 
constant of Dox. It has been shown previously in the literature that Dox uptake by cells is 
characterized by a linear diffusive component as well as a saturable, carrier-mediated 
component (El-Kareh & Secomb, 2005). A simplified version of the Dox uptake 
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equation, as presented by El-Kareh et al (El-Kareh & Secomb, 2005), was utilized in the 
description of Dox bioactivation for the EU1-Res and EU3-Sens cell lines at the high 
Dox concentration condition. It was assumed that at low Dox concentrations, the 
saturable, carrier-mediated component of Dox uptake was negligible; therefore for the 
low Dox concentration condition we utilized a simple diffusion-based equation to 
describe Dox permeation across the cell membrane (Adimora et al, 2010). Additionally, 
the permeability constant for Dox at the low Dox concentration was fitted to a value that 
was 10x higher than the permeability constant for Dox at the high Dox concentration. 
These results are in line with findings by Ghosn et al. that illustrated an inverse 
relationship between solute concentration and solute permeability coefficient (Ghosn et 




























Table 4-3: Initial concentration values of the components that comprise the in vivo Dox 
bioactivation model. 
 
Species Abbreviation Initial Condition (M) Reference 















Oxidized CPR CPRox 0 Assigned 
EC quinone Dox Ex_Doxq 1.0   10
-5
 / 1.0   10-7 Assigned 
IC quinone Dox In_Doxq 0
 
Assigned 
IC semiquinone Dox In_Doxsq 0 Assigned 
NADPH: (EU1-Res) NADPH 3.0   10
-5
  (Martinovich et al, 
2005) 
NADPH: (EU3-Sens) NADPH 5.4   10-5 Measured¥ 
NADP: (EU1-Res) NADP 3.0   10
-7 
(Schafer & Buettner, 
2001) 
NADP: (EU3-Res) NADP 5.4   10
-7 
(Schafer & Buettner, 
2001) 
Molecular Oxygen  O2 1.5   10
-9
 (James et al, 1998; 
Xu et al, 2005) 
Superoxide O2
- 
1.5   10-11 Assigned 




Measured = Fold change between the resistant and sensitive cell lines (as described in materials and 




Parameter Fitting  
Unknown parameters in the in vitro Dox activation model were fitted to in vitro 
experimental data generated by Kostrzewa-Nowak et al. (Kostrzewa-Nowak et al, 2005). 
The fitted parameter values for the in vitro model were then used, where applicable, in 
the in vivo Dox bioactivation model and additional parameter fits were made using 
experimental data generated from Dox-treated ALL cells.  
 
 
Table 4-4: Rate expressions and rate constants for the ODEs that comprise the in vitro 
Dox bioactivation models. 
 
Rxn No. Expression Parameter Reference 






in vitro model 
R2 k2 ([CPRox]) ([NADPH]) k2 = k1 in vitro model 













 (Koshkin et al, 1997) 




























in vitro model 
R7: 10 µM k7 ([Ex_Doxq]) (A)
£






R7: 100 nM k7 ([Ex_Doxq]) (A)
£




(Ghosn et al, 2008) 












R9 k8 ([NADP]) /( k9 + [NADP]) k9 = 5.7   10
-5






)   6.15   10-6 (cm2)   1   109 (cells/L) 
¥
Measured = Fold change between the resistant and sensitive cell lines (as determined by basal SOD and 
G6PD activity) multiplied by the parameter value for the resistant cell line.  
Ғ
The permeability constant for Dox permeation is non-constant for the duration of Dox treatment. See 




The parameter set of the in vitro model contains 6 kinetic parameters and 9 initial 
conditions. Three of the 6 kinetic parameters that make up the in vitro model were fitted 
to experimentally determined data sets (Table 4-2). In the fitting procedure, the 
experimental data provided by Kostrzewa-Nowak and colleagues describing the in vitro 
redox cycling and reductive conversion of Dox at varied concentrations of NADPH, Dox, 
cytochrome P450 reductase (CPR), and superoxide dismutase (SOD) (Kostrzewa-Nowak 
et al, 2005) were used. Because the model is comprised of a simple network with a 
relatively small number of parameters, parameter fitting was conducted by minimizing 













j tYtYU                                                                                 (4-1) 
 




j tY  represent the experimental and theoretical (model 
predicted) data, respectively, of Dox and NADPH (j = 1,2), at time points tk = 0, 2, 4, … , 
20 minutes (k = 1, 2, … , 11). As an initial approximation of the model parameters to be 
fitted, parameter values estimated from the literature for similar types of enzyme-
catalyzed reactions (Gray & Carmichael, 1992; Light et al, 1981) were used. For fitting 




j tY  were normalized to their maximal values. All the 
parameters used in the in vitro model are shown in Table 4-2.  
The catalysis of semiquinone Dox was modeled by a two-step process involving 
first the reduction of Dox by CPR followed by electron transfer by NADPH to oxidized 
CPR. The reaction rate of reduced CPR with quinone Dox (Reaction R1, Table 4-2) was 
fitted to the data describing the redox cycling of Dox (Kostrzewa-Nowak et al, 2005); the 
reaction rate for NADPH reacting with molecular oxygen (Reaction R4, Table 4-2) was 
fitted to experimental data showing the reductive conversion of Dox (Kostrzewa-Nowak 
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et al, 2005); the reaction rate for superoxide anion reacting with quinone Dox (Reaction 
R5, Table 4-2) was fitted to experimental data showing the SOD-induced redox cycling of 
Dox (Kostrzewa-Nowak et al, 2005). The cost function, U, was minimized independently 
for each fitted parameter because the data used in the fitting procedure were generated 
from three independent experiments with different sets of initial conditions (Kostrzewa-
Nowak et al, 2005). The initial conditions for the in vitro model were taken directly from 
the in vitro experiments describing redox cycling, reductive conversion, and SOD-
induced redox cycling of Dox (Kostrzewa-Nowak et al, 2005).   
The in vivo kinetic models of Dox bioactivation were based upon the fitted in 
vitro model of Dox bioactivation. The parameter set of the in vivo model contains 10 
kinetic parameters, six of which were either taken directly or estimated from the fitted in 
vitro model, and 10 initial conditions. Two of the 10 kinetic parameters that make up the 
in vivo model had to be fitted to experimentally determined data (Table 4-4). In the fitting 
procedure, 10 µM [Dox] NADPH depletion data for the EU1-Res cell line were used to 
fit 
8k , the parameter that describes the rate of NADPH supply by the G6PD enzyme, and 
10 µM [Dox] extracellular Dox depletion data for the EU1-Res cell line were used to fit 
k7, the parameter that describes the permeability coefficient of Dox. These parameter fits 
were conducted for the EU1-Res model only. To determine the fitted parameter value, the 















ktY  and  )(
)(
k
th tY  represent the experimental and theoretical (model 
predicted) data, respectively, of intracellular NADPH or extracellular Dox for the EU1-
Res cell line, at time points tk = 0, 10, …, 60 minutes (k = 1, …, 7). As an initial 
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approximation of the model parameter to be fitted, parameter values estimated from the 
literature were used (Adimora et al, 2010). For the fitting of parameter k8, )(
(exp)
ktY  and 
)()( k
th tY  were normalized to their maximal values to allow for the direct comparison of 
NADPH absorbance readings, generated experimentally using the spectrophotometer, and 
NADPH concentration values, generated in silico using the computational model. Most 
of the parameters fitted to the EU1-Res experimental data were used unaltered in the 
EU3-Sens in vivo model. However, to model experimentally determined enzymatic 
differences between the Dox-resistant EU1-Res cell line and the Dox-sensitive EU3-Sens 
cell line, the experimentally determined fold change values between the EU1-Res and 
EU3-Sens cell lines were utilized to estimate appropriate parameter values for the EU3-
Sens cell line in relation to the EU-Res cell line. This method was used to determine the 
EU3-Res cell line rate constants for NOX4-dependent superoxide generation (k4), SOD-
dependent superoxide elimination (k6), as well as G6PD-dependent NADPH reduction (
8k ). Tests of pharmacological interventions were conducted in silico using the fitted in 
vivo models of Dox bioactivation and assuming 20% inhibition of each target based on 
previously published data (Tian et al, 1998).  
 
Materials, cell culture and treatment conditions  
All reagents were from Sigma-Aldrich unless otherwise specified. Two ALL cell 
lines representing major phenotypes of childhood acute lymphoblastic leukemia (EU1-
Res and EU3-Sens) have been previously characterized (Zhou et al, 2003a; Zhou et al, 
1994). Human acute myelogenous leukemia (Arnelle & Stamler) cell lines exhibiting 
variable PgP expression and Dox resistance (8226/Pgp-, Dox6/Pgp+, and Dox40/PgP++) 
were donated by Dr. William Dalton, PhD, MD, of the Moffitt Cancer Center (Tampa, 
FL, USA) (Dalton et al, 1986). ALL and AML cell lines were cultured in RPM1-1640 
medium supplemented with 10% FBS and 100 U/ml of penicillin/streptomycin and 
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grown in a humidified atmosphere of 5% CO2 at 37°C. For all experiments, unless 
otherwise stated, ALL cells were resuspended in fresh media (1   106 cells/ml) and 
treated with various concentrations of Dox (Enzo Life Sciences, PA, USA), protected 
from light and incubated at 37°C. Phenol-red-free medium was comprised of phenol-red-
free RPMI-1640 medium supplemented with 10% FBS and 100 U/ml of 
penicillin/streptomycin.  
 
Cell viability and apoptosis 
ALL cells were treated with a range of Dox concentrations for various time 
periods. After treatment, cell viability was assayed with the cell proliferation reagent 
WST1 (Roche Applied Science) according to the manufacturer‟s protocol, using a 
Synergy 4 hybrid microplate reader (Biotek, Winooski, VT, USA).  
 
Dox accumulation 
ALL cells plated in 96-well plate format (1   106 cells/ml) were treated with Dox 
(10 µM or 100 nM) and protected from light at 37°C. Absorbance was read for 1 h, every 
10 min, using a Synergy 4 hybrid microplate reader (Absorbance = 480 nm). The 
absorbance readings of wells containing media and Dox without any cells, and wells 
containing cells and media without any Dox, were used as controls.  
 
Dox depletion 
After ALL cells were treated with 10 µM  Dox, phenol-red free media was 
removed and analyzed for Dox content using the Synergy 4 hybrid microplate reader 
(Absorbance = 480 nm). The absorption readings of media from wells containing media 
and Dox without any cells, and wells containing cells and media without any Dox, were 




DiOC2 dye efflux 
DiOC2 [3,3‟-Diethyloxacarbocyanine iodide] dye (Anaspec Inc.) efflux studies 
were conducted on ALL and AML cells. 12   106 ALL and AML cells were 
independently resuspended in 12 ml fresh ALL cell media and incubated for 2 h at 37°C 
in a humidified atmosphere. After incubation, cells were pelleted by centrifugation for 8 
min at 300 g. Supernatant was discarded and 12 ml of fresh media were used to 
resuspend the cells. 3 ml of the 12 ml were transferred to a new tube to serve as a 
negative control. To the remaining 9 ml, DiOC2 was added to a final concentration of 60 
ng/ml. All tubes were incubated for 30 min at 37°C in a water bath, gently agitating the 
tubes every 5 min to ensure adequate mixing. After 30 min incubation, cells were pelleted 
by centrifugation for 8 min at 300 g. Supernatant was discarded and cells were 
resuspended in fresh media (3 ml and 9 ml, respectively). The control tube was placed on 
ice immediately and the total volume in the other tube was divided into three equal parts 
and placed in three separate tubes. The first aliquot was placed on ice immediately; this 
was used for the baseline measurement of DiOC2 uptake. The cells in the remaining two 
tubes were pelleted and resuspended in 9 ml of fresh media and incubated for 90 min at 
37°C, to measure dye efflux. After 90 min, cells in all tubes were washed with cold PBS 
and then pelleted. Cell pellets were resuspended in fresh media (4°C) to a final cell 
concentration of 1   106 cells/ml. Propidium Iodide was added at a concentration of 1 
µg/ml to exclude dead cells. Intracellular dye content was then analyzed by flow 
cytometry (DiOC2: Ex = 488 nm, Em = 500 nm). 
 
NADPH Measurement 
ALL cells plated in 96-well plate format treated with Dox (10 µM or 100 nM) 
were protected from light at 37°C. Absorbance was read for 1 h, every 10 min, using a 
Synergy 4 hybrid microplate reader (Absorbance = 340 nm).  The absorption readings of 
wells containing media and Dox without any cells, and wells containing cells and media 
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without any Dox, were used as controls. In addition, the absorbance readings of wells 
containing media and peroxide without any cells, and wells containing media and 
peroxide with cells, were used as positive controls for NADPH depletion. 
 
Cellular fractionation and ER isolation 
Dox-treated and untreated cells were pelleted by centrifugation for 5 min at 300 
g. Cytoplasmic fractions were obtained by lysing in 2% NP-40 buffer containing 50 mM 
β-glycerophosphate, 10 mM NaPP, 30 mM NaF, 50 mM Tris-HCL, pH 7.5, 150 mM 
NaCl, 1 nM benzamidine, 2 nM EGTA, 100 µM sodium orthovanadate, 1 mM DTT, 10 
µg/ml aprotinin, 10 µg/ml leupeptin, 1 µg/ml pepstatin, 1 µg/ml microcystin-LR, and 1 
mM PMSF. Cells were lysed on ice for 1 h, followed by centrifugation for 10 min at 300 
g. For CPR activity analysis, endoplasmic reticulum (ER) isolation from Dox-treated 
and untreated cells was conducted using the ER isolation kit (Sigma-Aldrich) according 
to the manufacturer‟s protocol. 
 
Enzyme Activity Measurements 
Basal G6PD and CPR activities were determined in EU1-Res and EU3-Sens cells 
using the Glucose-6-Phosphate Dehydrogenase Assay Kit (BioVision, Mountain View, 
CA, USA), and the Cytochrome c Reductase (NADPH) Assay Kit (Sigma), respectively, 
according to the manufacturers‟ protocols. SOD activity was determined using the 
Superoxide Dismutase Activity Colorimetric Assay Kit according to the manufacturer‟s 
protocol (AbCam, MA, USA).  
 
qRT PCR Measurements 
RNA was isolated from cells using the RNeasy isolation kit with RNase-free 
DNase set according to the manufacturer‟s protocol. 1 g of RNA was used for reverse 
transcription. For detection of mRNA levels, a custom RT2 Profiler PCR Array was used, 
48 
 
according to the manufacturer‟s protocol.  The following PCR conditions were used: 10 
min at 95°C; 40 cycles of 1 minute at 60°C and 15 seconds at 95°C; melt curve with 
ramp from 60°C to 95°C. PCR reactions were run using the Applied Biosystems Step 
One Plus system. Results were normalized to the expression of -actin. Relative 
expression levels were calculated using the CT method (2
-CT
). All arrays were 
performed with triplicate sets of RNA isolation for each cell line for statistical analysis. 
 
Intracellular ROS determination  
For determination of Dox-induced O2
- 
formation, cells were plated at a density of 
1   106 cells/ml and pre-incubated with 50 µM Hydro-Cy5 dye (Kundu et al, 2009) 
resuspended in DMSO for 15 min. After pre-incubation, 10 µM Dox was added to 
respective wells and kinetic fluorescence readings were taking with the microplate reader 
every 10 min for 1 h (Ex = 635 nm, Em = 660 nm). Unstimulated cells, pre-incubated 
with and without Hydro-Cy5 dye, and phenol red-free media, pre-incubated with and 
without Hydro-Cy5 dye and Dox, respectively, were used as controls.  
 
Statistical Analysis 
All values reported are the average of three or more independent biological 
replicates +/- standard error. Statistical significance is based upon the criteria of p < 0.05 





A computational model describes in vitro Dox bioactivation 
To investigate the mechanisms that control Dox bioactivation, a kinetic 
mathematical model of the Dox bioactivation network in a cell free system was 
developed (Fig. 4-1). From here on, the term in vitro shall refer to acellular systems and 
the term in vivo shall refer to cellular systems. The in vitro model was used to reproduce 
previously published in vitro data generated by Kostrzewa-Nowak et al on the effect of 
NADPH concentration on Dox bioactivation (Kostrzewa-Nowak et al, 2005). In the 
model, the reaction of NADPH with molecular oxygen was allowed; however, it was 
assumed it to be non-enzymatic since NADPH oxidase was not present in the cell free 
reaction mixtures. The inclusion of the NADPH / O2 reaction in the bioactivation network 
model was particularly important because it provided a mechanistic pathway by which 
increased NADPH concentration could lead to enhanced Dox reductive conversion. 
Reductive conversion of Dox is characterized by conservative NADPH depletion and 
quinone Dox transformation, while redox cycling of Dox is characterized by rapid 
NADPH depletion and sustained quinone Dox. The in vitro model was capable not only 
of describing the switch in behavior between reductive conversion and redox cycling of 
Dox (Fig. 4-1 A, B) based upon the high and low NADPH concentrations, but it was also 
capable of replicating a new experimental condition: upon inclusion of SOD activity in 
the bioactivation network, the model demonstrated SOD-induced redox cycling of Dox at 











    
 
 
Figure 4-1. Three proposed mechanisms for in vitro Dox bioactivation. (A-C) 
Experimental data (Kostrzewa-Nowak et al, 2005) and model-fitted results for different 
Dox bioactivation pathways accompanied by a schematic representation of the 
hypothesized network underlying each pathway. The reaction of NADPH with O2 (k4) is 
a proposed reaction believed to be essential for the accurate description of NADPH-
dependent Dox bioactivation. Large fonts denote experimental conditions in which the 
[NADPH] was increased from 100 µM to 500 µM. 
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Dox sensitivities and bioactivation network components differ in EU1 and EU3 ALL cells 
The validated in vitro model of Dox bioactivation emphasizes the importance of 
the reaction between NADPH and molecular oxygen in the accurate representation of 
Dox bioactivation. Moreover, the model illustrates how the driving force of [NADPH] 
and levels of SOD can control the switching between reductive conversion and redox 
cycling. It was therefore hypothesized that the intrinsic differences in protein expression 
and redox state between leukemia cells could similarly give rise to shifts in control 
between these two processes, conferring differences in Dox cytotoxicity. In support of 
this hypothesis, others have observed that treatment of the HL60 human leukemia cell 
line with bioactivated Dox led to increased cytotoxic activity compared to treatment with 
nonactivated, or redox cycled, Dox (Kostrzewa-Nowak et al, 2005). These findings 
suggest that reductive conversion of Dox may be an important determinant of Dox 
toxicity in leukemia cells. To further investigate this possibility by computational 
modeling, the characterization of the Dox sensitivities of two ALL cell lines, EU1 (EU1-
Res) and EU3 (EU3-Sens), that were previously reported to have over a 10-fold 
difference in IC50 to Dox (Zhou et al, 2003a), was conducted. The EU1-Res line 
displayed limited toxicity to Dox treatment, retaining greater than 100% viability even 
after exposure to 10 µM Dox for 3 h, whereas the EU3-Sens cell line showed decreased 
viability after exposure to Dox at concentrations as low as 40 nM for the same treatment 
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Figure 4-2. Dox sensitivity and bioactivation network components differ in EU1 and 
EU3 ALL cells. (A) Scheme describing in vivo Dox bioactivation. (B) Cell viability for 
EU1-Res and EU3-Sens cells, determined by WST1 assay, after 3 h Dox treatment at 
varied concentrations. (C-D) Relative mRNA levels and enzyme activities of enzymes 











































































The cellular bioactivation network differs from the in vitro one by the inclusion of 
additional pertinent biochemical reactions (Fig. 4-2 A). The relative mRNA expression 
levels and activities of the enzymes involved in cytosolic Dox bioactivation were 
characterized (Fig. 4-2 C-D) for the two cell lines under investigation. G6PD enzymatic 
activity is the primary source for regenerating reduced NADPH in normal metabolism 
(Tome et al, 2006) and NADPH oxidases rely on oxygen and NADPH to produce 
superoxide. It has been previously reported that NOX activity is involved in Dox-induced 
cell death, implicating NOXs in the cellular Dox bioactivation network (Gilleron et al, 
2009). NOX4 is the NADPH oxidase isoform that controls constitutive superoxide 
production, whereas other isoforms are considered to be activated during signal 
transduction (Serrander et al, 2007). The EU1-Res cells contain significantly higher 
NOX4 mRNA levels and CPR activity, compared to the EU3-Sens cells (p < 0.05) (Fig. 
4-2 D). EU1-Res cells have significantly lower G6PD mRNA levels (Fig. 4-2 C) and 
activity (Fig. 4-2 D) (p < 0.05) compared to the EU3-Sens cells. There was no significant 
difference in the levels of SOD1 mRNA, or SOD1 activity, between the EU1-Res and 
EU3-Sens cells (Fig. 4-2 C, 4-2 D). There was a direct correlation between mRNA 
expression and enzyme activity for the enzymes under consideration.  
 
Cell line specific differences in Dox bioactivation for ALL cells  
To examine whether differences in mRNA expression levels and activities of Dox 
bioactivation enzymes would result in differences in Dox bioactivation between the EU1-
Res and EU3-Sens cell lines, intracellular Dox accumulation was measured in the ALL 
cells for 1 h during a 10 µM Dox treatment. The EU1-Res cells had significantly higher 
quinone Dox accumulation compared to the EU3-Sens cells, starting at 40 min of 
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Figure 4-3. Cell-line-dependence of Dox bioactivation. Experimentally-determined and 
model-predicted quinone Dox accumulation (A), Dox-induced NADPH depletion (B), 
and Dox-induced superoxide generation (C) in ALL cells treated with 10 µM Dox for 1 h 
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Figure 4-4. Dox transport is equivalent across ALL cell lines. (A) Dye efflux 
characterization for ALL and AML cell lines indicating that the Dox-resistant EU1 cells 
and the Dox-sensitive EU3 cells are not significantly different, regarding their PgP 
activities, from the PgP- AML cell line. (*p < 0.05). (B) Extracellular Dox depletion for 
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These results were not a function of differential Dox efflux/influx as both the 
EU1-Res and EU3-Sens cells displayed negligible PgP efflux activity, and the rate of 
Dox consumption from the cell medium was not significantly different between the cells 
(Fig. 4-4 A, Fig. 4-4 B).  Because NADPH depletion and superoxide production can be 
indicators for the extent of Dox reductive conversion that has taken place within a cell 
(Kostrzewa-Nowak et al, 2005), Dox-induced NADPH depletion and superoxide 
generation were monitored in both cell lines. NADPH depletion due to 10 µM Dox 
treatment was significantly lower in the EU3-Sens cells compared to the EU1-Res cells, 
starting as early as 10 min into the treatment regimen and continuing the trend for the 
duration of the treatment (p < 0.05) (Fig. 4-3 B). Dox-induced superoxide generation, 





al, 2009), was significantly higher in the EU3-Sens cells than in the EU1-Res cells 
starting 30 min into the treatment regimen and lasting for the remainder of the treatment 
duration (p < 0.05) (Fig. 4-3 C). 
Two in vivo models were generated for the EU1-Res and EU3-Sens cells based 
upon the network structure depicted in Figure 4-2 A (See Materials and Methods). The 
differences in quinone Dox accumulation (Fig. 4-3 A) and superoxide generation (Fig. 4-
3 C) between the EU1-Res and EU3-Sens cells were accurately captured by the kinetic 
model simulations. Although kinetic model simulations of Dox-induced NADPH 
depletion were able to reproduce the depletion trends seen in both the EU1-Res and the 
EU3-Sens cells, the magnitude of NADPH-depletion in both cell lines was slightly 
underestimated compared to experimental results (Fig. 4-3 B). Both experimental 
measurements and model simulations of Dox-induced intracellular Dox accumulation, 
NADPH depletion, and superoxide generation suggest that the extent of Dox reductive 
conversion in EU1-Res and EU3-Sens cells differ significantly. The EU1-Res cells 
exhibited higher quinone Dox accumulation, more NADPH depletion, and lower 
superoxide generation, which are all consistent with decreased reductive 
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conversion/increased redox cycling, as evidenced by the data generated by the validated 
in vitro model. Conversely, the EU3-Sens cells exhibited lower quinone Dox 
accumulation, lower Dox-induced NADPH depletion, and higher Dox-induced 
superoxide generation, which are consistent with the in vitro conditions that characterize 
increased Dox reductive conversion (Fig. 4-1 B, Fig. 4-3 A-C). These results suggest an 
intrinsic mechanistic switch between redox cycling and reductive conversion that takes 
place in the EU1-Res and EU3-Sens cells, one that is a function of cell-specific levels of 
intracellular Dox bioactivation components. 
 
Concentration-dependence of Dox bioactivation in ALL cells  
Because the apparent switch between redox cycling and reductive conversion 
appeared to be driven by different catalytic rates within the drug metabolism network, the 
question was asked as to whether the concentration of Dox would affect the behavior of 
the coupled redox reactions. To examine whether differences in the Dox concentration 
applied to the cells could alter the Dox bioactivation profile of the EU1-Res and EU3-
Sens cells, intracellular Dox accumulation, Dox-induced NADPH depletion and Dox-
induced superoxide generation were again analyzed in the ALL cells for 1 h during a 100 
nM Dox treatment regimen. The 100 nM Dox concentration represents a 100-fold change 
in Dox concentration compared to the 10 µM Dox treatment regimen that had been 
previously administered to the cells. Experimental results show that the overall shape of 
the quinone Dox accumulation curve for both ALL cells at the 100 nM Dox treatment 
level was significantly different that that seen for the 10 µM level. At the 10 µM Dox 
treatment level, there was a steady increase in the accumulation of quinone Dox in both 
cell lines as a function of time, although the rate of increase was higher in the EU1-Res 
cells than the EU3-Sens cells (Fig. 4-3 A). Conversely, at the 100 nM Dox treatment 
level, there was a rapid increase in quinone Dox accumulation at 10 min, but this increase 
was followed by a sharp decrease in intracellular quinone Dox which then appeared to 
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equilibrate to a steady state level that was maintained for the rest of the treatment 
duration (Fig. 4-5 A). Additionally, for the 100 nM Dox treatment regimen, the 
intracellular quinone Dox levels in the EU1-Res cells were significantly lower than those 
seen in the EU3-Sens cells (p < 0.05) (Fig. 4-5 A), representing a complete switch in 
behavior compared to that seen at the 10 µM Dox treatment level (Fig. 4-3 A). Without 
additional parameter fitting, the kinetic simulation of the low Dox treatment condition 
was able to capture the decreased amounts of quinone Dox observed in the EU1-Res 
cells, compared to the EU3-Sens cells, as well as the general shape of the intracellular 
quinone Dox accumulation curve (Fig. 4-5 A), providing further validation of the quality 
of the cell-line specific models for explaining the complex responses that were observed 
experimentally. 
The Dox-induced NADPH depletion in the EU1-Res cells was not significantly 
different from that seen in the EU3-Sens cells (Fig. 4-5 B). While model simulations 
accurately predicted similar NADPH depletion trends between EU1-Res and EU3-Sens 
cells, the underestimation of NADPH depletion in the model simulations was still 
apparent at the 100 nM Dox concentration condition (Fig. 4-5 B). Differences in Dox-
induced superoxide generation between the EU1-Res and EU3-Sens cells were negligible 
(Fig. 4-5 C) and kinetic model simulations of Dox-induced superoxide generation 
accurately captured this behavior. The lack of sustained accumulation of quinone Dox in 
both the EU1-Res and EU3-Sens cells, paired with the experimentally determined 
NADPH depletion and superoxide generation profiles at the 100 nM Dox treatment 
condition, suggest that both the EU1 and EU3 cells undergo a shift in the control of their 
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Figure 4-5. Concentration-dependence of Dox bioactivation in ALL cells. 
Experimentally-determined and model-predicted quinone Dox accumulation (A), Dox-
induced NADPH depletion (B), and Dox-induced superoxide generation (C) in ALL cells 
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Model-generated hypotheses of altered NADPH and quinone Dox dynamics are 
confirmed by pharmacological intervention in drug-sensitive cells 
Concentration-dependent differences in Dox bioactivation exist between the EU1-
Res and the EU3-Sens cells (Fig. 4-3, Fig. 4-5). Based on these differences, it was 
hypothesized that successful intervention strategies for altering the behavior of the Dox 
bioactivation network within ALL cells would be Dox concentration-dependent. To test 
this hypothesis in the EU3-Sens cell line, a series of pharmacological intervention 
strategies was carried out, for both the 10 µM and the 100 nM Dox concentration 
condition; these strategies were aimed at decreasing the amount of Dox reductive 
conversion that occurs within the EU3-Sens cells. The capacity for NADPH regeneration 
(k8/k9) was adjusted using the pharmacological G6PD inhibitor, DHEA. NADPH 
regeneration was modified because NADPH is involved in the CPR- and oxygen-
dependent enzymatic reactions that play a role in reductive conversion and redox cycling 
of Dox, respectively (Fig 4-2). Furthermore, simulations of G6PD inhibition on Dox 
bioactivation in EU3-Sens cells for the 10 µM Dox concentration condition predicted an 
appreciably increased accumulation of quinone Dox and an increased depletion of 
NADPH over one hour (Fig. 4-6 A, B). These processes are indicative of increased redox 
cycling of Dox, at the expense of Dox reductive conversion, and are similar to the 
dynamics that occur in the Dox-resistant EU1-Res cells (Fig. 4-3 A). Model predictions 
were confirmed through pharmacological modification of G6PD activity by the G6PD 
inhibitor, DHEA, for the 10 µM Dox concentration condition (Fig. 4-6 A, B). 
Next, we utilized the kinetic model to simulate the effect of G6PD inhibition on 
Dox reductive conversion in EU3-Sens cells for the 100 nM Dox concentration condition. 
The model predicted that inhibition of G6PD activity in the EU3-Sens cells would have 
no effect on the accumulation of quinone Dox or the depletion of NADPH over one hour 
(Fig. 4-6 A, B). The in silico model predictions of the behavior of the Dox bioactivation 
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network after pharmacological intervention at the 100 nM Dox concentration condition 
were also confirmed (Fig. 4-6 A, B).  
 
 















































































































Figure 4-6. Effects of pharmacological intervention on Dox reductive conversion in 
EU3-Sens cells. (A) Model-predicted and experimentally determined quinone Dox 
accumulation in EU3-Sens cells, with and without DHEA intervention, at the 10 µM and 
100 nM Dox concentration conditions. (B) Model-predicted and experimentally 
determined NADPH depletion in EU3-Sens cells, with and without DHEA intervention, 





NADPH supply alters viability of Dox-treated ALL cells by controlling semiquinone Dox 
formation and superoxide generation in a Dox concentration-dependent manner.  
To further explore the concentration-dependent effects of DHEA treatment on 
Dox bioactivation, the cellular network models of Dox bioactivation were used to 
quantify the fluxes of semiquinone Dox formation and superoxide generation in both the 
EU1-Res and EU3-Sens cells with and without DHEA treatment. Analyses indicate that 
inhibition of NADPH production by G6PD at 10 M Dox concentration leads to a 
decrease in the formation of semiquinone Dox in both the EU1-Res and EU3-Sens cells 
(Fig. 4-7 A), but has no effect on the accumulation of semiquinone Dox in either cell line 
at the 100 nM Dox condition. Because DHEA will indirectly impact the NADPH-
dependent NOX4 by substrate limitations, we also analyzed superoxide fluxes. The 
models demonstrate that DHEA decreases O2
- 
production in all conditions and cell lines 




To relate the model findings to experimentally determined changes in cell 
viability, we analyzed both EU1-Res and EU3-Sens cell survival for the different Dox 
treatment conditions using a WST1 cell viability assay. Corresponding to our model 
simulated predictions of quinone Dox accumulation (Fig. 4-6 A), NADPH depletion (Fig. 
4-6 B) and semiquinone Dox flux (Fig. 4-7 A), we observed that DHEA was able to 
rescue EU3-Sens cells from Dox-induced cytotoxicity at the 10 µM Dox concentration 
condition. Conversely, we found that DHEA treatment at the 10 µM Dox concentration 
condition significantly decreased cell viability of the EU1-Res cells (p < 0.05) (Fig. 4-7 
C). At the low Dox concentration condition, DHEA treatment still enhanced Dox toxicity 
in the EU1-Res cells (Fig. 4-7 C), to a similar degree. However, in the EU3-Sens cells, 
DHEA treatment at the 10 µM Dox concentration condition enhanced Dox toxicity (Fig. 









































































































































Figure 4-7. NADPH supply alters Dox sensitivity in ALL cells in a concentration- 
and cell-dependent manner. (A) in silico model predictions of NADPH-dependent 
semiquinone Dox flux in ALL cells, with and without DHEA intervention, at the 10 µM 
and 100 nM Dox concentration conditions. (B) in silico model predictions of NADPH-
dependent superoxide flux in ALL cells, with and without DHEA intervention, at the 10 
µM and 100 nM Dox concentration conditions. (C) Experimentally determined (WST1 
assay) cell viability for ALL cells after 3 h Dox treatment, at the 10 µM and 100 nM Dox 




 Although the anthracycline drug Dox is used clinically for the treatment of 
leukemias and solid tumors (Berlin & Haseltine, 1981; Gilleron et al, 2009; Kostrzewa-
Nowak et al, 2005), the efficacy of Dox treatment is limited by the development of drug 
resistance (Akman et al, 1990; Doroshow et al, 1991; Sinha et al, 1989b). Evidence 
points to the reductive conversion of Dox as an important „first step‟ in the regulation of 
Dox toxicity (Akman et al, 1990; Gilleron et al, 2009; Kostrzewa-Nowak et al, 2005; 
Sinha & Chignell, 1979; Sinha et al, 1989b). While the Dox bioactivation network has 
been studied extensively, with the overall network structure for cytosolic Dox 
bioactivation having been deciphered and believed to be conserved across different cell 
types (Bachur et al, 1979; Cummings et al, 1992; Sinha et al, 1989b), the adaptation of 
the bioactivation network to changes in the levels of system components or changes in 
Dox concentration is much less well understood. This study illustrated the dynamic 
nature of the Dox bioactivation network and revealed the sensitivity of the Dox 
bioactivation network to network component levels and Dox concentrations. This study 
illustrated how the intracellular Dox bioactivation network is capable of executing 
multiple modes of Dox metabolism; the network contains toxicity-generating and ROS-
generating reactions that control Dox metabolism via reductive conversion or redox 
cycling. Finally, this study illustrated how the reactions that comprise the Dox 
bioactivation network can be modulated by pharmacological intervention strategies to 
either enhance or hinder Dox toxicity in a concentration-dependent manner.  
Validation of an in vitro Dox bioactivation model suggested that the reaction of 
molecular oxygen with NADPH is a necessary and significant component of the overall 
Dox bioactivation network. By analyzing the in vitro Dox bioactivation network under 
the distinctively different conditions described by Kostrezewa-Nowak et al (Kostrzewa-
Nowak et al, 2005), three distinct pathways of Dox metabolic conversion were revealed: 
66 
 
CPR-independent redox cycling, CPR-dependent redox cycling, and reductive 
conversion.  
The CPR-independent redox cycling of quinone Dox is the first method by which 
Dox can be metabolically altered (Fig. 4-1 A). This form of redox cycling of Dox 
dominates when NADPH is limited. The in vitro system has no way of recycling oxidized 
NADPH once it has reacted with oxidized CPR; the result of this limitation is that when 
reduced NADPH has been fully consumed, the reduction of quinone Dox by CPR can no 
longer take place. At this point, the only reactions that can occur are the oxygen-
dependent redox cycling reactions of Dox (k3 / k5), which result in a zero net 
transformation of the quinone Dox molecule and the generation of superoxide.   
The second Dox metabolic pathway to consider is the CPR-dependent redox 
cycling of Dox. CPR-dependent redox cycling of Dox is very similar to CPR-independent 
redox cycling of Dox in that there is a zero net transformation of quinone Dox into its 
semiquinone form (Fig. 4-1 C). However, whereas CPR-independent redox cycling takes 
place at low [NADPH] conditions, CPR-dependent redox cycling takes place when high 
concentrations of NADPH and molecular oxygen are present simultaneously. When these 
two conditions are met, the rapid reduction of quinone Dox via CPR occurs, maintained 
by the high levels of NADPH in the system; the rapid reoxidation of semiquinone Dox by 
molecular oxygen also occurs, maintained by the SOD-dependent regeneration of 
molecular oxygen.  The analogous in vivo scenario was observed in both the EU1-Res 
and EU3-Sens cells at the low Dox concentration condition (Fig. 4-5 A-C). The NADPH 
fraction for both cell lines was maintained at a nearly constant level due to the non-
enzymatic reactions defined by k3 / k5. Superoxide is produced as a byproduct to a 
significant degree for a 100-fold lower Dox treatment due to CPR-dependent redox 
cycling.  
The third and final Dox metabolic pathway to consider is the reductive conversion 
of Dox. When the flux of Dox semiquinone production exceeds the flux of Dox 
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semiquinone consumption, there is a net transformation of quinone Dox into its 
semiquinone form (Fig. 4-1 B). Dox reductive conversion dominates at the in vitro high 
[NADPH] condition because there is enough NADPH to support the CPR-mediated 
reduction of quinone Dox, forcing Dox semiquinone production to overwhelm Dox 
semiquinone consumption by molecular oxygen. Furthermore, the increased NADPH 
level diminishes oxygen-dependent semiquinone Dox consumption (k5) because NADPH 
effectively competes with semiquinone Dox for molecular oxygen. The dominance of 
reductive conversion, in vivo, was observed with the EU3-Sens cells during the 10 µM 
Dox treatment regimen (Fig. 4-3 A). This behavior occurred because as the EU3-Sens 
cells have an increased capacity to reduce oxidized NADPH, evidenced by their higher 
G6PD mRNA and activity levels, they can drive a stronger flux through CPR than their 








Figure 4-8. Proposed model of Dox metabolism in ALL cells that emphasizes the 
toxicity-generating and signal-generating modules that comprise the network. The 
toxicity-generating module is NADPH-limited at the high Dox condition, allowing 
DHEA administration to decrease NADPH-dependent semiquinone Dox formation. The 
signal-generating module is NADPH-limited at the low Dox condition, allowing DHEA 
administration to decrease NADPH-dependent superoxide formation. (DHEA = 10 µM, 
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After investigating the NADPH-dependent Dox semiquinone and superoxide 
fluxes that occur during Dox treatment of EU1-Res and EU3-Sens cells, at both the high 
and the low Dox concentration conditions, and comparing these model generated fluxes 
to experimental viability studies (Fig. 4-7 C), it was concluded that the Dox bioactivation 
network is comprised of a toxicity-generating module and a ROS-generating module that 
likely is implicated in additional signaling (Fig. 4-8). The models suggest that at different 
Dox concentrations, certain components become limiting in either the toxicity-generating 
module or the ROS-generating module, and these limiting components effectively 
determine the extent of Dox toxicity that a cell will experience.   
Prior in vitro biochemical studies have established a minimal concentration of 
NADPH that is required to promote the reductive conversion of Dox in vitro (Kostrzewa-
Nowak et al, 2005). Here it is proposed that a cell-specific set-point of intracellular 
NADPH availability exists, controlled in part by G6PD activity, above which the 
modulation of NADPH concentration will have little effect on the ROS-generating 
module of Dox bioactivation within a particular cell. At the high Dox concentration 
condition, DHEA promoted decreased superoxide flux in the EU1-Res cells, whereas it 
had little effect on the EU3-Sens cells (Fig. 4-7 B). This is most likely due to the fact that 
the basal level of NADPH in the EU1-Res cell is already below the threshold level at 
which the ROS-generating module of Dox bioactivation can be affected by changes in 
G6PD activity. It was shown experimentally that the basal level of NADPH in the EU1-
Res cell is significantly lower than that of the EU3-Sens cell (Fig. 4-9) making it more 
susceptible to the effects of DHEA at the high Dox concentration condition, as evidenced 
by the strong effect of DHEA on cell viability (Fig. 4-7 C). The inhibition of G6PD 
activity by DHEA at the high Dox concentration condition was able to rescue EU3-Sens 
cells from Dox induced toxicity because it selectively hindered CPR-dependent Dox 
reductive conversion (Fig. 4-7 A-C) without affecting the ROS-generating module of 
70 
 
Dox bioactivation; the threshold of NADPH below which the ROS-generating module 
becomes compromised had not yet been reached in the EU3-Sens cells.  
Inhibition of G6PD at the low Dox concentration condition did not rescue any of 
the ALL cells from Dox toxicity, but rather promoted Dox-induced cell death. Because 
Dox has been shown to activate NOXs in vivo (Gilleron et al, 2009), NOX activity can be 
thought of as being dependent on [NADPH], [O2], and [Dox]. Therefore, at the low Dox 
concentration, compared to the high Dox concentration, more NADPH is needed to 
maintain the same level of NOX activity; this effectively lowers the NADPH threshold of 
the signal generating module. The NOX reaction becomes more sensitive to [NADPH] at 
the low Dox condition and DHEA can effectively decrease NOX-induced superoxide flux 
for both cell lines (Fig. 4-7 C). Inspection of the trends between the model fluxes (Fig. 4-
7 A-B) and the resultant cytotoxicity (Fig. 4-7 C) suggests that perturbation of the 
bioactivation network by DHEA affects the CPR-driven reductive conversion component 
(red module, Fig. 4-8) at 10 M Dox and the ROS-producing redox cycling component 






Figure 4-9. Basal NADPH levels are significantly different between the EU1 and 
EU3 cells. Relative basal intracellular [NADPH] in Dox-resistant EU1 and Dox-sensitive 
EU3 cells determined by absorbance readings. (340 nm; *p < 0.05) 
 
 
It has already been shown in the literature that Dox reductive conversion increases 
Dox toxicity in cancer cells (Bartoszek & Wolf, 1992; Kostrzewa-Nowak et al, 2005a) 
and our findings corroborate this understanding. When we related our experimental 
viability studies with our model-simulated flux analyses for the EU1-Res and EU3-Sens 
cells, a distinct pattern emerged: conditions that hindered the toxicity-generating module 
of Dox bioactivation decreased Dox-sensitivity, while conditions that hindered the ROS-
generating module of Dox bioactivation increased Dox-sensitivity. Moreover, cell-
specific levels of NADPH, and to some extent the cell-specific activities of G6PD, 
determined the ultimate effect of G6PD pharmaceutical perturbation on cell viability at 
each Dox condition investigated. Therefore, during Dox treatment, one can assume that 
both the toxicity- and the ROS-generating modules of Dox bioactivation are functioning 
within a given cancer cell. It is the relative dominance of either the toxicity- or the ROS-
generating modules of Dox bioactivation that will ultimately determine cell sensitivity to 
Dox treatment. A systemic approach to understanding how variability in enzyme activity 
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and concentration control both the toxicity- and the ROS-generating modules of the Dox 
bioactivation network may provide more efficacious strategies for cancer chemotherapy.  
This study showed that by limiting the influence of the ROS-generating module of 
Dox bioactivation, one can effectively promote Dox-induced toxicity in a Dox-resistant 
cell line (Fig. 4-7). Based on these results, it is possible that Dox-induced NOX-
dependent ROS generation in the ALL lines serves as a second messenger for 
downstream signaling pathways that contribute to cell viability. The idea of ROS 
modulating cell viability is not unprecedented as several intracellular signaling pathways 
are known to be redox sensitive, the most notable being the NF-κB pathway (Oliveira-
Marques et al, 2009). The transcription factor NF-B itself is a redox-sensitive protein 
(Liao et al, 2010; Loukili et al, 2010; Maioli et al, 2009) known to potentiate cell survival 
during chemotherapy treatment (Annunziata et al, 2010; Ban et al, 2010; Jani et al, 2010; 
Pham et al, 2010). Thus, the resulting effect of ROS generation on cell viability most 
likely involves other downstream signaling pathways.  
This study has revealed the concentration-dependence of Dox bioactivation that 
exists in leukemia cells. The study proposes that oxygen-dependent, ROS-generating 
reactions have greater influence over Dox toxicity at low Dox concentrations. If this 
concentration-dependence is exhibited by a variety of other transformed or non-
transformed cells, it could help explain the conflicting evidence in the literature regarding 
the importance of different enzymatic systems in conferring Dox sensitivity (Akman et 
al, 1990; Bartoszek & Wolf, 1992; Berggren et al, 2001; Doroshow et al, 1991; Kim et al, 
2001; Ramji et al, 2003; Sinha et al, 1989b). Work conducted by Asmis et al seems to 
support the universality of these findings. They observed in macrophages that at low Dox 
concentrations (0 – 2 µM) there is a concentration-dependent decrease in the ratio of 
GSH/GSSG, a marker of increased oxidative stress; however, when Dox concentrations 
were increased from 2 µM to 5 µM, the GSH/GSSG ratio was recovered (Asmis et al, 
2005). This finding appears to be in line with the proposed theory that at low Dox 
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concentrations, the ROS-generating module of Dox bioactivation is more significant than 
it is at high Dox concentrations, where it gives way to the toxicity-generating module. 
The ROS-generating module, however, may also be capable of promoting cell injury in 
some cell lines. In the same study, Asmis reports, that Dox-induced ROS modified 
glutathione-dependent thiol oxidation in macrophage cells to promote increased cell 
injury, implicating the glutathione antioxidant system in the management of Dox-induced 
cell injury (Asmis et al, 2005). This result suggests that cell-specific antioxidant capacity 
may ultimately determine whether Dox-induced ROS promotes cell viability, by 
modifying signaling pathways, or whether it promotes cell death, by inducing cellular 
damage via a thiol oxidation-based mechanism.  
The two cell-line specific models of Dox bioactivation have demonstrated 
predictive power and have recapitulated the dynamics of the Dox bioactivation network 
for multiple conditions. The model behavior, however, falls short in explaining the 
delayed onset of O2
-
 or the initial drop in NADPH upon Dox treatment. One reason for 
this model limitation could be our description of the NADPH-dependent NOX4 
enzymatic reaction that utilizes NADPH and molecular oxygen to produce superoxide. 
The reaction of NADPH with molecular oxygen, as a result of NOX4 activity, was 
modeled as a function of the concentrations of NADPH, molecular oxygen, and 
intracellular quinone Dox because it has been shown previously in the literature that Dox 
treatment promotes intracellular NOX activity in other cell types (Gilleron et al, 2009). 
Although the cell-specific ALL computational models incorporated the Dox-dependence 
of NOX activity, the lack of knowledge on the exact mechanism by which this 
dependence is executed introduces some uncertainty into the mathematical formulation 
that was utilized to describe the reaction. However, it should be noted that the 
computational modeling analyses do support the idea that without Dox-dependent NOX 
activation both the in vitro and the in vivo descriptions of Dox bioactivation were limited 
in their ability to recapitulate experimental results. Perhaps, testing the effect of time 
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delays in various processes involved in the Dox bioactivation network would reveal 
additional aspects of kinetic regulation that could increase the robustness of the model.   
An additional limitation of the in vivo models is that they are incomplete in scope 
and complexity. There are multiple mechanisms for anthracycline bioactivation in 
mammalian cells: the mitochondria-dependent bioactivation of Dox by mitochondrial 
complex I and NADH (Davies & Doroshow, 1986; Doroshow & Davies, 1986), and the 
mitochondria-independent mechanisms of Dox bioactivation by CPR and NADPH 
(Bartoszek, 2002). Some studies have even placed the cytotoxic action of Dox in the 
nuclear compartment of mammalian cells (Egorin et al, 1974). As it currently stands, the 
cell-specific models of Dox bioactivation only consider cytosolic Dox bioactivation, and 
are therefore inherently limited. Additionally, the in vivo Dox bioactivation network 
includes species that are involved in a variety of other intracellular reactions which are 
independent of Dox bioactivation, such as NADPH. NADPH is a metabolite that is used 
ubiquitously in cells for a variety of redox dependent reactions (Adimora et al, 2010). 
Moreover, NADPH-dependent thiol oxidation-based mechanisms may actually contribute 
to Dox-induced cell injury in some cells (Asmis et al, 2005), thereby providing a link 
between intracellular thiol-disulfide status and Dox-induced toxicity; a link that was 
unaccounted for by the model because of the qualitative nature of the findings.  
In summary, examining the cytosolic Dox bioactivation pathway from a systems 
biology perspective has provided insight into the redox-dependent mechanisms that may 
be responsible for conferring Dox sensitivity in cancer cells. Kinetic modeling of the 
electron transfer mechanisms demonstrates that the Dox bioactivation pathway is dual 
natured and dynamic, exhibiting sensitivity to initial levels of system components, as 
defined by cell specific enzyme levels, as well as Dox concentration conditions. This 
study has shown, through mathematical modeling and experimental analysis, that the 
toxicity-generating module of Dox bioactivation overwhelms the ROS-generating module 
in the EU3-Sens cell line, whereas the ROS-generating module of Dox bioactivation 
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overwhelms the toxicity-generating module in the EU1-Res cell line. This discrepancy in 
Dox metabolism between the EU1-Res and EU3-Sens cells determines the effectiveness 
of pharmacological intervention strategies that are aimed at modifying Dox induced 
toxicity. The model elucidates an important role for NAPDH supply, as modulated by 
G6PD activity, in controlling concentration-dependent Dox cytotoxicity in tumor cells. 
This work demonstrated the feasibility of enhancing Dox cytotoxicity via the 
pharmacological modification of G6PD activity in both the EU1-Res and EU3-Sens 
leukemia cell lines. Moreover, the work has demonstrated how this same intervention 
strategy can be used in concert with a high dose of Dox, or within a cell containing 
protein expression levels that promote reductive conversion, to promote cell viability 
rather than impede it. The dynamic nature of the Dox bioactivation network, and its 
ability to metabolize Dox via distinctively different modes, allows for the controlled 
manipulation of the system to either promote cell viability, as would be desired when 
protecting non-transformed cells from unwanted Dox toxicity, or to promote Dox-
induced transformed-cell death. Finally, because the quinone structure of Dox is 
conserved across the anthracycline drug family, future studies may elucidate similar 





KINETIC MODEL OF HYDROGEN PEROXIDE CLEARANCE 
Introduction 
 An accumulation of reactive oxygen species within the cell can lead to oxidative 
stress, resulting in changes in the redox state of many proteins (Watson & Jones, 2003). 
Although cellular processes such as growth, proliferation and apoptosis are controlled by 
the overall redox state of the cell (Schafer & Buettner, 2001), high levels of ROS can be 
toxic (Liu et al, 2005; Seaver & Imlay, 2001). The oxidant hydrogen peroxide (H2O2) is 
of great interest to researchers because it is continuously produced as a result of cellular 
metabolism, diffuses across cellular membranes, has a longer half-life than other 
oxidative species, and reversibly oxidizes protein thiols (Antunes & Cadenas, 2000; 
D'Autreaux & Toledano, 2007; Liu et al, 2005). 
The apparent paradox between the role of H2O2 as a cellular signaling molecule and 
its role as a cellular toxin appears to be highly dependent on its intracellular 
concentration, and the resolution of several key questions regarding how mammalian 
cells handle peroxide levels will facilitate our understanding of this paradox: Which 
antioxidant mechanisms exert the most control over the removal of hydrogen peroxide 
from the cell, and how could this be impacted by intervention? How independent are the 
redox couples from one another during oxidative stress? What role does the global 
protein thiol pool play in antioxidant defense? In order to accurately address these 
questions, quantitative computational modeling that integrates the known mechanisms by 
which mammalian cells control intracellular H2O2 accumulation during periods of 
oxidative stress is necessary.  
 
*
Modified from Adimora NJ, Jones DP, Kemp ML “A model of redox kinetics implicates thiol proteome in 




This form of analysis addresses whether current knowledge can quantitatively account for 
observed cellular behavior. Ultimately, modeling can provide additional insight regarding 
the discrimination of the physiological function of H2O2 from its pathological role.  
Researchers have a general understanding of the key players involved in a cell‟s 
ability to maintain its intracellular redox state and most models of H2O2 depletion can 
accurately describe one or two aspects of this system (Antunes & Cadenas, 2000; Makino 
et al, 2004; Sasaki et al, 1998; Seaver & Imlay, 2001). A previous mathematical model 
developed by Antunes and Cadenas (Antunes & Cadenas, 2000), for example, offered 
great insight into the enzymatic contributions of glutathione peroxidase (GPx) and 
catalase to the development of peroxide gradients across cellular membranes. Antunes‟ 
model provided a new quantitative estimate for the H2O2 membrane permeability 
coefficient, one that was an order of magnitude smaller than what was cited in the 
literature (Makino et al, 2004; Seaver & Imlay, 2001). Although Antunes‟ model 
provided novel findings, the model did not consider the enzymatic contribution of 
peroxiredoxins and the non-enzymatic contributions of protein thiols. Since the 
publication of Antunes‟ model, multiple studies have revealed that the previously 
accepted reaction rate of peroxiredoxin with H2O2 grossly underestimated its true value 
(Manta et al, 2009; Peskin et al, 2007). Increased rates of H2O2 consumption, therefore, 
may suggest a H2O2 permeability coefficient that is even smaller than that predicted by 
Antunes and coworkers. As researchers gain a more thorough understanding of the 
different components that play a role in intracellular H2O2 consumption, the accepted 
kinetic reactions rates of particular species with H2O2 will have to be amended. 
Over the past few years, knowledge of the varied intracellular antioxidant systems has 
increased and the need for a comprehensive model that incorporates these new findings is 
evident. The highly complex nature of the system in question, which results from the 
interconnectivity between protein thiol oxidation and redox couples during transient 
oxidative stress, has made development of integrative models difficult. For instance, the 
78 
 
anti-oxidative roles of glutathione peroxidase (GPx) and peroxiredoxins (Prx) depend 
directly on the reducing capacities of their respective co-substrate molecules, glutathione 
(GSH) and thioredoxin (Trx). In order to maintain their reducing capacities, GSH and Trx 
depend on the enzymes glutathione reductase (GR) and thioredoxin reductase (TR), 
respectively, in addition to NADPH. Moreover, the co-dependence of both the GSH and 
Trx thiol/disulfide redox couples on NADPH regeneration does not readily explain their 
maintenance at dissimilar non-equilibrium redox potentials (Jones et al, 2004; Kemp et 
al, 2008). 
In this study, a network model of the major redox reactions and cellular thiol 
modifications involved in H2O2 metabolism is generated in order to improve 
understanding of the processes by which a cell deals with H2O2-induced oxidative stress. 
At this point, the use of the term “buffering” as it applies to the redox systems that are 
described will be clarified. Here, the term buffering is not used to describe a system at 
equilibrium; rather, it is used to describe the process by which the intracellular redox 
network, as a whole, protects against deviations in the redox states of the individual 
components that make up the network. This model, therefore, takes into account not only 
the key components of the network, but also the hierarchical interdependence of each 
component on the other. It builds in scope upon prior modeling studies (Antunes & 
Cadenas, 2000; Makino et al, 2004; Sasaki et al, 1998; Seaver & Imlay, 2001) to explore 
the collective features of an intact redox system by accounting for all the major enzymes 
known to consume hydrogen peroxide in the cytosol as well as the pseudo-enzymatic 
oxidative turnover of protein thiols. The use of computational modeling to study peroxide 





Materials and Methods 
Overview of model structure 
A computational model, based upon ordinary differential equations, was 
developed using mass action and Michaelis-Menten kinetics to describe the changes in 
concentration of cellular redox-buffering components upon exposure to extracellular 
H2O2. Figure 5-1 is an illustration of the reactions included in the model. Organellar 
compartmentation provides additional regulatory control in redox mechanisms by 
maintenance of non-equilibrium redox potentials (Hansen et al, 2006); this model was 
simplified in description to the extracellular medium, intracellular cytosol and the 
peroxisomes. Intracellular generation of hydrogen peroxide by the mitochondria was 
described by a zero-order production term, and the more rapid oxidation rate of Trx2 
(Hansen et al, 2006) was excluded from the model.   
In this model, the anti-oxidative capacity of the cell is divided into several 
branches, with each branch describing a particular mode of H2O2 elimination. The first 
branch describes H2O2 elimination by the catalase enzyme. An average of 2 peroxisomes 
per cell has been measured in Jurkat cells (Ishizuka et al, 2004) and all the catalase 
activity within the cell is assumed to occur inside the peroxisomes.  
The second branch of H2O2 elimination describes the glutathione peroxidase 
enzymes (GPx). While multiple GPx isozymes are present in cells, and some glutathione 
S-transferases have GPx activity, a reliable value for the cytosolic concentration of GPx 
in Jurkat cells is unknown (Antunes & Cadenas, 2000). For the purpose of modeling this 
system, this description was simplified by considering the predominant glutathione 
peroxidase, GPx1, and implementing the literature-reported estimate of its intracellular 
concentration as predicted by a previous generalized mathematical model (Ng et al, 
2007). GPx catalyzes the reaction of hydrogen peroxide with GSH to produce glutathione 
disulfide (GSSG). Glutathione disulfide is subsequently reduced through the actions of 
GR and NADPH (Antunes & Cadenas, 2000; Makino et al, 2004).   
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The third branch of H2O2 elimination accounts for the peroxiredoxin (Prx) 
enzymes in conjunction with Trx, TR, and NADPH. Mammalian cells have several 
members of the peroxiredoxin family but the predominant mammalian cytoplasmic Prxs 
are peroxiredoxin 1 and 2 (Moore et al, 1991; Peskin et al, 2007); the combined 
contribution of these two isoforms are described in the model. The total concentration of 
cytosolic Prx in Jurkat cells was estimated from the literature (Chae et al, 1999; Moore et 
al, 1991). The total concentrations of reduced and oxidized NADPH were estimated from 
values reported in the literature (Martinovich et al, 2005; Schafer & Buettner, 2001). 
Cytosolic Trx1, at a concentration of 0.5 µM (Watson et al, 2004), was distributed 
between its reduced and oxidized forms as experimentally determined for this study by 
redox western blot.  
The fourth branch of H2O2 elimination involved the oxidation of cysteine residues 
of intracellular proteins (Pr-SH/Pr-(SH)2). Cysteine (Cys) residues of intracellular 
proteins contain redox-sensitive thiols that are susceptible to oxidation (Watson & Jones, 
2003). Upon oxidation, the Cys residues of proteins can be reduced, with different 
characteristics depending on the microenvironment, via a system of reactions involving 
GSH or Trx (D'Autreaux & Toledano, 2007; Peltoniemi et al, 2006; Watson & Jones, 
2003); vicinal dithiols are considered to form protein disulfides (P-SS-P) that are reduced 
by Trx1. Other thiols are oxidized to protein sulfenic acids (P-SOH) which undergo 
protein S-glutathionylation (P-SSG). The model reserves protein disulfide reduction 
exclusively for Trx, while protein sulfenic acids are reduced exclusively by GSH-
dependent reactions (Fig. 5-1) (D'Autreaux & Toledano, 2007). Methionine residues are 
also subject to oxidation but the rates are not known. Because methionine sulfoxide 
reductases are thioredoxin-dependent, the model, as described, can be considered to have 








Figure 5-1. Model of hydrogen peroxide (H2O2) elimination by Jurkat T-cells. The 
modeled system was that of an individual cell with three compartments being considered: 
the extracellular medium, the intracellular cytosol, and the peroxisomes. H2O2 is allowed 
to move freely between compartments by permeating through the cytoplasmic and 
peroxisomal membranes. A constant intracellular H2O2 production rate was defined by a 
mitochondrial source. Within the intracellular cytosol, H2O2 was metabolized by a series 
of reactions (denoted by arrows) each with a given reaction rate constant (Table 1). There 
were four main pathways by which H2O2 was metabolized by the simulated cell. The first 
was controlled by catalase and the second was controlled by glutathione peroxidase 
(GPx) enzymes working in conjunction with GSH, GR, and NADPH. The third was 
controlled by the peroxiredoxin enzymes (Prx) working in conjunction with Trx, TR, and 
NADPH. The fourth and final pathway described the non-enzymatic elimination of H2O2 
through the oxidation of cysteine residues on intracellular proteins. This can occur at 
single Cys residues resulting in sulfenic acids which react with GSH to form 
glutathionylated intermediates. Alternatively, this can occur at dithiols resulting in the 




Table 5-1: Rate expressions and rate constants for the ODEs that comprise the 
intracellular peroxide clearance model. 
 
Rxn # Expression Parameter Reference 
R1 k1 ([H2O2]media) (A)
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Parameter and species fitting  
For this global model which encompassed 28 kinetic parameters and 24 species, 
there existed several values that had yet to be appropriately defined in the literature: the 
H2O2 permeability constant, the rate of protein thiol oxidation, and the concentration of 
protein thiols dependent on GSH and Trx1, respectively, for reduction (Tables 5-1 and 5-
2). Experimentally determined dynamics, therefore, were used for model fitting in order 
to arrive at acceptable estimates for these parameters and species (Fig. 5-2). The first 
experimental data set used for parameter fitting was digitized from the results of Antunes 
and Cadenas describing the consumption of a bolus addition of extracellular H2O2 by 
intact Jurkat cells (Antunes & Cadenas, 2000) (Fig. 5-2 B). Four additional data sets were 
generated under identical experimental conditions and quantified using HPLC techniques 
and redox western blots. These results describe the changes in distribution of GSH and 
GSSG as well as reduced and oxidized cytosolic Trx1 that occur as a result of H2O2 
treatment (Fig. 5-2 C, D). Parameters were estimated by minimizing an objective 
function, comprising the normalized root mean square deviation (RMSD) between 
experimentally observed time course data and computed model predictions (Chen et al, 














Table 5-2: Initial concentration values of the components that comprise the intracellular 
peroxide clearance model. 
 
 Species Initial Condition (M) Reference 
[H2O2]media 1 x 10
-4
 Assigned 
[H2O2]cytosol 1 x 10
-9
 (Oliveira-Marques et al, 2009) 
[GPxred] 5 x 10
-5
 (Ng et al, 2007) 
[GPxox] 1 x 10
-14 ‡
 Assigned 
[GPx-SSG] 1 x 10
-14 ‡
 Assigned 
[GSH] 3.68 x 10
-4
 Measured 
[GSSG] 1.78 x 10
-6
 Measured 
[Catalase] 9 x 10
-7
 (Mueller et al, 1997; Poole, 1975) 
[H2O2]peroxisome 1 x 10
-10 ‡
 Assigned 
[Prx-(SH)2] 1.9 x 10
-5
 (Hansen et al, 2006; Rhee et al, 2001) 
[Prx-(SOH)] 1 x 10
-14 ‡
 Assigned 
[Prx-(SOOH)] 1 x 10
-14 ‡
 Assigned 
[Prx-SS] 9.6 x 10
-8 
† (Jones, 2008) 
[Trxred]  4.3 x 10
-7
 Measured 
[Trxox] 7.5 x 10
-8
 Measured 
[Pr-SH]] 1.22 x 10
-4
  Fitted 
[Pr-SOH] 6.1 x 10
-7 
† (Jones, 2008) 
[Pr-SSG] 6.1 x 10
-7 
† (Jones, 2008) 
[Grx-SH] 1.2 x 10
-6
 (Lundberg et al, 2004) 
[Grx-SSG] 6.0 x 10
-9 
† (Jones, 2008) 
[Pr-(SH)2] 1.0 x 10
-3
 Fitted 
[Pr-(SS)] 5.5 x 10
-6 
† (Jones, 2008) 
[NADPH] 3.0 x 10
-5
 (Martinovich et al, 2005) 
[NADP
+
] 3.0 x 10
-7
 (Schafer & Buettner, 2001) 
‡
Baseline assignment to highlight the effects of exogenously applied H2O2 only 
†




Two models of protein oxidation 
Accurate modeling of the contribution of protein thiols to the overall redox 
network requires knowledge of the concentration of protein thiols that are susceptible to 
hydrogen peroxide oxidation as well as the rates at which these oxidation reactions occur. 
In order to determine the proper description of intracellular protein oxidation, two distinct 
models of protein thiol oxidation, a “slow” model and a “fast” model, were postulated 
and tested for their ability to recapitulate experimental data (Fig. 2). The slow model was 
constructed by assuming the total available protein thiol pool, as estimated by Jones 
(Jones, 2008), would react with intracellular hydrogen peroxide with the pre-established 






, the rate at which GAPDH is estimated to react with 
hydrogen peroxide (Winterbourn & Hampton, 2008). In this model, the available protein 
thiol pool was further divided into two subgoups: the protein monothiol pool (Pr-SH), 
which contained 50% of the total available protein thiols, and the protein dithiol pool (Pr-
(SH)2), which contained the remaining 50% of the total protein thiol pool (Figure 5-2 A, 
left panel).  
The fast model, on the other hand, was constructed by assuming that there existed 
a smaller subset of protein thiols, approximately 20% of the total available protein thiol 
pool, which reacted with hydrogen peroxide at an appreciably faster rate than what was 
estimated for GAPDH oxidation. The remaining 80% of the total protein thiol pool was 
divided equally between the protein monothiol group and the protein dithiol group and 







The purpose of the fast model was to determine the percentage of the highly reactive 
protein thiols that belonged to the protein monothiol group and the protein dithiol group, 
respectively, and to predict the rates of reactions of these fast reacting thiols with 







Figure 5-2. A model with rapid protein dithiol oxidation accurately describes 
hydrogen peroxide consumption. (A) Assignment of the distribution of protein thiol 
pools and rate constants for the slow and fast protein thiol oxidation models. (B) 
Experimental data (Antunes & Cadenas, 2000) and model fitted results for the slow and 
fast protein thiol oxidation models showing the consumption of H2O2 by intact Jurkat T-
cells at a density of a 1106 cells/ml after being exposed to a bolus addition of 100 µM 
extracellular H2O2. (C) Redox states of the glutathione redox couple as experimentally 
determined and model fitted for the slow and fast models. Experimental values represent 
the mean ± S.E.M. of three separate experiments. (D) Redox states of the thioredoxin 
redox couple as experimentally determined and model fitted for the slow and fast protein 












The parameters predicted by the model were i) the concentration of fast reacting 
protein monothiols (Pr-(SH)), ii) the reaction rate constant for the fast reacting protein 
monothiols with hydrogen peroxide, iii) the concentration of fast reacting protein dithiols 
(Pr-(SH)2), iv) the reaction rate constant for the fast reacting protein dithiols with 
hydrogen peroxide and v) the permeability coefficient of the cytoplasmic membrane. The 
protein oxidation parameters to be fitted were initialized to randomized values that lay 
within the literature-reported estimates of their upper and lower bounds (D'Autreaux & 
Toledano, 2007; Winterbourn & Hampton, 2008; Winterbourn & Metodiewa, 1999). Due 
to conflicting estimates of the lower bound of the permeability coefficient (Antunes & 
Cadenas, 2000; Makino et al, 2004; Seaver & Imlay, 2001), it was deemed appropriate to 
expand the lower bound of the explored parameter space for this parameter by one order 
of magnitude. Multiple simulations were conducted for each condition (n = 2000 runs) in 
which each of the three unknown parameters was simultaneously assigned a random 
initial value from its allowable parameter space and the objective function calculated. 
The parameter set that resulted in the minimization of the objective function was selected 
as the optimal model description.  
 
Membrane H2O2 transport 
The rate of movement of H2O2 across the cytoplasmic membrane has been 
described previously by the following (Seaver & Imlay, 2001): 
 































        (5-1) 
 
where [H2O2]media and [H2O2]cytosol represented the concentration of peroxide in the 
extracellular media and the intracellular cytosol, respectively, at time t. H2O2 flux across 
the cytoplasmic membrane is a function of the intra- and extra-cellular concentration of 
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H2O2, the permeability coefficient of H2O2 through the cytoplasmic membrane, P, and 
the surface area of the cell, A, approximately 1.0 10-5 cm2 as calculated from the  
average diameter of the Jurkat cell, 20 µm (ViCell Viability Counter, Beckman Coulter). 
The volume of the cytoplasmic compartment was calculated assuming the Jurkat cell to 
be a perfect sphere of diameter 20 µm. The concentration of H2O2 in a cell has been 
described previously as a sum of the influx, production, efflux and scavenging of H2O2 
within a particular cellular compartment (Bienert et al, 2006). H2O2 flux across the 
peroxisomal membrane was modeled in a similar fashion using the concentration of 
peroxide in the cytosol and the concentration of peroxide in the peroxisome to generate 
the gradient force for diffusion. The permeability coefficient of H2O2 through the 
peroxisomal membrane, P, was obtained from the literature (Poole, 1975), assuming a 
uniform concentration of H2O2 within a particular compartment. 
 
Parameter values 
The majority of the rate constants and initial species concentrations used in this 
model were derived from published data (Tables 5-1 and 5-2, respectively). Where 
possible, values reported specifically for Jurkat cells were used; there were reactions and 
species, however, for which Jurkat cell line specific values were undefined. For these 
types of reactions, published data for other cell lines were used as appropriate estimates. 
The fractional cytosolic volume used for concentration calculations was defined as 30% 
of total cell volume by estimation from images of Hoescht nuclear-stained Jurkat cells. 
 
Description of reaction kinetics 
The series of differential equations were solved using Matlab R2008a 
(Mathworks, Natick, MA). The generalized equation for a particular species constituted 
the sum of all reactions that produced the species minus the sum of all reactions that 
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consumed it. Several components in the model, however, deviated from the generalized 
equation form as described below.  
Ideally, if the law of mass action was used to describe the reduction of GSSG by 
GR to produce GSH the resulting equations would resemble the following:   
 






GSHd                      (5-3) 
 
where [GSH], [GSSG], and [NADPH] represent the intracellular concentrations of 
reduced glutathione, glutathione disulfide, and NADPH, respectively, at time t, and k20 
represents the rate constant for the reduction reaction. Instead of equation 3, the change in 
concentration of GSH as a result of the reduction of GSSG by GR was described in the 







i                                                            (5-4) 
 
where [GSSG]i represents the initial concentration of glutathione disulfide in the cell. 
Because the cell maintains a fixed non-equilibrium ratio of [GSH]:[GSSG] under normal 
oxidative conditions (Kemp et al, 2008), the spontaneous reduction of GSSG in the 
absence of oxidants could not be allowed. To prevent this behavior, the reduction of 
GSSG was modeled as a function of the difference between [GSSG] and [GSSG]i. While 
this model description correctly captures oxidant-induced changes to the glutathione 
disulfide reduction rate, the absolute GSSG reduction rate in the model may be somewhat 
underestimated by the endogenous rate at baseline because the Km of GR is high relative 
to concentrations of GSSG achieved in cells (Gilbert, 1990). The same basic principles 
and assumptions were applied to the reactions involving the Trx redox couple. The 
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complete list of rate expressions governing the change in concentration of each species of 
the model is listed in Table 5-1.  
 
Objective function for parameter estimation 
Parameters were estimated by minimizing a modified version of a previously 
described objective function, U, comprising the normalized root mean square deviation 
(RMSD) between experimentally observed time course data and computed model 



























                                                                               (5-5) 
 
where x is the concentration of some particular species in the model, x
e
 is the 
experimentally observed concentration of the same species, Nobs is the number of 
experimentally observed species, Nexpt is the number of experimental conditions, as 
defined by the relative percentage of proteins assigned to the monothiol and dithiol 
protein pools, and Nt is the number of time points sampled. 
 
Sensitivity analysis 
The finite difference approximation (FDM) method was used to calculate the 
sensitivity coefficient, si,j, which defined the difference between the nominal and 
perturbed solutions offered by the model according to the equation (Yue et al, 2006): 
 
si,j(t) = 












 ,,)(                                                                             (5-6)    
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where xi(θj, t) represents a measured model output at time t, when a particular parameter 
has the value θj; subsequently, xi(θj + ∆θj, t) represents the value of the same model 
output when the same parameter is perturbed by the value ∆θj. For the purposes of this 
model, all parameters were perturbed by ±10% of their initial values. As a result of the 
difference in magnitude between parameters, the absolute sensitivity values obtained 
from Equation 6 were not accurate measures of relative sensitivity. To calculate the 
relative sensitivities, for a more direct comparison of model response at different states 
across different parameters, a previously described normalization method was employed 
(Yue et al, 2006): 
 







                    (5-7)   
                                                                                                                                   
From this equation, the normalized sensitivity of a particular model output to 
perturbations in a particular parameter at time, t, could be determined. All sensitivity 
analysis calculations were done at t = 5 min and parameter sensitivities were calculated 
with respect to the concentrations of the experimentally determined model species 
(extracellular peroxide, intracellular GSH, intracellular GSSG, intracellular reduced Trx1, 
and intracellular oxidized Trx1). 
 
Materials cell culture and stimulation conditions 
All reagents were from Sigma-Aldrich, St. Louis, MO unless specified otherwise. 
Jurkat cells (clone E6-1) were obtained from American Type Culture Collection (ATCC, 
Manassas, VA). Cells were cultured in supplemented RPMI-1640 medium (glutamine, 
non-essential amino acids, 100 U/ml penicillin/streptomycin, 1 mM sodium pyruvate, 10 
mM HEPES, 10% FBS). For stimulation, cells were resuspended in fresh media (1106 
cells/ml) and treated with H2O2 for various times at 37°C before lysing. Pyruvate is 
92 
 
known to undergo oxidative decarboxylation in the presence of H2O2 so a control 
experiment was performed to determine the rate of H2O2 removal by the culture media 
alone. An Amplex Red assay (Invitrogen, Carlsbad, CA) showed that the background 
oxidation of sodium pyruvate in the media by H2O2 was not detectable for the duration of 
the treatment conditions used throughout the study. 
 
Cellular fractionation and derivatization of protein thiols 
After treatment, cells were pelleted by centrifugation at 300   g. The cell pellet 
was immediately resuspended in guanidine-Tris solution (50 mM Tris-HCL, pH 8.3, 3 
mM EDTA, 6 M guanidine-HCL, 0.5% Triton X-100) supplemented with 50 mM 
iodoacetic acid (IAA, pH 8.3) and incubated at 37°C in the dark for 45 min (Watson & 
Jones, 2003). This procedure was carried out to simultaneously lyse the cells and 
derivatize reduced protein thiols. After incubation, the samples were run through 
Microspin G-25 columns (GE Healthcare, Buckinghamshire, U.K.) to remove excess 
IAA.  
 
Redox western blot analysis 
To analyze the redox state of cytosolic Trx1, derivatized proteins were separated 
by native polyacrylamide gel electrophoresis as previously described (Watson & Jones, 
2003). PVDF membranes were probed with antibody to human Trx1 (American 
Diagnostica, Stamford, CT) and a goat IgG-IRDye 800 CW conjugated antibody 
(Rockland Immunochemicals, Gilbertsville, PA). Trx1 bands were visualized and 
quantified using the LI-COR Odyssey scanner 2.1 (Lincoln, NE) and the LI-COR 




Measurement of intracellular GSH and GSSG 
GSH and GSSG were measured by high-performance liquid chromatography 
(HPLC) as S-carboxmethyl N-dansyl derivatives using γ-glutamylglutamate as an 
internal standard (Jones, 2002). 
 
Calculation of Eh values 
The redox potentials of GSH and Trx1 were calculated using the Nernst equation. 
To convert total values for GSH and GSSG into intracellular concentrations, measured 
intracellular protein concentrations were used and a constant cellular water volume 
(5µl/mg protein) was assumed. The integrated band intensities of reduced and oxidized 
Trx1, as quantified by the LI-COR Odyssey 2.1 gel analysis software, were assumed to 
be directly proportional to the normalized intracellular concentrations of these species 
(Watson et al, 2003). The intracellular pH was assumed to be 7.4 (Nordstrom et al, 1992) 
and to be unaffected by H2O2 treatment. E0 values used for pH 7.4 were as follows: 
GSH/GSSG redox couple, -264 mV; and for the active site dithiol/disulfide of Trx1, -254 







Parameter and species fitting  
Table 5-1 lists the kinetic parameter values obtained from the literature and the 
fitted values determined for the unknown parameters in the fast model. While the slow 
model (Fig. 5-2 A, left panel) was able to accurately represent the dynamics of peroxide 
consumption and the oxidation dynamics of the glutathione redox couple, it was unable 
to accurately capture the oxidation dynamics of the thioredoxin redox couple, Figure 5-
2D. The fast model (Fig. 5-2 A, right panel), on the other hand, was able to capture the 
entire dynamic dataset. The fitted values in the fast model for the rates of protein 













. These values were within the order of magnitude range of predicted reaction 






) (D'Autreaux & Toledano, 2007). 
Because the fast model was able to better replicate the experimental data, we used this 
model to generate all subsequent parameter estimates and model predictions. The 
permeability constant (Eq. 5-1) that describes the movement of peroxide through the 




. This value was 
approximately 1 order of magnitude smaller than the value estimated by Antunes and 
Cadenas (Antunes & Cadenas, 2000).  
Table 5-2 lists the initial species concentrations obtained from the literature and 
the fitted values determined for the concentration of protein thiols dependent on GSH and 
Trx1, respectively, for reduction. The protein thiol distribution that resulted in the 
minimization of the objective function was 42% GSH-dependent protein thiols and 58% 
Trx1-dependent protein thiols.  
 
Consumption of H2O2 by intact Jurkat cells 
The rate at which Jurkat cells clear the extracellular environment of H2O2 is an 
effective measure of their internal anti-oxidative response system. The model was fitted 
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to the condition of a bolus addition of 100 µM extracellular H2O2 being consumed by 1
10
6







 cells. This decay rate was very close to the experimentally determined 1.0 






Figure 5-3. Model validation for varied initial extracellular peroxide concentrations. 
(A) Model-simulated and experimentally determined (Hampton & Orrenius, 1997) 
consumption of H2O2 by intact Jurkat T-cells (cell density = 110
6
 cells/ml) after being 
exposed to a bolus addition of 50 µM extracellular H2O2. (B) Model-simulated and 
experimentally determined glutathione and thioredoxin redox potentials for a varying 
initial extracellular [H2O2] (Jurkat T-cell density = 110
6





After the model parameters and protein thiol distributions were optimized based upon the 
bolus condition, the ability of the model to describe hydrogen peroxide consumption by 
Jurkat cells at varied extracellular peroxide conditions was investigated. Without any 
additional parameter optimization, the fitted model accurately simulated the extracellular 
decay of 50 µM hydrogen peroxide at a cell density of 1 x 10
6
 cells/ml from another 
published dataset (Hampton & Orrenius, 1997). This new peroxide concentration was 
50% less than what was used in the model fitting exercises (Fig. 5-3 A). Simulations of 
peroxide consumption dynamics of a population of Jurkat cells exposed to low steady 
state levels of extracellular H2O2 were carried out. Since the steady state consumption 
behavior of Jurkat cells was not used to fit any of the parameters contained in the model, 
the steady state consumption experiment, previously carried out by Antunes and Cadenas 
(Antunes & Cadenas, 2000), served as additional validation for the model. In this 
experiment, cells at a concentration of 1106 cells/ml were incubated simultaneously 
with a low concentration of H2O2 and glucose oxidase to generate a steady state 
extracellular H2O2 concentration of approximately 9 µM (Antunes & Cadenas, 2000). 
The model simulation for this condition accurately predicted that Jurkat cells (1106 
cells/ml) would be able to maintain, at a constant level, the low concentration of H2O2 in 
their extracellular environment for at least one hour after exposure. 
 
The intracellular GSH/GSSG pool is transiently oxidized by H2O2 treatment   
Glutathione disulfide (GSSG) was quantified as approximately 0.5% of the total 
glutathione pool in resting Jurkat cells (Eh value of cytosolic GSH/GSSG = -230 ± 3 
mV). At 5 min post-H2O2 addition, the intracellular GSH/GSSG redox potential had been 
oxidized by approximately 8 mV (Fig. 5-2 C). Within 30 min of treatment, the 
concentration of GSSG was approaching its baseline level. In contrast, the intracellular 
GSH concentration increased slightly; therefore, a net change in total glutathione was 
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occurring over the experimental window of observation. At 60 min of exposure, the Eh 
value of the GSH/GSSG pool was -235 ± 4 mV.  
Using the measured baseline values of oxidized and reduced glutathione as initial 
conditions for GSH and GSSG, the model simulated the changing glutathione redox 
potential due to H2O2 treatment as a function of time (Fig. 5-2 C). A rapid oxidation of 
the GSH/GSSG pool upon H2O2 treatment resulted in an Eh value of -224 mV at 5 min 
post-treatment, very close to the 8 mV magnitude oxidation measured. The model curve 
showed a return to baseline redox potential after 60 minutes and, as a result of the 
incorporation of glutathione transport and synthesis, the model was capable of capturing 
the slight overshoot seen experimentally. 
 
Cytosolic Trx1 oxidation is sustained after H2O2 treatment 
Cytosolic Trx1 was measured in resting Jurkat cells and found to be 
approximately 85% reduced, corresponding to an Eh value for cytosolic Trx1 of -277 ± 
1.4 mV (Fig. 5-2 D), a value that is in agreement with previous reports of the steady state 
redox potential of cytosolic Trx1 (Kemp et al, 2008). The potential of the Trx1 redox 
couple at 5 min of treatment was approximately -263 mV, reflecting 14 mV oxidation. 
From 5 min to 30 min of treatment, the percentage of oxidized Trx1 began to decline 
towards its baseline value. At 60 minutes of treatment, however, the redox potential of 
the cytosolic Trx1 redox couple was re-oxidized. The 60 minute Trx Eh value of -265 ± 
1.6 mV was very similar to the level of Trx1 oxidation seen at 5 min of treatment (Fig. 5-
2 D).  
The fitted model was capable of simulating transient Eh values for cytosolic Trx1 
following exposure to 100 µM H2O2 (Fig. 5-2 D). The baseline distributions of oxidized 
and reduced Trx1 were used as the initial conditions for the Trx1 species in the 
simulation. An appropriate degree of Trx1 oxidation upon exposure to H2O2 was 
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reproduced by the model and the model was capable of simulating the re-oxidation 
observed at the 60 minute time point.  
 
Model sensitivity analysis 
Sensitivity analysis was conducted on the model to identify the parameters with 
the greatest influence on model simulation results. Sensitivity analysis was conducted at 
5 min because the maximum effect of peroxide treatment was seen at or close to that time 
point. The parameter to which a majority of the species investigated was most sensitive 
was k1, the permeability constant of the cytoplasmic membrane. Reduced and oxidized 
Trx1 showed the highest sensitivity to the parameters k1, k12 and k21, where k12 and k21 
represented the rate constant for the reduction of oxidized peroxiredoxin (Prx-SS) by 
reduced Trx1 and the rate constant for the reduction of oxidized Trx1 by TR and 
NADPH, respectively. GSH showed the highest sensitivity to k1 and k3, where k3 
represented the rate constant for the GPx-catalyzed removal of hydrogen peroxide. GSSG 
showed the highest sensitivity to k3 and k20, where k20 represented the reduction of GSSG 
by GR and NADPH. While both the glutathione and thioredoxin redox couples showed 
relatively high sensitivity to k22, the rate constant describing the rate of NADPH resupply 
by the G6PDH enzyme, the Trx redox couple was more sensitive to perturbations in this 
parameter than the GSH redox couple. Experimental studies showing the effect of G6PD 
inhibition on peroxide-induced protein S-glutathionylation in Jurkat cells corroborate the 
model-predicted sensitivity of G6PD-dependent NADPH resupply to the intracellular 
ROS buffering capacity of Jurkat cells (Appendix A). Model components, in general, 
were “insular” in their sensitivities (i.e. affected by rate constants of reactions in which 
they played either a direct or very nearly direct role) with very few enzymatic parameters, 




Model predicts oxidation profiles of glutathione and thioredoxin redox couples for varied 
initial extracellular [H2O2] 
The anti-oxidative properties of the model were capable of replicating in vivo 
Jurkat dynamics for particular instances of both the transient and steady state condition of 
oxidative stress. To further interrogate the system, we explored the model‟s ability to 
predict these dynamic responses for a variety of oxidation levels. We simulated a bolus 
extracellular H2O2 addition of 10 µM and 50 µM at a cell density of 110
6
 cells/ml, and 
compared the results to the redox potential of the glutathione and thioredoxin redox 
couples experimentally measured 5 minutes post-treatment (Fig. 5-3 B). There were 
significant statistical differences (alpha = 0.05) between the experimentally determined 
redox potentials of the glutathione and thioredoxin redox couples at 5 min of 10 µM 
peroxide treatment compared to the 100 µM peroxide treatment. Statistically significant 
differences were also seen between the 50 µM and the 100 µM extracellular peroxide 
treatments. Model simulations of the redox potential of the glutathione and thioredoxin 
redox couples for the 10 µM, 50 µM, and 100 µM peroxide treatments deviated slightly 
from the experimental values but accurately captured the oxidative change between the 
redox potentials of both redox couples for all peroxide treatment conditions examined 




                
 
Figure 5-4. Model predicted intracellular [H2O2]. Dynamic model-simulated 
extracellular (top) and intracellular (bottom) peroxide concentration as a result of 100 µM 
H2O2. (Jurkat T-cell density = 110
6
 cells/ml).  
 
Model predicts intracellular peroxide concentrations and levels of protein thiol oxidation 
resulting from exogenous hydrogen peroxide 
One benefit of the model is the ability to offer quantitative estimates for the 
intracellular [H2O2] resulting from an external source of hydrogen peroxide. The model 
predicts that a concentration of about 810-8 M of hydrogen peroxide develops within the 
cell when it is exposed to 100 µM of extracellular peroxide at a cell density of 1106 
cells/ml (Fig. 5-4); thereby representing a gradient of about 1000 that develops between 
the extracellular environment and the intracellular cytosol.  
 
                 





                           
                            
B. 
                            
 




Figure 5-5. Model predicted protein oxidation profiles. Simulated percentages of S-
glutathionylated proteins and protein disulfides that form as a result of oxidative stress 
(100 µM H2O2; Jurkat T-cell density = 110
6
 cells/ml) for the fast (A) and slow (B) 
models.  
  



















































In addition to offering quantitative estimates of the intracellular peroxide 
concentration, the model is capable of providing predictions of protein thiol oxidation. 
The protein thiol pool may significantly contribute to the cellular antioxidant defense due 
to the substantial concentration of protein thiols in the cell (Jones, 2008). To investigate 
the independent roles of monothiol and dithiol proteins during dynamic oxidative 
conditions, the model was used to predict the level of peroxide-induced protein oxidation 
as a function of initial extracellular [H2O2] (Fig. 5-5). For this in silico experiment, 
protein oxidation was quantified by the concentration of protein disulfides ([Pr-SS-Pr]) 
and S-glutathione adducts ([Pr-SSG]) observed at 5 min of 100 µM H2O2 treatment for 
the slow and the fast model of peroxide consumption. The slow model, which was unable 
to fit all the experimental data (Fig. 5-2), showed very little protein oxidation, with the 
maximum concentration of protein S-glutathione adducts and protein disulfides not 
exceeding 1% of the total thiol pool (Fig. 5-5, bottom). The fast model, on the other hand, 
which was capable of fitting all the experimental data, predicted a significant increase in 
the concentration of protein disulfides, approximately 10% of the total protein thiol pool 





The development of kinetic computational models of redox enzyme systems 
presents unique challenges in comparison to other biochemical networks. The non-
equilibrium condition of intracellular thiol based-redox couples provides for a rapid and 
highly sensitive switching mechanism in response to changes in intracellular redox state 
(Kemp et al, 2008). Because many thiol-based redox couples are set at different 
potentials, the model species tend to equilibrate even in the absence of oxidative stress. 
The spontaneous change in redox potential that is due to this inherent non-equilibrium 
condition must be filtered out in order to focus entirely on those changes that are the 
result of oxidative stress alone. One modeling approach is to define the driving force for 
electron transfer to be the function of the difference between the homeostatic potential 
and the actual potential of the system as defined by the redox couple of interest (Kemp et 
al, 2008). With this approach, the defined system can describe the dynamic response to 
changes in intracellular [H2O2] without having to explicitly include the numerous steady-
state fluxes that must occur across cellular membranes in order to maintain the redox 
couples out of equilibrium.  
 
Importance of membrane permeability in cellular antioxidant defense 
The model highlights the sensitivity of the entire redox enzyme network to the 
membrane permeability constant for hydrogen peroxide and revises estimates for this 
constant. The first barrier to extracellular hydrogen peroxide consumption is the 
cytoplasmic membrane. Transmembrane diffusion of H2O2 is an important factor in the 
maintenance of peroxide gradients between the extracellular environment and the 
intracellular cytosol (Bienert et al, 2006). The model recapitulated this experimental 
observation by highlighting k1, the model parameter describing the permeability 
coefficient of the cytoplasmic membrane, as the parameter to which most model 
components were the most sensitive. The optimized permeability coefficient was 
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approximately 1 order of magnitude smaller than what was previously estimated by 
Antunes and Cadenas (Antunes & Cadenas, 2000). The literature-reported estimate 
calculated by Antunes and Cadenas was based on the assumption that the GPx and 
catalase pathways were the only pathways working towards H2O2 removal. Realistically, 
however, the cell has several additional enzymatic and non-enzymatic methods of H2O2 
clearance, most of which have been integrated into this present model. Without the 
incorporation of all redox reactions that take place in vivo, an overestimated value for the 
permeability coefficient is expected. From a systems perspective, therefore, it would be 
beneficial if the cell could control its cytoplasmic membrane permeability in order to 
control the amount of transmembrane H2O2 diffusion it experiences. Indeed, recent 
studies have shown that some membranes are poorly permeable to H2O2, compared to 
other membranes, implying that transport of H2O2 could in fact be regulated (Bienert et 
al, 2006). Differences in membrane permeability could be attributed to changes in 
membrane lipid composition or changes in the number of membrane-bound diffusion-
facilitating channel proteins, all of which can be controlled by the cell. The importance of 
the membrane permeability coefficient, as dictated by the model sensitivity analysis, 
suggests that the cytoplasmic membrane permeability is a parameter capable of being 
tuned by the cell in order to control H2O2 transport and, ultimately, the concentration of 
H2O2 inside the cell. Whether such transport could be actively controlled by aquaporins is 
presently unknown. 
Precise modeling of the intracellular peroxide consumption dynamics and 
membrane permeability provides a more accurate description of intracellular peroxide 
levels. The model-predicted peak intracellular concentration of hydrogen peroxide that is 
induced by 100 µM is about 100 nM. The model is the most comprehensive model to 
date to offer quantitative and dynamic estimates of the intracellular concentration of 




Unequal anti-oxidative burden of intracellular redox enzymes and thiol containing 
compounds  
The model addresses which redox enzymes and thiol containing compounds are 
primarily responsible for the antioxidant capacity of the cell. The Trx1 and GSH redox 
couples are often used as measures of the overall redox state of the cell (Schafer & 
Buettner, 2001). We utilized the model to describe the dynamics of these two redox 
couples under conditions of oxidative stress. Experimental results showed the Eh value of 
the Trx1 redox couple to be oxidized by a maximum of 17 mV after treatment with 100 
µM H2O2. This maximum level of oxidation was about twice as high as that seen for the 
GSH redox couple. Analysis of the model system under the steady state peroxide 
condition (Table 5-3) suggests an unequal distribution of the anti-oxidative burden exists 
between the Trx1 and GSH redox couples in the intracellular cytosol; this unequal 
distribution offers one explanation for the unequal oxidation of the Trx1 and GSH redox 
couples described above. These results should be interpreted carefully as the flux 
distribution between the Trx1 and GSH redox couples may very well be compartment-
specific and therefore altered in other subcellular compartments. Furthermore, Trx1 
kinetics may change with hyperoxidation of the enzyme (Watson & Jones, 2003), and the 
kinetics of the G6PD enzyme are altered as a result of increasing levels of GSSG in the 
cell (Ursini et al, 1997). Future modeling efforts may need to account for these complex 
kinetic regulatory mechanisms to appropriately simulate more extreme oxidative 
conditions.  
The steady-state concentration of H2O2 that develops within an individual cell as a 
result of a low (~ 9 µM), constant level of extracellular H2O2 was approximately 1 nM. 
From this steady state value, and using the respective rate constants of peroxide 
metabolism for each anti-oxidative branch (catalase, GPx/GSH, Prx/Trx1, Pr-SH, Pr-
(SH)2), in addition to the relative concentrations of the species in each branch, we were 
able to calculate the hydrogen peroxide flux (M/s) that passes through each anti-oxidative 
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branch (Table 5-3). These calculations reveal that the GPx and Prx enzyme systems were 
responsible for the majority of the peroxide metabolism at this steady-state condition, 
with calculated fluxes of 6.010-6 Ms-1 and 4.410-6 Ms-1, respectively. In comparison, 
the flux through the catalase enzyme system was only 3.710-8 Ms-1, approximately 0.6% 
of the flux through the GPx enzyme system. The contribution of catalase to the 
consumption of externally generated hydrogen peroxide is low compared to other 
antioxidant enzymes such as peroxiredoxin and glutathione peroxidase. This result 
reflects not only the low peroxisomal content of Jurkat cells, but also the inefficiency of 
intact peroxisomes in degrading externally generated hydrogen peroxide (Fritz et al, 
2007). It must be noted that while catalase may be somewhat inefficient at degrading 
external hydrogen peroxide, it is highly efficient at degrading hydrogen peroxide 
generated within the peroxisomal matrix.  
 
Table 5-3: Model-predicted steady-state hydrogen peroxide fluxes. 
 
Branch Flux (M/s) Flux (% of Total) Flux (M/s) Flux (% of Total) 
Prx 4.4 x 10
-6
 32 5.6 x 10
-6
 42 
GPx 6.0 x 10
-6
 44 7.7 x 10
-6
 57 
Catalase 3.7 x 10
-8
 < 1 4.6 x 10
-8
 < 1 
Pr-SH 7.0 x 10
-9
 < 1 1.1 x 10
-8
 < 1 
Pr-(SH)2 3.1 x 10
-6
 23 1.1 x 10
-8
 < 1 
 Fast Model Slow Model 
 
  Another prediction by the model flux analysis was the contribution of the protein 
dithiol pool to the steady-state peroxide consumption. The flux of hydrogen peroxide 
through the protein dithiol pool was 3.110-6 Ms-1, approximately 23% of the total 
hydrogen peroxide consumption within the cell. Comparatively, the flux through the 
protein monothiol pool was less than 1%. These results are in line with previous 
predictions of protein thiol oxidation that suggest a majority of the proteins in the cell 
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react at relatively slow rates with hydrogen peroxide, whereas a few proteins, primarily 
those that form disulfide bonds, react with hydrogen peroxide at appreciably faster rates 
(Winterbourn & Hampton, 2008; Winterbourn & Metodiewa, 1999). This result offers 
another possible explanation for why the thioredoxin redox couple experienced more 
pronounced and sustained oxidation during times of oxidative stress as compared to its 
glutathione counterpart.  
 
The current model advances our understanding of intracellular redox biology  
Multiple advancements in knowledge have been gained by this modeling study. 
The question that motivated this study was whether the current knowledge in the redox 
biology field can explain experimental data, or if are there additional redox nodes, which 
have not yet been discovered, that may significantly contribute to peroxide clearance 
from the intracellular environment. This study has shown that the model topology - as it 
currently stands and with current parameter measurements available in the literature - is 
capable of describing the behavior of a particular cell line upon exposure to an external 
source of hydrogen peroxide if supplemented with the optimized estimates of unknown 
parameters. Although customized for Jurkat cells, the reactions that are described by the 
model can easily be adapted to other cell lines by inserting enzyme concentrations and 
reaction rate constants for the particular cell line of interest. The second contribution 
given by this model is its ability to provide predictions of the oxidation profiles of 
specific intracellular components that are not yet able to be quantified experimentally. 
The current model offers what can be called the first fully quantitative estimate for the 
concentration of intracellular hydrogen peroxide that results from an extracellular source 
in addition to the percentage of protein thiols that undergo both protein S-
glutathionylation as well as protein disulfide formation. By including the contribution of 
the protein thiols to hydrogen peroxide clearance, the model explains why the glutathione 
and thioredoxin redox potentials are purported to be independent from one another; the 
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larger flux through the dithiol pool causes a capacitance in the thioredoxin branch that 
leads to a sustained oxidation of thioredoxin. Finally, the model is capable of 
simultaneously determining relative fluxes through each antioxidant branch, which would 
be extremely difficult to measure using traditional experimentation.  
This framework used the controlled induction of oxidative stress to construct a 
kinetic model that is capable of describing the observed oxidation of redox couples as a 
function of time. As a tool for interrogation of a particular biochemical network, a bolus 
condition is extremely useful to “reverse-engineer” features. While the current model was 
fitted and validated with data based on the extracellular administration of hydrogen 
peroxide, this does not negate the ability of the model to simulate and predict the 
behavior of intracellular components as a result of endogenous generation of hydrogen 
peroxide. To validate these dynamics, however, advancements in the ability to 
quantitatively measure intracellular peroxide will need to be developed. Furthermore, 
while compartmentation was included, spatial gradients within the cell were not 
described by this model. With the network structure and kinetic description intact, future 
challenges to modeling efforts will involve the added complexity of intracellular H2O2 
spatial gradients generated by NADPH oxidases, peroxisomes, and mitochondria.  
  





GLUTATHIONE REDOX BALANCE REGULATES DOX-INDUCED 
NF-ΚB ACTIVITY IN LEUKEMIC CELLS 
Introduction 
High concentrations of intracellular ROS can inflict irreparable damage to cellular 
biomolecules and cause subsequent cell death (Nordberg & Arnér, 2001). Low levels of 
ROS, however, are more likely to alter cellular signal transduction through the reversible 
modification of intracellular redox-sensitive proteins (Valko et al, 2007). The cellular 
protein modifications caused by low levels of ROS do not necessarily result in cell death, 
and may even promote cell viability in some instances (Oliveira-Marques et al, 2009). 
For this reason, increased understanding of the mechanisms through which low levels of 
ROS modify redox-sensitive signal transduction pathways can provide new insight into 
the intracellular networks that regulate cell growth and proliferation and help further 
understanding of how these networks are modified by changes to the intracellular redox 
environment.   
The complex nature of the mammalian antioxidant network which stems from the 
interconnectivity of the many components that comprise the network (Adimora et al, 
2010) makes the characterization and computational description of ROS-dependent 
signaling exceedingly challenging. In an attempt to address this complexity, a key 
question has emerged: Can redox-sensitive signaling pathways be somewhat insulated 
from one another, or are they all interconnected via the intracellular antioxidant network?  
 
*
Modified from Finn NA, Kemp ML “Pro-oxidant and antioxidant effects of N-acetylcysteine regulate 




This will determine whether the accurate description of ROS-dependent signaling is 
contingent on the ability to model the entire antioxidant network as a whole, or whether a 
more simplified description of a portion of the antioxidant network suffice.  
  This investigation aimed to systematically analyze the biochemical mechanisms 
by which low levels of ROS induced by the redox recycling of Dox between its quinone 
and semiquinone forms potentially alter a redox-sensitive signal transduction pathway. 
The NF-κB signal transduction pathway was chosen for analysis because it is extremely 
well-characterized, and potential points of redox susceptibility have been reported to exist 
within the pathway. Moreover, the NF-κB signal transduction pathway is an oncogenic 
pathway believed to be involved in cellular growth, proliferation, and drug resistance 
development (Dolcet et al, 2005; Zhou et al, 2003b). The ability of chemotherapy to 
regulate NF-κB transcriptional activation has been shown previously (Lin et al, 2007), 
however, the mechanistic details behind this regulation are incompletely defined and 
extremely complex (Bednarski et al, 2009). 
  The glutathione antioxidant system has emerged as a potential mediator of the 
NF-κB activation pathway (Gallogly & Mieyal, 2007; Ghezzi, 2005; Peltoniemi et al, 
2006). Furthermore, glutathione has been implicated in the drug resistance of 
hematological malignancies – most acute lymphoblastic leukemia (ALL) patients who are 
insensitive to Dox treatment show an increased expression of glutathione (Singh Ghalaut 
et al, 1999; Volm et al, 2002). Additionally, intracellular proteins that are involved in 
redox-dependent signaling can be susceptible to glutathione-dependent inactivation via 
protein S-glutathionylation (Reynaert et al, 2006). Because changes to the intracellular 
redox environment, as characterized by changes to the glutathione redox potential, can 
alter redox-sensitive signaling pathways, it was hypothesized that the intracellular redox 
environment likely modulates Dox-related NF-κB activation. 
  The use of the antioxidant N-acetylcysteine (NAC) to systematically alter 
intracellular GSH/GSSG redox potential during Dox treatment provided a mechanistic 
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framework for studying the manner in which a particular redox couple, acting 
independently of other intracellular redox couples, could potentially regulate 
chemotherapy-induced signaling. The objectives of this study, therefore, were to (a) 
determine which protein thiols in the NF-κB activation pathway are sensitive to ROS 
induced by clinically relevant concentrations of Dox, (b) determine how the 
glutathione/glutathione disulfide (GSH/GSSG) redox balance alters the redox sensitivity 
of the points identified in (a) and how this alteration affects Dox-induced NF-κB activity, 
and (c) develop a semi-quantitative computational model, based on the qualitative 
descriptions of individual redox-dependent reactions, that is capable of predicting the 
extent to which Dox treatment will affect NF-κB activity as a function of the varying 
GSH/GSSG redox potential. The results of this study provide evidence that the 
mechanistic description of a single redox couple, relatively isolated from the intracellular 
antioxidant network, is sufficient to accurately explain the ROS-dependent regulation of a 




Materials and Methods 
Materials, cell culture and treatment conditions  
     All reagents were from Sigma-Aldrich unless otherwise specified. A B-cell 
precursor ALL cell line derived from a pediatric patient (EU1-Res / EU1) has been 
previously characterized (Zhou et al, 2003a). EU1-Res cells were cultured in RPM1-1640 
medium supplemented with 10% FBS and 100 U/ml of penicillin/streptomycin. For all 
experiments, unless otherwise stated, ALL cells were resuspended in fresh media (1   
10
6
 cells/ml) and treated with various concentrations of Dox (Enzo Life Sciences), the 
IKK-β inhibitor, SC-514 (Enzo Life Sciences), or NAC (Alfa Aesar, MA, USA), 
protected from light and incubated at 37°C in a humidified atmosphere of 5% CO2. 
Phenol-red-free RPMI-1640 medium was supplemented with 10% FBS and 100 U/ml of 
penicillin/streptomycin. Antibodies: Mouse anti-IκB-α primary antibody (Genetex, CA, 
USA), rabbit anti-IKK-γ primary antibody (Cell Signaling, MA, USA), rabbit anti-IKK-β 
primary antibody (Santa Cruz Biotechnology, CA, USA) and rabbit anti-actin primary 
antibody (Sigma-Aldrich, MO, USA). 
 
Luciferase transduction 
EU1 cells were transduced with Cignal
TM
 lentiviral particles expressing Renilla 
(control) and Luciferase (NF-κB reporter) binding elements according to manufacturer‟s 
protocol (SA Biosciences, MD, USA). EU1 cells were seeded, in triplicate, in a 96-well 
plate format at a starting concentration of 1   105 cells/ml in 100 µl of RPMI-1640 
media. Cells were allowed to incubate for 24 h. After 24 h, growth media was removed 
from the wells and Renilla and Luciferase lentiviral particles, diluted in a mixture of 
SureEntry Transduction Reagent and RPMI media without antibiotics, was added to the 
cells at a multiplicity of infection (MOI) of 25. Cells were incubated for 18 h, then the 
lentiviral-containing media was removed and 100 µl of fresh RPMI growth media was 
added to the cells. On day 4 of the transduction protocol, the growth media was removed 
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and replaced with 100 µl of fresh RPMI media containing 2 µg/ml of puromycin 
antibiotic. On day 7 of the transduction protocol, live cells were harvested and assayed 
for expression of the NF-κB reporter gene. Cells were maintained in culture using RPMI 
media supplemented with 2 µg/ml of puromycin antibiotic. 
 
NF-κB activation (Luciferase Reporter Assay) 
Luciferase reporter activity was quantified using the Dual-Luciferase Reporter 
Assay System (Promega, WI, USA) according to manufacturer‟s protocol. Transduced 
EU1 cells, suspended in 100 µl of RPMI-1640 media without puromycin antibiotic, were 
plated in 96-well plate format (1   106 cells/ml). Cells were treated with various 
treatment conditions (see below) for indicated times. After treatment, cells were lysed 
and luciferase protein expression was quantified using a Synergy 4 hybrid microplate 
reader (Biotek). 
 
Intracellular ROS determination  
EU1 cells were treated with (Dox/NAC samples) or without (Dox samples) 1 mM 
NAC in phenol red-free media (for Dox samples) for 30 min. After pretreatment, Dox, at 
a final concentration of 5 µM, was added to the cells and allowed to incubate for the 
indicated times. After Dox treatment, cells were spun down and the media removed. For 
determination of Dox-induced ROS formation, H2DCFDA resuspended in DMSO was 
added to the cells after Dox treatment to a final concentration of 5 µM and cells were 
incubated for 15 min. After incubation, the cells were pelleted and resuspended in fresh 
PBS at room temperature and the plate was assayed for DCFDA fluorescence signal 
using the microplate reader (Ex = 500 nm, Em = 535 nm). Unstimulated cells, pre-
incubated with and without H2DCFDA dye, and phenol red-free media, pre-incubated 





Cytoplasmic fractions were obtained by cell lysing in non-reducing 2% Triton X 
buffer containing 50 mM β-glycerophosphate, 10 mM NaPP, 30 mM NaF, 50 mM Tris-
HCL, pH 7.5, 150 mM NaCl, 1 nM benzamidine, and 2 nM EGTA. Cells were lysed on 
ice for 1 h, followed by centrifugation for 10 min at 300 g.  
 
Immunoprecipitation (IP) 
Cytosolic lysates (150 µl) were incubated with 50 µl of magnetic protein A beads 
(Millipore, MA, USA) and placed on a rotating plate for 3 h at 4°C to minimize non-
specific binding. After incubation, beads were removed and the supernatant transferred to 
a new tube. To the supernatant, 1 µl of anti-GSH antibody was added (Virogen, MA, 
USA) and the mixture was allowed to incubate overnight at 4°C. After overnight 
incubation, 50 µl of magnetic protein A beads were added to the sample mixture and 
allowed to incubate overnight at 4°C. After the secondary overnight incubation, samples 
were spun at 300 g and the supernatant was discarded. The pellet was washed 3 times 
with RIPA buffer. After the final wash step, the pellet was resuspended in 25 µl of 
resuspension buffer (a mixture of RIPA buffer and lysis buffer used for cell fractionation) 
then boiled for 10 min at 100 °C.  
  
Western blotting 
To analyze the redox state of IKK-γ, also known as NEMO, and to quantify S-
glutathionylation of IKK-β and IκB-α, cytosolic and IP fractions were separated by native 
polyacrylamide gel electrophoresis and transferred to PVDF membranes. Primary 
antibodies were used at a dilution of 1:1000 in 10 ml of blocking buffer and incubated 
overnight at 4 °C, followed by three washes in TBS-T. Imaging and image analysis were 
conducted using the Li-Cor Odyssey Infrared Imaging System with the Odyssey 2.1 




Intracellular GSH and GSSG quantification 
Glutathione/glutathione disulfide assay (Oxford Biomedical, MI, USA) was used 
to measure GSH and GSSG levels in EU1 cytoplasmic lysate samples obtained after 
various Dox treatment conditions. GSH/GSSG quantification was achieved by the 
enzymatic recycling assay according to manufacturer‟s protocol. 
 
Statistical Analysis 
All values reported are the average of three or more independent biological 
replicates +/- standard error. Statistical significance is based upon the criteria of p < 0.05 
for a Student‟s t-test (two-tailed, equal variance). 
 
Computational modeling  
To reconcile our experimental findings and to better understand the effect of the 
glutathione redox potential and the intracellular redox environment on chemotherapy-
induced IKK-β S-glutathionylation, a biochemical model of pertinent reactions was 
constructed (Fig. 6-1). Previous models of ROS-induced protein thiol oxidation have 
characterized rate constants for the oxidation reactions that result in general protein thiol 
modification (Adimora et al, 2010; Antunes & Cadenas, 2000; Makino et al, 2004; Sasaki 
et al, 1998; Seaver & Imlay, 2001). The identification of oxidant targets based on the 
relative chemical reactivity of potential substrates (Winterbourn & Hampton, 2008), 
provided the quantitative basis by which a protein-specific S-glutathionylation model 
could be constructed.  
A schematic diagram of the general framework of the model is shown in Figure 6-
1. The model describes the relevant literature-reported processes that control oxidant-
induced IKK-β S-glutathionylation. Upon Dox administration, intracellular enzymes 
convert the anthracycline drug into a semiquinone free radical (Bachur et al, 1979; 
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Cummings et al, 1992; Sinha et al, 1989). The differential equation describing the rate of 
change of intracellular semiquinone Dox as a function of time is modeled by the 
following equation: 
 
 [      ]
  
           (
 
  
)                                                                             (6-1)                                                            
 
where t represents time in seconds. This equation was fit to the semiquinone Dox profile 
for a 500 nM Dox treatment condition, as predicted by a previous model of Dox 
bioactivation in EU1 cells (Chapter 4). 
Reactions involving semiquinone Dox can also lead to the intracellular production 
of hydrogen peroxide (H2O2) and thiyl radicals (RS
•
) (Kostrzewa-Nowak et al, 2005; 
Menna et al, 2007; Ravi & Das, 2004). Molecular oxygen can react with semiquinone 
Dox to produce superoxide, which is converted to H2O2 by superoxide dismutase. 
Alternatively, intracellular proteins can react with the semiquinone Dox radical to 
produce the protein thiyl radical, RS
•
. The rate constants that describe the formation of 
H2O2 and RS
•
 from intracellular semiquinone Dox were estimated from the literature-
reported reaction rates of molecular oxygen and protein thiols, respectively, with 
semiquinone Dox (Kalyanaraman et al, 1980; Winterbourn & Hampton, 2008).  
The rate constants for the reactions used in the mathematical model for each 
treatment condition are shown in Table 6-1. Although these rates have units of inverse 




), the literature-reported proportionalities between 
the rate constants for the different reactions are conserved (Adimora et al, 2010; 
D'Autreaux & Toledano, 2007; Dalle-Donne et al, 2009; Winterbourn & Hampton, 
2008). Correspondingly, the initial concentrations of the species utilized in the model 
(Table 6-2) also mirror the literature-reported proportionalities between each of the 
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Figure 6-1. Mechanistic model of glutathione-dependent IKK-β S-glutathionylation. 
Schematic representation of the reactions involved in glutathione-dependent IKK-β S-
glutathionylation. Dox treatment promotes the formation of hydrogen peroxide (H2O2) 
and protein thiyl radicals (RS
•
). Once formed, H2O2 mediates the S-glutathionylation of 
reduced IKK-β via the peroxide-dependent oxidation of IKK-β. Concurrently, Dox-
induced RS
•
 formation induces IKK-β S-glutathionylation via the radical-dependent 
oxidation of IKK-β. However, increased thiyl radical levels simultaneously promote the 
radical oxidation of GSH into the glutathione thiyl radical (GS
•
) which serves to 
effectively diminish reduced GSH levels from the intracellular environment. NAC, the 
GSH precursor, regulates the peroxide-dependent and the radical-dependent mechanisms 
of IKK-β S-glutathionylation via its ability to promote glutathione synthesis as well as its 
ability to contribute to free-radical formation. 
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Table 6-1: Rate expressions and rate constants for the ODEs that comprise the 
mechanistic IKK-β S-glutathionylation model. 
 
  Parameter Value at Various [NAC](mM)
*
  






      
R1 k1 ([Dox sq])  H2O2 k1 = 6.0 x 10
-3
  6.0 x 10
-3
 6.0 x 10
-3
 6.0 x 10
-3
 
R2 k2 ([GSH]) ([H2O2])  GSSG k2 = 2.0 x 10
-3
  2.0 x 10
-3
 2.0 x 10
-3
 2.0 x 10
-3
 
R3 k3 ([IKK-SH]) ([H2O2])  IKK-SOH k3 = 5.0 x 10
-5
 5.0 x 10
-5
 5.0 x 10
-5
 5.0 x 10
-5
 
R4 k4 ([IKK-SOH]) ([GSH])  IKK-SSG k4 = 6.0 x 10
-3
 6.0 x 10
-3
 6.0 x 10
-3
 6.0 x 10
-3
 
R5 k5 ([Dox sq])  RS
• 
k5 = 1.2 x 10
-3
 3.7 x 10
-3
 3.7 x 10
-3
 3.7 x 10
-3
 




k6 = 5.0 x 10
-3
  5.0 x 10
-3
 5.0 x 10
-3
 2.5 x 10
-3
 




 k7 = 5.0 x 10
-4
  5.0 x 10
-4
 5.0 x 10
-4
 5.0 x 10
-4
 
R8 k8 ([GSH]) ([IKK-S
•
])  IKK-SSG k8 = 5.0 x 10
-3 
  5.0 x 10
-3 
  5.0 x 10
-3 
  5.0 x 10
-3 
  
R9 k9   [GSH] k9 = 6.0 x 10
-2
  1.8 x 10
-1
 3.7 x 10
-1
 6.0 x 10
-1
 
R10 k10 ([H2O2])  Null k10 = 5.2 x 10
-3
  5.2 x 10
-3
 5.2 x 10
-3





Reaction rate constants highlighted in red represent the rate constants that were fitted to 
experimentally-determined IKK-SSG behavior for the various NAC pretreatment conditions 
investigated. The rate constants are given in units of inverse a.u.   inverse time (a.u.-1s-1) 
 
Table 6-2: Initial concentration values of the components that comprise the mechanistic 
model of IKK-β S-glutathionylation.                                                                    
 Species Initial Condition (A.U.) Reference 
[Dox sq] 6.5 Assigned 
[H2O2] 0 Assigned 
[RS
•
] 0 Assigned 
[GSH] 500 (Schafer & Buettner, 2001) 
[GSSG] 5 (Schafer & Buettner, 2001) 
[GS
•
] 0 Assigned 
[IKK-SH] 50 (Winterbourn & Hampton, 2008) 
[IKK-SOH] 0 Assigned 
[IKK-S
•
] 0 Assigned 




Major assumptions of the mechanistic model  
The mechanistic model constructed for this study was based on the assumption 
that the GSH/GSSG redox couple is effectively insulated from the other major redox 
couples that comprise the mammalian antioxidant network (Adimora et al, 2010; Jones et 
al, 2004; Kemp et al, 2008). One of the main goals of this study was to evaluate whether 
variations in the redox potential of the GSH/GSSG redox couple can be significant 
enough to alter a redox-sensitive signaling process, the S-glutathionylation of IKK-β. 
Moreover, this study sought to determine whether qualitative observations regarding the 
directional effects of NAC pretreatment on particular redox-reaction rates could be 
effectively translated into accurate quantitative descriptions of IKK-β S-
glutathionylation. To accomplish these tasks, it was necessary to develop a model for 
ROS-dependent IKK-β S-glutathionylation that explicitly described glutathione-
dependent reactions only.  
The next major assumption involved the effect of NAC pretreatment on the rates 
of formation of reduced glutathione (GSH), protein thiyl radical (RS
•
) and glutathione 
thiyl radical (GS
•
). NAC is well known for its ability to affect intracellular glutathione 
levels as it can be utilized as a substrate for glutathione synthesis (Raftos et al, 2010). 
However, because a molecule of NAC does not instantaneously transform into a 
molecule of GSH upon entrance into the cell, and because the kinetic characteristics of 
the enzymatic transformation of NAC into GSH are not well characterized (Raftos et al, 
2010), it was deemed inappropriate to directly model the effect of NAC pretreatment as 
an instantaneous change to the initial level of reduced GSH in the model system. Instead, 
the effect of NAC pretreatment was modeled as a change to the synthesis rate of total free 
glutathione, as described previously (Raftos et al, 2010); NAC pretreatment was assumed 




The proposed model explicitly describes only a subset of the glutathione-
dependent reactions that are assumed to take place within a given cell upon Dox 
administration. However, because other glutathione-dependent reactions occur during 
conditions of oxidative stress (Adimora et al, 2010) these additional reactions had to be 
implicitly taken into account by the model. Without the explicit inclusion of all GSH-
dependent reduction reactions that involve intracellular proteins, an alternate technique 
was needed to accurately represent the competition over reduced GSH that exists across 
potential GSH targets in vivo. To prevent overestimation of GSH-dependent reduction in 
the model system, a viable modeling technique is to estimate the relative concentration of 
GSH that would be specifically available for reaction with oxidized IKK-β. This scaled 
GSH concentration was calculated from a previously published competition equation 
(Winterbourn & Hampton, 2008) that takes into account the ratio of [IKK-β] to [total 
protein] and the rate constant describing the GSH-dependent reduction of oxidized 
protein thiol (Adimora et al, 2010; Winterbourn & Hampton, 2008). Other assumptions 
made in the construction of the mechanistic model include the assumption that Dox 
degradation and efflux was negligible for the duration of the treatment (Ozols et al, 1979) 
and that all oxidation reactions occurred in the absence of target recycling. 
 
Major assumptions utilized during mechanistic model fitting 
Certain rules were utilized and assumptions made to determine the exact way in 
which NAC-dependent rate constant modulation was to be modeled and tested for its 
ability to explain experimental data. First, the reaction rates that were allowed to be 
modified by the presence of NAC were determined through an extensive literature search 
of the possible ways in which NAC can alter the intracellular redox environment. 
Preliminary searches indicated that a role for NAC, and other low molecular weight 
thiols, in the direct elimination of intracellular H2O2 is improbable due to low rate 
constant values for their reaction with hydrogen peroxide (D'Autreaux & Toledano, 2007; 
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Winterbourn & Hampton, 2008; Winterbourn & Metodiewa, 1999). The high proportion 
of GSH that is oxidized to GSSG by H2O2, as described by the model (Fig. 6-1), is 
representative of the GSH-dependent, GPx-catalyzed reduction of peroxide which occurs 
at a significantly fast rate (Ng et al, 2007). Based on this experimental detail, all 
peroxide-dependent reactions were excluded from explicit NAC-dependent alterations. 
Next, the effect of NAC pretreatment on GSH-dependent reactions was 
investigated because NAC is known to modulate GSH synthesis. Since quantitative 
details of the effect of NAC pretreatment on GSH synthesis have been shown in the 
literature (Raftos et al, 2010), these quantitative effects were directly modeled for the 
various NAC pretreatment conditions considered. The fold-increases over the basal GSH 
synthesis rate that were experimentally reported for the various extracellular NAC 
treatment conditions being simulated were directly utilized in the mechanistic model, e.g. 
if 0.5 mM extracellular NAC was reported to result in a 2-fold increase in the rate of total 
free glutathione synthesis, then the basal rate of GSH synthesis in the model was 
automatically increased by 2-fold for the 0.5 mM [NAC] pretreatment condition. It was 
assumed that any additional modulation of non-radical, GSH-dependent reactions as a 
result of NAC pretreatment, through the explicit alteration of their respective rate 
constants, would overestimate the effect of increased GSH availability on the protein S-
glutathionylation network being modeled. As a result, NAC-induced changes to the 
peroxide-dependent reactions that involve GSH were implicitly described by the 
literature reported effects of NAC pretreatment on GSH synthesis. 





) was considered. A major goal of this study was to develop a mechanistic description 
of the effect of NAC pretreatment on a redox-sensitive process, namely IKK-β S-
glutathionylation. Moreover, this goal was to be achieved without the explicit inclusion 
of all the details involved in the S-glutathionylation process. The following reactions 
were consulted to determine which, if any, of the radical-related reactions could 
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potentially be modified by NAC pretreatment in vivo, and the directionality of the 
proposed modifications (Nappi & Vass, 1997):  
 
        
                                                                                         (6-2)                                                       
 
    (     )                                                                                       (6- 3)                                                               
 
Equation 6-2 represents the Fenton reaction of transition metals (Fe
2+





 radical. Equation 6-3 represents the Haber-Weiss reaction of low 
molecular weight thiols or NAC with Fe
3+
 to produce protein thiyl radical species. 
Because iron is in excess in most mammalian cells (Kabat & Rohan, 2007), these two 
reactions, taken together, qualitatively illustrate that in the presence of peroxide, 
increased NAC availability will promote the formation of protein thiyl radicals.  
The literature reports suggest that increased thiol availability, as a result of NAC 
administration, increases thiyl radical formation and thiyl-based oxidation by 
approximately 3-fold (O'Brien, 1988; Sagrista et al, 2002). Moreover, the systematic 
titration of various extracellular NAC concentrations, at various levels of initial [H2O2], 
yields a sigmoidal relationship between the extracellular NAC pretreatment concentration 
applied and the extracellular NAC concentration at which the 3-fold-change increase in 
thiyl radical formation was observed (Sagrista et al, 2002) (Fig. 6-2). From these 
literature-reported findings, it was concluded that the effect of NAC pretreatment could 
be modeled as a 3-fold increase in the rate of RS
•
 formation (k5), for a given NAC 
pretreatment condition. Moreover, due to the sigmoid behavior of the effect of NAC 
pretreatment on thiyl radical formation, it was assumed that once the 3-fold increase in 
protein thiyl radical formation rate was fit to a particular NAC pretreatment condition, all 




                    
 
Figure 6-2. Effect of NAC thiols on peroxide-dependent protein thiyl (RS
•
) radical 
formation. The proposed extracellular [NAC]-dependent effects on protein thiyl radical 
formation rate as a function of initial H2O2 concentration. The rates of formation of 
protein thiyl radicals are not increased by NAC pretreatment until the concentration of 
NAC reaches a critical level. If [NAC] is at or above this threshold level, the rate of 
protein thiyl radical formation is increased by a factor of 3. Additionally, the threshold 
level of NAC at which this 3-fold increase in RS
•
 formation rate occurs is dependent on 
the initial concentration of H2O2 in the system. For lower levels of H2O2, the critical 
[NAC] is relatively high, whereas for higher levels of H2O2, the critical [NAC] is 
relatively low. Image adapted from the lipid peroxidation profiles described by (Sagrista 
et al, 2002). 
 
The effect of NAC pretreatment on GS
•
 formation rate (k6) was deduced using the 
same methodology that was employed to determine the effect of NAC pretreatment on 
RS
•
 formation rate (k5). Consider the following radical-related reactions (Halliwell, 1991; 
O'Brien, 1988; Sagrista et al, 2002): 
 
                                                                                                          (6-4)                                                                        
 
                                                                                                            (6-5)                                                                             
 
Equations 6-4 and 6-5 represent the potential fates of the protein thiyl radical upon 




(k6) is larger than the rate of formation of GS
• 
in the presence of NAC. This occurs 
because NAC and GSH effectively compete over the limited pool of available 
intracellular radicals (Winterbourn & Hampton, 2008). Because this competition exists 
between NAC and GSH, as is illustrated by Equations 6-4 and 6-5, one can qualitatively 
conclude that increased NAC availability will decrease the formation of glutathione thiyl 
radicals.  
Once the directionality of NAC-dependent modification was determined for the 
rate of formation of glutathione thiyl radicals, an appropriate quantitative estimate of the 
magnitude of this modification was needed. The rate at which NAC reacts with radicals is 
comparable to the rate at which GSH reacts with radicals (Winterbourn & Hampton, 
2008; Winterbourn & Metodiewa, 1999). If it is assumed that the intracellular 
concentration of NAC at which NAC begins to compete with GSH for thiyl radicals is 
comparable to the intracellular concentration of GSH, then NAC pretreatment will 
decrease GSH thiyl radical formation by 2-fold according to the following equations 
(Winterbourn & Hampton, 2008):  
 
  [   ]
  
     [  
 ][   ]       [  
 ][   ]                                                          (6-6) 
 
    
    
     [   ]     [   ]                                                                                    (6-7)                                                                                
 
Equation 6-6 represents the rate equation for the second order RS
•
 reduction 
processes involving GSH and NAC, respectively. Equation 6-7 represents the flux ratio 
between the GSH-dependent and NAC-dependent RS
•
-reduction reactions. If [NAC] is 
equal to [GSH], as was previously assumed, and if kGSH is equal to kNAC, as has been 
previously reported (Winterbourn & Hampton, 2008; Winterbourn & Metodiewa, 1999), 
then a 1:1 flux ratio exists between the two competing reactions. Therefore in the 
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presence of NAC, it can be assumed that the rate of GSH thiyl radical formation will be 
decreased by a factor of 2.  
Assuming that NAC pretreatment will only affect GS
•
 formation when the 
intracellular NAC concentration is at or above a certain threshold allows us to impose a 
sigmoidal type of relationship between NAC pretreatment and NAC-induced effects on 
GS
•
 formation rates. Moreover, because intracellular NAC is efficiently converted to 
GSH and cysteine (Cys) (Raftos et al, 2010), and because the levels of these species are 
regulated by transport mechanisms (Jones, 2008), the maximum levels of free 
intracellular NAC will most likely not exceed intracellular levels of GSH within the cell 
(Burgunder et al, 1989). Therefore, NAC pretreatment conditions above those that 
produce the threshold level of intracellular NAC at which the GS
•
 formation rates are 
affected will still result in a 2-fold decrease in the rate of GS
•
 formation. This type of 
sigmoidal behavior, as a function of NAC-pretreatment, is not unprecedented (Sagrista et 





Dox treatment induces ROS in EU1 cells that can be attenuated by NAC pretreatment 
To characterize the capacity for Dox treatment to induce ROS generation in 
leukemia cells, the EU1 ALL cell line was treated with Dox (5 µM) for various time 
points, after which, Dox-induced ROS generation was quantified by plate reader 
measurement of H2DCFDA fluorescence (Fig. 6-3). A significant increase in ROS 
production was seen at around 40 min of Dox treatment. This increase in ROS production 
was substantial with regards to its amplitude and its duration. After 40 min of Dox 
treatment, ROS levels had increased by 50% above baseline and the Dox-induced ROS 
levels continued to rise, almost reaching 2x its baseline value by 60 min of Dox treatment 
(Fig. 6-3). 
Next, the ability of NAC to prevent Dox-induced ROS generation was assessed. 
EU1 cells were pretreated with NAC (1 mM) for 30 min followed by Dox administration 
(5 µM) for various time points up to 1 h (Fig. 6-3). Results show that NAC pretreatment 
was able to inhibit Dox-induced ROS in the EU1 cells. The deviation between the ROS 
profiles of EU1 cells with and without NAC pretreatment was evident by 30 min of Dox 
treatment and became more pronounced during the remainder of the treatment (Fig. 6-3). 
While the EU1 cells without NAC pretreatment experienced increased Dox-induced ROS 
levels up to 2x their baseline values, the NAC pretreated EU1 cells were able to maintain 





         
 
Figure 6-3. Dox treatment induces ROS in EU1 cells that can be attenuated by N-
acetylecysteine (NAC) pre-treatment. Time-dependent Dox-induced H2O2 in EU1 cells, 
with and without NAC pre-treatment, quantified by plate reader measurement of 
H2DCFDA fluorescence. ([NAC] = 1 mM, 30 min pre-treatment; [Dox] = 5 µM, 1 hr 
treatment; *p < 0.05)  
 
 
NAC promotes Dox-induced NF-κB by selectively regulating ROS-induced IKK-β S-
glutathionylation  
The role that ROS play in regulating NF-κB activation has been addressed 
previously in the literature and multiple points of redox regulation have been reported, 
such as the disulfide-based dimerization of NEMO, the S-glutathionylation of IB-α, and 
the S-glutathionylation of IKK-β (Oliveira-Marques et al, 2009). However, if a greater 
understanding of the mechanism by which Dox alters this pathway is to be achieved, it is 
necessary to determine the specific components in the pathway that are susceptible to 
Dox-induced ROS. To achieve this goal, luciferase-transduced EU1 cells were treated for 
1 h with various combinations of NAC, Dox, and the IKK-β inhibitor, SC-514; the effects 


























measurement of luciferase luminescence (Fig. 6-4 A). Dox treatment of luciferase-
transduced EU1 cells led to a significant increase in NF-κB reporter activity. NAC 
pretreatment prior to Dox administration resulted in an even greater response in NF-κB 
reporter activity; luciferase luminescence values were almost 2x that of the Dox-only 
treatment group. However, when luciferase-transduced cells were pretreated with SC-514 
(100 µM) prior to Dox administration, the Dox treatment regimen was no longer able to 
induce NF-κB reporter activity (Fig. 6-4 A). Moreover, when SC-514-pretreated cells 
were exposed to NAC, prior to Dox administration, the Dox treatment regimen was also 
unable to induce NF-κB reporter activity.  
Having examined the general effects of NAC pretreatment on Dox-induced NF-κB 
activation, a more specific examination of the individual components of the NF-κB 
activation pathway was carried out. NEMO has been shown to undergo disulfide bond 
formation during periods of oxidative stress and this process is thought to positively 
contribute to NF-κB activation (Herscovitch et al, 2008). The effect of Dox treatment and 
NAC pretreatment on NEMO dimerization was assessed. Dox treatment did not result in 
any significant changes to the levels of disulfide bonded NEMO protein in EU1 cells; the 
same results were seen in the NAC-pretreated cells (Fig. 6-4 B).  
Cys 179 of IKK-β (de Oliveira-Marques et al, 2007; Oliveira-Marques et al, 2009; 
Reynaert et al, 2006) and Cys 189 of IκB-α (Kil et al, 2008) have been reported as 
potential targets of protein S-glutathionylation with functional consequences on catalytic 
activity and protein-protein interactions; the addition of a glutathione moiety to an active 
cysteine residue of a protein can result in structural changes to the protein or blocked 
access to critical amino acid residues, two processes that can potentially inhibit DNA 
binding, enzyme attachment, or protein phosphorylation (Dalle-Donne et al, 2009). To 
assess the effect of Dox treatment on the S-glutathionylation of IKK-β and IκB-α, EU1 
cells, with or without NAC pretreatment, were exposed to Dox for 1 h and then lysed. 
Protein-glutathione mixed disulfides were immunoprecipitated from cytoplasmic lysates 
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with an anti-GSH antibody then run on a western blot to quantify the relative amounts of 
IKK-β and IκB-α (Fig. 6-4 C, D). Doxorubicin treatment induced significant S-
glutathionylation of IKK-β but insignificant S-glutathionylation of IκB-α. The basal level 
of S-glutathionylated IKK-β was significantly larger than that of S-glutathionylated IκB-
α. NAC pretreatment was able to rescue the EU1 cells from Dox-induced IKK-β S-
glutathionylation; however, NAC pretreatment had no effect on the low levels of Dox-
induced IκB-α S-glutathionylation that were quantified (Fig. 6-4 C, D). NAC 







Figure 6-4. Dox-induced NFKB activity in EU1 cells is IKK-β dependent and 
promoted by NAC pre-treatment. (A) NF-κB activity, expressed as luciferase fold 
induction, in untreated and Dox-treated EU1 cells with and without pre-treatment with 
NAC or IKK-β inhibitor, SC-514. Representative immunoblot analysis, with 
accompanying densitometry quantification normalized to lane 1, of (B) Dox-induced 
NEMO dimerization, (C) Dox-induced IKK-β S-glutathionylation, and (D) Dox-induced 
IκB-α S-glutathionylation in EU1 cells, with and without NAC pretreatment. ([NAC] = 1 
mM, 30 min pre-treatment; [SC-514] = 100 µM, 1hr pre-treatment; [Dox] = 5 µM, 4 hr 
treatment; *p < 0.05).  
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NAC modulates Dox-induced glutathione redox status, Dox-induced IKK-β S-
glutathionylation and Dox-induced NF-κB activation 
To examine the effect of NAC pretreatment on Dox-induced glutathione redox 
balance, EU1 cells were pretreated with various concentrations of NAC (0.5 – 5 mM) to 
alter the intracellular GSH/GSSG redox state prior to Dox treatment. The EU1 cells were 
pretreated with designated concentrations of NAC for 30 min followed by Dox (500 nM) 
administration for 1 h. A Dox concentration of 500 nM was utilized because a previous 
model of Dox bioactivation (Chapter 4) suggested a more substantial role for Dox-
mediated signaling at low Dox concentrations. After Dox treatment, the intracellular 
glutathione redox balance was quantified (Fig. 6-5 A). NAC pretreatment prior to Dox 
administration promoted increased ratios of GSH/GSSG. The 0.5 mM NAC pretreatment 
condition resulted in GSH/GSSG values that were 3x higher than the GSH/GSSG values 
measured for the EU1 cells treated with Dox in the absence of NAC. The 5 mM NAC 
pretreatment group displayed similar GSH/GSSG values to the 0.5 mM NAC 
pretreatment group. Interestingly, however, the 1 mM NAC pretreatment condition, 
though it too resulted in increased GSH/GSSG values compared to the Dox-only controls, 
showed a slightly decreased GSH/GSSG compared to the 0.5 mM and 5 mM treatment 
groups (Fig. 6-5 A). Dox-induced ROS formation was also quantified as a function of 
NAC pretreatment condition (Fig. 6-5 B). The 0.5 mM NAC pretreatment group showed 
no significant difference in Dox-induced ROS formation compared to the Dox-only 
controls. Significant decreases in Dox-induced ROS, compared to the Dox-only controls, 






Figure 6-5. NAC controls Dox-induced IKK-β S-glutathionylation by modifying 
intracellular glutathione redox balance. EU1 cells were treated with various 
concentrations of NAC prior to Dox administration. After treatment, cells were harvested 
and lysed; (A) the intracellular GSH/GSSG ratio was quantified using an enzymatic 
recycling assay, and (B) the intracellular ROS was quantified using plate reader 
measurement of H2DCFDA fluorescence. Luciferase-tranduced and non-tranduced EU1 
cells, respectively, were pretreated with various concentrations of NAC prior to Dox 
administration and then lysed; (C) the intracellular levels of S-glutathionylated IKK-β 
were quantified by IP and western blot, and (D) the activity of NF-κB was quantified by 
plate reader measurement of luciferase luminescence. (E, F) Correlation plots of 
standardized Dox-induced IKK-β S-glutathionylation and standardized Dox-induced 
luciferase luminescence were plotted against standardized GSH/GSSG ratios. Pearson 
coefficients for the linear correlations are shown in each graph. (NAC = 30 min pre-
treatment; [Dox] = 500 nM, 1 hr treatment; *p < 0.05) 
133 
 
To examine the effect of altered glutathione redox balance on Dox-induced NF-
κB activity, non-transduced and luciferase-transduced EU1 cells were pretreated for 30 
min with various concentrations of NAC (0.5 – 5 mM) prior to Dox (500 nM) 
administration for 1 h. After treatment, the intracellular concentration of S-
glutathionylated IKK-β was quantified in the non-transduced EU1 cells, while Dox-
induced NF-κB was quantified in the luciferase-transduced cells (Fig. 6-5 C, D). 
Surprisingly, none of the NAC pretreatment conditions were able to inhibit Dox-induced 
IKK-β S-glutathionylation at the 500 nM [Dox] condition (Fig. 6-5 C), as was previously 
seen for the 5 µM [Dox] treatment condition (Fig. 6-4 C). In fact, both the 0.5 mM and 
the 5 mM NAC pretreatment groups led to an increased level of Dox-induced IKK-β S-
glutathionylation. The 1 mM NAC pretreatment group exhibited the same amount of 
Dox-induced IKK-β S-glutathionylation as the Dox-only treatment group (Fig. 6-5 C). 
Correspondingly, none of the NAC pretreatment groups were able to promote Dox-
induced NF-κB activity to levels that were significantly higher than the Dox-only group 
(Fig. 6-5 D), a phenomenon that was exhibited at the 5 µM [Dox] treatment condition 
(Fig. 6-4 A). Both the 0.5 mM and the 5 mM NAC pretreatment groups experienced 
significantly less Dox-induced NF-κB activity compared to the Dox-only group. NAC 
pretreatment at the 1 mM level did not significantly affect Dox-induced NF-κB activity 
compared to the Dox-only controls (Fig. 6-5 D). 
Linear correlation analyses were carried out to determine the degree to which the 
GSH/GSSG redox balance can be related to Dox-induced IKK-β S-glutathionylation and 
Dox-induced NF-κB activity. Results of this analysis reveal that the GSH/GSSG redox 
balance has a strong positive correlation to the level of Dox-induced IKK-β S-
glutathionylation (Fig. 6-5 E). The Pearson‟s correlation value for this linear relationship 
was + 0.64. Interestingly, the GSH/GSSG redox balance has a strong negative correlation 
to the level of Dox-induced NF-κB activity (Fig. 6-5 F), with a Pearson‟s correlation 
value for this linear relationship of -0.68. 
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A Mechanistic model predicts dual roles for NAC in modulating glutathione-dependent 
IKK-β S-glutathionylation 
The consistent biphasic trends we observed with NAC dosage required the 
development of biochemical models to test potential mechanisms by which NAC 
modulates IKK-β S-glutathionylation. Literature-reported effects of NAC treatment were 
systematically simulated and tested for their ability to reproduce the complex behavior of 
IKK-SSG levels under various NAC pretreatment conditions (Fig. 6-6). NAC treatment is 
known to induce GSH synthesis, so with increasing levels of NAC, the rate constant for 
GSH synthesis was proportionally increased according to published data on the effect of 
NAC treatment on the rate of GSH synthesis in the erythrocyte cell (Raftos et al, 2010). 
The rates of GSH synthesis for the four NAC treatment conditions are shown in Table 6-
1. Literature-reported qualitative details related to NAC-dependent protein and GSH thiyl 
radical formation rates were translated into semi-quantitative rules that were used to 
determine the extracellular NAC pretreatment concentrations at which a 3-fold increase 
in protein thiyl radical formation rate and a 2-fold decrease in GSH thiyl radical 





 formation rates were deduced from literature-published studies and the 
related redox-reactions that were derived from those studies (Halliwell, 1991; Nappi & 
Vass, 1997; O'Brien, 1988; Raftos et al, 2010; Sagrista et al, 2002; Winterbourn & 
Hampton, 2008). An illustration of the systematic process by which the model-fitting was 






Figure 6-6. Schematic representation of the algorithm utilized to systematically 
predict the effect of NAC pretreatment on NAC-sensitive model parameters. 
Directional arrows represent the experimentally-measured effect of the NAC 







The systematic alteration of the rate constants describing the NAC-sensitive 
reactions (k5, k6) was carried out for the various NAC pretreatment conditions. The effect 
of NAC pretreatment on GSH synthesis was not considered to be a testable parameter in 
need of model fitting since the effect of NAC on GSH synthesis had already been 
quantitatively characterized in the literature (Raftos et al, 2010). The two NAC-
dependent alterations that were tested were the threshold NAC concentrations at which 
the 3-fold NAC-dependent increase in RS
•
 formation rate (k5) and the 2-fold NAC-
dependent decrease in GS
•
 formation rate (k6) occurs.  
The 0.5 mM NAC pretreatment condition was analyzed first. For the 0.5 mM 
NAC pretreatment condition, all permutations of the two potential NAC-dependent 
effects were tested for their ability to replicate experimentally derived IKK-SSG levels 
(Fig. 6-6). The combinations that produced an increase in IKK-SSG levels compared to 
the 0 mM NAC pretreatment condition (basal), as was seen experimentally, were selected 
as potential candidates for further analysis. Those combinations that did not produce the 
experimentally-determined increase in IKK-SSG levels at the 0.5 mM condition were 
rejected; further analysis of these combinations at the 1 and 5 mM NAC pretreatment 
conditions were unnecessary due to the sigmoidal nature of the NAC-dependent effects 
(Fig. 6-2). This process was carried out consecutively for the 1 mM and 5 mM NAC 
pretreatment conditions to determine which of the possible combinations could 
effectively describe experimentally-determined Dox-induced IKK-SSG for all NAC 
pretreatment conditions (Fig. 6-6).  
The results of the model-fitting simulations predict that the two processes 
susceptible to NAC modulation (apart from the well characterized GSH synthesis 
reactions (R9)) exhibit their NAC-susceptibility at different extracellular NAC 
concentrations (Table 6-1). The model predicts that increasing concentrations of NAC 
result in a threshold-dependent decrease in the rate of GSH thiyl formation (R6). The 
model confirms literature reports that show increasing concentrations of NAC result in a 
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threshold-dependent increase in the rate of protein thiyl radical formation (R5) (Sagrista 
et al, 2002). The model predicts that the minimum [NAC] that produces the threshold-
dependent decrease in the rate of GSH thiyl radical formation is higher than the minimum 
[NAC] that produces the threshold-dependent increase in the rate of protein thiyl radical 
formation (Table 6-1).  
The mechanistic model behavior was fitted to the experimental dataset of Dox-
induced IKK-β S-glutathionylation (Fig. 6-7 A). To test the universality of the model-
predicted mechanism of IKK-β S-glutathionylation, the model-predicted step-like 
responses of (R5) and (R6) and the graded response of (R9) to increasing NAC 
concentrations were tested in their ability to predict IKK-β S-glutathionylation as a result 
of a new experimental condition, NAC treatment only, independent of Dox. The 
mechanistic model was able to accurately predict NAC-dependent IKK-β S-
glutathionylation in the absence of Dox treatment for a variety of NAC pretreatment 






Figure 6-7. Mechanistic mathematical model of IKK-β S-glutathionylation predicts 
experimental behavior. (A) Model-fitted and experimentally-derived values for Dox-
induced IKK-β S-glutathionylation after various NAC pretreatment regimens. (B) Model-
predicted and experimentally-derived values for IKK-β S-glutathionylation after various 






IKK-β, NEMO and IκB-α have differential sensitivities to chemotherapy-induced ROS 
The NF-κB signal transduction pathway is a well-characterized redox sensitive 
pathway containing several proteins that are believed to be regulated by oxidative stress 
(Oliveira-Marques et al, 2009; Reynaert et al, 2006). In this study, the administration of 
clinically-relevant concentrations of Dox were utilized to decipher the points in the NF-
κB activation pathway that are most sensitive to chemotherapy-induced ROS generation 
in a pediatric ALL cell line. Results suggest that in EU1 cells, NEMO dimerization is 
insensitive to ROS induced by Dox (Fig. 6-4 B). While it has been shown in the literature 
that NEMO dimerization does occur within mammalian cells (Herscovitch et al, 2008), 
and is a necessary step for some methods of NF-κB activation (Marienfeld et al, 2006), 
these results are consistent with reports that in some cell lines NEMO dimer formation 
remains unaltered upon stimulation (Marienfeld et al, 2006). This insensitivity could be 
the result of several factors. Primarily, the formation of disulfide bonds is a relatively fast 
process (Adimora et al, 2010; Winterbourn & Metodiewa, 1999) and is therefore highly 
sensitive to the intracellular redox environment. Cancer cells are well known to have 
higher than normal levels of oxidants and are considered to be under oxidative stress 
conditions even in the absence of external stimuli (Marnett, 2000; Mates et al, 1999). 
This basal oxidative condition could potentially induce substantial amounts of NEMO 
dimerization in the absence of external stimuli. If this is the case, then Dox treatment 
would result in little to no change in NEMO dimer levels. This dependency of NEMO 
dimerization on the intracellular redox environment is further supported by the fact that 
cells of different lineages exhibit significantly different levels of NEMO dimerization 
under basal conditions (Herscovitch et al, 2008). 
The administration of Dox to the EU1 cells did not result in significant increases 
in the level of IκB-α-SSG, but did result in increases in the level of IKK-β-SSG (Fig. 6-4 
C, D). While both of these processes involve protein-S glutathionylation (Kil et al, 2008), 
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it appears that the sensitivity of IKK-β to this modification is substantially greater than 
that of IκB-α. Differential sensitivity of cysteine residues is not an unprecedented idea; 
however, most of the studies that have provided insight into differential sensitivity have 
utilized the exogenous administration of oxidants in an in vitro system to accurately 
characterize the relative susceptibility of certain protein thiol species to oxidation 
(Winterbourn & Hampton, 2008; Winterbourn & Metodiewa, 1999). This study provides 
evidence that ROS induced endogenously by the metabolic bioactivation of Dox in a 
cellular system can also result in differential protein oxidation. Moreover, in EU1 cells, 
the S-glutathionylation process, compared to the protein disulfide formation process, may 
undergo differential regulation by other ROS-related enzymes, given the fact that Dox-
treatment was able to induce higher levels of S-glutathionylated IKK-β which was 
attenuated by NAC treatment (Fig. 6-4 C). Correspondingly, protein S-glutathionylation 
has been considered in the literature to occur at a slower rate than protein disulfide 
formation (Adimora et al, 2010; Winterbourn & Hampton, 2008; Winterbourn & 
Metodiewa, 1999). IκB-α S-glutathionylation at Cys 189 has been proposed as a potential 
mechanism by which NF-κB is regulated (Kil et al, 2008), however, the results of our 
study suggest that this is not a relevant mechanism by which NF-κB is regulated in EU1 
cells under the treatment conditions applied.  
 
IKK-β S-glutathionylation occurs in the presence of multiple competing reactions 
A schematic representation of the proposed reactions involved in glutathione-
dependent IKK-β S-glutathionylation is presented in Figure 6-1. The protein S-
glutathionylation mechanisms considered in the model include protein S-
glutathionylation via peroxide-induced IKK-β sulfenic acid formation and via radical-
induced IKK-β thiyl radical formation. The model was constructed after the systematic 
consideration of the literature-reported reactions that could potentially contribute to 
intracellular protein S-glutathionylation (Dalle-Donne et al, 2009; Mieyal et al, 2008). 
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This systematic consideration occurred in iterative steps. First, the literature reported 
rates of reactions and necessary conditions for the possible mechanisms of protein S-
glutathionylation were utilized to rule out non-essential pathways of S-glutathionylation 
(Mieyal et al, 2008), pathways that would most likely not occur under the low level 
oxidative stress conditions induced by a 500 nM [Dox] treatment condition.  
The results of this analysis immediately excluded thiol-disulfide exchange as a 
possible mechanism for IKK-β S-glutathionylation because the ratio of GSH/GSSG 
would have to decrease by over 100 fold (from 100/1 to 1/1) to drive 50% conversion of 
protein-SH to protein-SSG (Gilbert, 1990). For this reason, H2O2-induced GSSG 
formation was modeled as a GSH sink, rather than a source of IKK-β S-glutathionylation 
(Fig. 6-1). S-nitrosylation (protein-SNO) mechanisms of protein S-glutathionylation were 
disregarded, even though cysteine sulfhydryls do undergo nitrosylation in vivo, because 
protein-SNO is more prevalent in extracellular spaces (Meyer et al, 1994). Moreover, 
protein-SNO is a relatively stable sulfhydryl derivative with half-lives on the order of 
hours (Arnelle & Stamler, 1995; Park, 1988; Singh et al, 1996), making this mechanism 
of  protein S-glutathionylation unlikely to be involved in the time frame of this study.  
Sulfenylamide-dependent (protein-SNCO) protein S-glutathionylation was 
ignored in the model description because it has only been reported to occur for one 
protein, protein tyrosine phosphatase 1B, after treatment with H2O2, and is thought to 
develop from an initial protein sulfenic acid species (protein-SOH) (Salmeen et al, 2003; 
van Montfort et al, 2003). Thiolsulfinate mechanisms of protein S-glutathionylation 
(protein-SOS-protein) were not directly ruled out because thiolsulfinates are reported to 
be highly reactive with thiols and are very similar in characteristic to sulfenic acids. 
However, because it is difficult to distinguish between thiolsulfinate-dependent and 
sulfenic acid-dependent mechanisms of protein-S-glutathionylation, one can consider the 
thiolsulfinate-dependent mechanism of protein S-glutathionylation to be buried within the 
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sulfenic acid-dependent mechanism of protein S-glutathionylation that is accounted for 
by the model.  
  Thiyl radical-dependent IKK-β S-glutathionylation was considered in the model 
because production of thiyl radicals has been reported under in vivo conditions of redox 
signaling (Jourd'heuil et al, 2003; Karoui et al, 1996; Kwak et al, 1995; Maples et al, 
1990). Although there are several mechanistic pathways for thiyl radical-dependent 
protein S-glutathionylation, only one pathway was taken into account by the model, the 
reaction of the IKK-β thiyl radical (IKK-β-S
•
) with reduced glutathione (GSH). The 




 was deemed too improbable 
given the fact that thiyl radicals are the shortest-lived sulfhydryl derivatives (Schoneich, 
1995; Wardman & von Sonntag, 1995; Winterbourn & Metodiewa, 1995) and the 
concentrations of IKK-β, and subsequently IKK-β-S
•
, are not significantly high enough to 
compete with the other intracellular thiols or thiyls that are capable of reacting with GS
•
 
or GSH, respectively (Adimora et al, 2010). This was the same reasoning that was used to 
exclude the formation of S-glutathionylated IKK-β through the reaction of GS
• 
with 




 formation was 
modeled as a GSH sink, rather than a source of IKK-β S-glutathionylation (Fig. 6-1). 
 
The antioxidant and pro-oxidant effects of NAC modulate IKK-β-SSG 
The results of the mechanistic modeling revealed that the three processes that are 
susceptible to NAC modulation, GSH synthesis (R9), protein thiyl radical formation (R5), 
and glutathione thiyl radical formation (R6) (Table 6-1), are each affected in a different 
way by NAC pretreatment. The GSH synthesis rate increases in a graded manner as a 





formation rates revealed different threshold responses to increasing concentrations of 
extracellular NAC (Table 6-1). The model predicts that the NAC-dependent 3-fold 
increase in RS
•
 formation rate occurs at relatively low NAC pretreatment concentrations 
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(0.5 mM). Whereas, the NAC-dependent 2-fold decrease in GS
•
 formation rate occurs at 
relatively high NAC pretreatment concentrations (5 mM). The predicted behavior of the 
RS
•
 formation rate as a result of NAC pretreatment suggests that the level of H2O2 
induced by a 500 nM Dox treatment regimen is significant enough to promote the Fenton 
and Haber-Weiss reactions, which lead to increased protein thiyl radical formation in the 
presence of NAC. The predicted behavior of the GS
•
 formation rate as a result of NAC 
pretreatment suggests that a relatively high extracellular concentration of NAC is needed 
to effectively compete with GSH for the quenching of intracellular thiyl radicals. This 
result offers some insight into the robust capacity of intracellular glutathione to deal with 
radical-induced oxidant assault.  
       Moreover, the ability of NAC to promote or hinder S-glutathionylation of IKK-β 
appears to be dependent on intracellular ROS levels. NAC addition to an intracellular 
environment with relatively low levels of H2O2 can effectively lower the amount of IKK-
β S-glutathionylation (Fig. 6-7 B), a consequence that was not observed when NAC was 
administered in an intracellular environment with relatively high levels of H2O2 (Fig. 6-7 
A). This discrepancy suggests that the intracellular ROS buffering capacity of leukemia 
cells may dictate the ability of NAC to alter Dox-induced NF-κB activation. 
 
The intracellular redox environment dictates Dox-induced NF-κB activity by 
systematically regulating IKK-β S-glutathionylation 
 Exposure of cells to clinically relevant doses of Dox has the potential to regulate 
intracellular signal transduction pathways that are known to be redox-sensitive. The NF-
κB signal transduction pathway was shown to be sensitive to Dox-induced ROS; the 
sensitivity of the NF-κB signal transduction pathway was regulated by NAC 
administration. Since NAC is a precursor to the antioxidant glutathione, it can effectively 
alter the intracellular redox environment by its ability to change the GSH/GSSG redox 
balance. The mechanistic model of Dox-induced IKK-β S-glutathionylation, therefore, 
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was utilized to predict the behavior of susceptible substrates (GSH and IKK-β) to varying 
doses of Dox for different NAC pretreatment conditions. This analysis was carried out to 
provide a qualitative description of the variability in Dox-induced IKK-β S-
glutathionylation and ultimately NF-κB activation that can be realized in cancer cells 
with different intracellular redox environments (Fig. 6-8). This analysis reveals the 
importance of not only the intracellular redox environment, as modulated by NAC 
pretreatment, but also the concentration of Dox that is administered.  
By necessity, these results are only approximations as the model contains only a 
few potential reactions, the concentrations of the species are not directly known, and the 
reactions are carried out in the absence of substrate recycling; however, the concept that 
variability in intracellular redox environment can promote variability in chemotherapy-









Figure 6-8. Quantitative simulation of GSH oxidation and IKK-β S-
glutathionylation for varying NAC and Dox treatment conditions. Simulation of the 
oxidation of the thiol proteins IKK-β and GSH after treatment with increasing 
concentrations of Dox under various NAC pretreatment conditions: (A) 0 mM NAC 
pretreatment, (B) 0.5 mM NAC pretreatment, (C) 1 mM NAC pretreatment, and (D) 5 
mM NAC pretreatment. Simulations of the kinetic traces were carried out using the 
proposed mechanistic model of IKK-β S-glutathionylation. The concentrations and rate 




NAC-dependent modulation of the intracellular redox environment may affect clinical 
efficacy of Dox administration 
 During Dox treatment, cells are exposed to a variety of oxidants, some of which 
have the potential to alter redox sensitive signaling pathways that play a role in cell 
growth and proliferation and could potentially alter the efficacy of Dox treatment. 
Previous studies of Dox-induced toxicity in leukemia cells have revealed a possible role 
for Dox-induced ROS-mediated signaling (Chapter 4). Whether a particular redox-
sensitive pathway is modified by Dox treatment or not, therefore, is dependent on the 
susceptibility to oxidation of the protein thiols that comprise the pathway.  
The NF-κB activation pathway is a redox sensitive pathway that can be modified 
by chemotherapy-induced ROS via a variety of different mechanisms. The different 
sensitivities of protein cysteine residues to oxidative modification suggest that IKK S-
glutathionylation is a primary mechanism by which Dox-induced ROS regulates the NF-
κB activation pathway. Details of the mechanisms that drive Dox-induced IKK-β S-
glutathionylation reveal the significance of protein thiyl and glutathione radical formation 
and the susceptibility of these reactions to the intracellular redox environment.  
The results of this study provide a mechanistic rationale for the way in which 
intracellular glutathione levels, and ultimately the intracellular redox state, can regulate 
Dox-induced NF-κB signal transduction in ALL cells. If NF-κB activation is a 
mechanism by which cancer cells elude chemotherapy induced toxicity, then the 
systematic modulation of the glutathione redox balance through the controlled 
administration of NAC or other antioxidants, could potentially serve as a simple 
therapeutic measure to combat chemotherapy-induced drug resistance development. 
The use of antioxidant supplements by patients with cancer is estimated between 
13% and 87% (Block et al, 2007) and controversy over whether antioxidant 
supplementation alters the efficacy of cancer treatment still exists (Block et al, 2007). As 
NAC continues to be assessed for its cytoprotective capabilities during chemotherapy in 
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non-cancerous cell types (Shi et al, 2009), it is worth considering that the pro- and anti-
oxidant effects of this molecule, induced by the competing reactions shown in this study, 
could prove to be deleterious in some cell types and beneficial or innocuous in others. 
This study shows the presence of NAC can either promote or hinder the activation of a 
redox-sensitive transcription factor whose actions may control the efficacy of Dox 
treatment; however, the ability of NAC to modify this redox-sensitive pathway is 
dependent on the intracellular environment into which it is introduced, a parameter that 
varies from one cancer cell type to the next. The directionality of this effect depends on 
the Dox dose to which the cells are exposed and the intracellular levels of ROS 
experienced by the cell. Therefore, the characterization of patient-specific intracellular 
redox capacity might inform the beneficial or harmful effects of NAC administration in 
conjunction with chemotherapy. 
 
The current model advances our understanding of the independent behavior of particular 
redox systems 
This study aimed to address issues related to the independent behavior of 
particular redox systems that comprise the mammalian antioxidant network and the ways 
in which these redox systems are computationally described. The modeling analysis 
carried out in this study demonstrates that the mathematical description of a particular 
redox-sensitive signaling pathway can be effectively carried out in isolation of the 
intracellular antioxidant network. More importantly, these modeling techniques 
highlighted the ability to translate qualitative descriptions of redox-dependent processes 
into semi-quantitative mathematical descriptions with the use of simple logical analysis. 
A simplified description of a portion of the antioxidant network was capable of 
accurately describing in vivo ROS-dependent signaling, as was evidenced by the ability 
of the model to predict IKK-β S-glutathionylation for various NAC pretreatment 
conditions (Fig. 6-7). In this modeling analysis, a detailed and highly complex signaling 
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network was simplified in description to reactions involving the GSH redox couple and 
IKK-β. Logical analysis based on simple redox-reactions was used to determine the 
possible effects of NAC treatment on a potentially important signaling pathway. 
Systematic comparisons of the possible NAC-dependent effects revealed intricacies of 
the redox signaling network with very little computational expense. This work has shown 
that the use of computational modeling in conjunction with traditional experimentation 
can effectively provide the framework necessary to “reverse-engineer” the features of the 
mammalian antioxidant system as they pertain to ROS-mediated signaling. Moreover, 
this study provides strong evidence that variations to the intracellular redox environment, 
as characterized by variations in GSH/GSSG redox balance, confers significant control 





CONCLUSIONS AND FUTURE WORK 
 The body of work presented in this dissertation advances knowledge of the role of 
redox systems in anthracycline chemotherapy administration. The redox dependence of 
Dox bioactivation (Chapter 4), the ability of cells to remove ROS (Chapter 5), and the 
ability of ROS to modulate signal transduction (Chapter 6), provide substantial evidence 
to the possibility that redox pathways modulate the efficacy of Dox treatment in cancer 
cells. The objective of this research was to investigate how the redox properties of the 
Dox bioactivation network influence Dox toxicity in acute lymphoblastic leukemia cells 
through the generation of toxic Dox metabolites and the induction of ROS. The central 
hypothesis behind this dissertation was that the Dox bioactivation pathway is regulated 
by intracellular levels of antioxidant components and metabolites that work collectively 
to generate toxic Dox metabolites or to generate intracellular ROS signals. Moreover, it 
was proposed that certain molecular conditions would lead to the preferential formation 
of toxic Dox metabolites at the expense of ROS generation, thereby promoting Dox-
induced cell death. Lastly, because ROS can potentially affect redox-sensitive signaling 
pathways that regulate cell proliferation and growth, it was hypothesized that Dox-
induced ROS could either promote cell death or cell viability, depending on the 
intracellular redox context in which the ROS signals are generated.  
 To test these hypotheses, a systems-based network of intracellular Dox 
bioactivation was developed (Chapter 4) and used to construct cell-specific models of 
cytosolic Dox bioactivation (Fig. 4-3, Fig. 4-5). This work helped to advance knowledge 
of how adaptation of the Dox bioactivation network to changes in Dox treatment or to 
patient-specific changes in network components could ultimately alter cellular sensitivity 
to Dox chemotherapy treatment. The importance of cell-specific protein levels to the 
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degree of Dox bioactivation that occurs in vivo supports the need for more personalized 
strategies in chemotherapy administration.  
Secondly, a comprehensive network model of cellular ROS buffering was 
developed (Chapter 5) to predict changes to the intracellular redox environment that 
occur as a result of chemotherapy-induced oxidative stress (Fig. 5-1). This work helped 
to address the apparent paradox between the role of H2O2 as a cellular signaling molecule 
and its role as a cellular toxin. Through the development of a comprehensive model of 
H2O2 buffering in mammalian cells, this work provided quantitative and dynamic 
information regarding the antioxidant mechanisms that exert the most control over the 
removal of hydrogen peroxide from the cell, and how this control can be impacted by 
intervention.  
Finally, a mechanistic model of chemotherapy-induced redox signaling was 
proposed (Chapter 6). This work set out to address the issue of redox-system isolation 
within the global context of the mammalian antioxidant network. The work highlighted in 
this study illustrated that redox-sensitive signaling pathways can be thought to exist 
somewhat in isolation of one another and the accurate description of ROS-dependent 
signaling was not contingent on the ability to describe the entire antioxidant network as a 
whole. Analyzing the redox-sensitivity of the NF-κB activation pathway, through the 
systemic modulation of the GSH/GSSG redox couple, demonstrates that knowledge of a 
particular redox-sensitive signaling pathway can be achieved through the mechanistic 
analysis of a single intracellular redox couple.  
All three of the specific aims set out in this work utilized both computational and 
experimental approaches to further understand the role of redox systems in 
chemotherapy. The successful completion of the studies highlighted in this work has 
revealed some very unique challenges that exist in the development of kinetic models to 
help explain biological phenomena related to reduction and oxidation reactions. 
Intracellular redox reactions are highly regulated processes that are further complicated 
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by variations in susceptibility to oxidation of intracellular proteins and variations in 
availability of oxidants and reductants across different compartments of the intracellular 
milieu. For these reasons, many thiol-based redox couples are set and maintained at 
different redox potentials. The non-equilibrium redox potentials of intracellular redox 
couples make the computational modeling of signaling processes involving these redox 
couples somewhat difficult to accomplish.  
This study offers one modeling approach to dealing with this issue: the driving 
force for electron transfer can be defined as a function of the difference between the 
homeostatic potential and the actual potential of the redox couple of interest (Equation 5-
4) (Kemp et al, 2008). With this approach, the mathematical representation of a redox 
network can be used to accurately describe the dynamic response of the network to 
changes in intracellular [H2O2] without having to explicitly include the numerous steady-
state fluxes that must within the network. This modeling technique allows for a more 
robust framework with which to investigate differences in chemotherapy-induced ROS 
buffering between cancer cell lines of different lineages of from different patients. 
Without having to explicitly define the numerous steady-state fluxes that will most likely 
be different across different cancer cell lines, the models can simply depend on the 
experimental determination of steady state concentrations in order to provide an accurate 
picture of the way in which individual cells eliminate chemotherapy-induced ROS from 
their intracellular environments.  
The use of computational models to try to explain biological behavior is 
invaluable. Superior computational models, those that are based on validated and well 
established experimental data, are capable of providing meaningful insight into biological 
phenomena that would otherwise be difficult to interpret. However, because the 
construction of valid computational models relies on quantitative experimental data, the 
comprehensiveness of these models can sometimes be limited. Insufficient experimental 
techniques can sometimes be incapable of providing the depth of quantitative information 
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that is needed to construct valuable and useful computational models. This study has 
provided evidence that, when it comes to intracellular redox signaling, the need for a 
comprehensive model that takes into account all aspects of a particular signaling pathway 
may not be necessary to understand the important characteristics of the pathway (Chapter 
6). Through the mechanistic modeling carried out for the S-glutathionylation of IKK-β, it 
was shown that an accurate description of glutathione-dependent reactions, somewhat 
independent of the rest of the intracellular antioxidant network, was sufficient enough to 
describe the signaling dynamics of the NF-κB activation pathway. This modeling effort 
provides precedent for the global understanding of a particular redox-sensitive signaling 
pathway using only a subset of the components that comprise the intracellular redox 
network. 
 The relative importance of the glutathione-dependent and thioredoxin-dependent 
antioxidant systems was also quantitatively characterized as a result of the studies 
highlighted in this work. The unequal anti-oxidative burden of intracellular redox 
enzymes and thiol-containing compounds was revealed. The Trx1 and GSH redox 
couples are often used as measures of the overall redox state of the cell (Schafer & 
Buettner, 2001) and a computational model was utilized to describe the dynamics of these 
two redox couples under conditions of oxidative stress. Analysis of the model system 
under the different peroxide generation conditions (Table 5-3) suggested an unequal 
distribution in anti-oxidative burden exists between the cytosolic Trx1 and GSH redox 
couples; this unequal distribution could help to inform potential therapeutic targets for the 
modulation of chemotherapy-induced ROS within cancer cells. Future modeling efforts 
will most likely be needed to accurately describe how changing oxidative conditions, 
perhaps as a result of changing doses of anthracycline chemotherapy, could potentially 
affect the oxidative burden distribution across the GSH-dependent and Trx-dependent 
intracellular antioxidant systems.  
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Interestingly, the role of NADPH, a metabolite that provides reducing equivalents 
for both the Trx- and GSH-dependent antioxidant systems, was shown to be extremely 
important in relation to the bioactivation of anthracyclines (Chapter 4). Modulation of 
NADPH availability in the EU1 and EU3 cell lines produced enough intracellular change 
to alter the bioactivation profile of Dox; DHEA-dependent alterations of NADPH 
availability were capable of modifying the sensitivity of ALL cells to Dox treatment. The 
importance of the NADPH metabolite is further exhibited in its ability to alter ROS-
induced protein S-glutathionylation levels in vivo. An immortalized Jurkat T-cell line 
with decreased levels of the G6PD enzyme experiences a significantly different protein 
S-glutathionylation profile compared to Jurkat cells with normal levels of G6PD activity 
(Appendix A: Fig A-1).  
The importance of NADPH availability to chemotherapy administration can be 
exhibited in multiple ways. NADPH has been shown to modulate anthracycline 
bioactivation in a manner that can potentially alter sensitivity to anthracycline treatment, 
but NADPH can also alter chemotherapy-induced redox signaling via its ability to 
modulate ROS-induced protein S-glutathionylation. These NADPH-dependencies should 
be further investigated given the fact that frequently-occurring somatic mutations in 
gliomas and leukemias can result in a directional change from NADPH production to 
NADPH consumption by isocitrate dehydrogenases (IDH1/2) resulting in lower 
intracellular NADPH levels (Dang et al, 2009; Ward et al, 2010). Whether these 
mutations promote chemotherapy drug resistance or not, is left to be investigated. 
Chemotherapy administration is one way in which oxidative stress can be induced 
in mammalian cells. Previous discussions have highlighted the possibility that variations 
in ROS buffering components across different cancer cell lines can result in different 
levels of ROS being experienced by the cancer cells even for the same dosage of 
chemotherapy (Appendix B: Fig. B-1). This phenomenon becomes all the more important 
considering that ROS can potentially alter cellular signal transduction through the 
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reversible modification of intracellular redox-sensitive proteins (Valko et al, 2007); such 
alterations may serve to promote cell viability as a result of chemotherapy administration 
(Oliveira-Marques et al, 2009).  
To address this issue, specific analysis of how low levels of ROS can modify 
redox-sensitive signal transduction pathways that regulate cell growth and proliferation 
was carried out in the EU1 acute lymphoblastic leukemia cell line (Chapter 6). This study 
aimed to characterize the importance of the intracellular redox environment in controlling 
the degree to which Dox-induced ROS modulates a redox-sensitive signal transduction 
pathway. The working hypothesis for this study was that the intracellular redox 
environment, as defined by the intracellular levels of the major antioxidant glutathione 
(GSH), determines the ability of Dox-induced ROS to modulate a redox-sensitive signal 
transduction pathway.  
The role of the glutathione/glutathione disulfide (GSH/GSSG) redox balance in 
controlling Dox-induced NF-κB activity in ALL cells was investigated. The examination 
of Dox-induced NF-κB activation between two ALL cell lines with dissimilar antioxidant 
capacities (Appendix B: Fig. B-2), and the use of the antioxidant N-acetylcysteine (NAC) 
to systematically alter intracellular GSH/GSSG redox potential during Dox treatment, 
clearly illustrated how intracellular glutathione redox balance can regulate Dox-induced 
NF-κB signal transduction to potentially alter sensitivity ALL cell sensitivity to Dox 
treatment. A validated model of IKK-β S-glutathionylation was used to assess the 
antioxidant and pro-oxidant roles that NAC could potentially play during chemotherapy 
administration and, more importantly, how these roles ultimately affect the level of IKK- 
β S-glutathionylation that is induced by Dox treatment (Fig. 6-7, Fig. 6-8). The results of 
this study have shed some much needed light on the role that the intracellular redox 
environment can play in modulating chemotherapy-induced signal transduction. It has 
been shown previously that different cancer cells operate under distinctively different 
redox environments (Appendix B: Fig. B-1).  Therefore, one cannot consider the capacity 
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for chemotherapy-induced ROS to alter a redox-sensitive signaling pathway to be a 
conserved parameter that is universally defined for all cancer cells. The capacity for 
chemotherapy-induced ROS to alter a redox-sensitive signaling pathway is a dynamic 
parameter that must be re-defined from one cell to the next, from patient to patient, and 
from dose to dose (Fig. 6-8).  
Future Directions: A systems approach to cancer chemotherapy 
 Cancer is not a single disease but instead a collection of diseases that have distinct 
histopathological features, genetic and genome variability, and diverse prognostic 
outcomes (Vargo-Gogola & Rosen, 2007). If one understands cancer to be a 
heterogeneous disease, then perhaps the search for that mysterious “magic cancer bullet” 
should be substituted by a deeper understanding of cancer as a systems biology disease. 
With this understanding, one can begin to integrate quantitative experimental data 
through the use of comprehensive mathematical models to better understand the 
dynamics of chemotherapy-induced intracellular signaling. Advances in knowledge of 
how chemotherapy affects intracellular signaling pathways on a patient-to-patient basis 
will help not only in the understanding of chemotherapy-induced toxicity and drug 
resistance development, but also potentially in the discovery of more efficacious 
strategies to combat cancer cell growth and proliferation.  
To help motivate this progress, future work can be conducted in all three areas of 
study highlighted in this dissertation. Aim 1 of this work focused on understanding the 
redox-dependent processes that contribute to Dox toxicity; however, the computational 
models generated in this study fall short in their dynamic description of some of the 
intracellular components involved in Dox bioactivation, e.g. the NADPH-dependent 
NOX4 enzymatic reaction that utilizes NADPH and molecular oxygen to produce 
superoxide. The importance of the NOX enzymes in Dox bioactivation requires a more 
in-depth characterization. Experiments that aim to decipher the exact mechanism by 
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which NOX activity is regulated by anthracycline treatment will add some much needed 
depth to the understanding of Dox bioactivation in cancer cells.  
The Dox bioactivation models were also limited in scope due to the fact that they 
only considered cytosolic mechanisms of Dox bioactivation. There are multiple 
mechanisms for anthracycline bioactivation in mammalian cells: the mitochondria-
dependent bioactivation of Dox by mitochondrial complex I and NADH (Davies & 
Doroshow, 1986; Doroshow & Davies, 1986), and the mitochondria-independent 
mechanisms of Dox bioactivation by CPR and NADPH (Bartoszek, 2002). Future work 
in this area could include the compartmentalization of Dox bioactivation. It was assumed 
that most of the Dox administered to the cells was metabolized in the cytosol, but this 
may not necessarily be the case. If nuclear-dependent or mitochondria-dependent 
bioactivation processes dominate in some cell lines, as opposed to others, then a 
computational model capable of describing these compartmentalized actions would 
increase the predictive power of such models.   
Additionally, the in vivo Dox bioactivation network includes species that are 
involved in a variety of other intracellular reactions which are independent of Dox 
bioactivation, such as NADPH. NADPH is a metabolite that is used ubiquitously in cells 
for a variety of redox dependent reactions (Adimora et al, 2010). Moreover, NADPH-
dependent thiol oxidation-based mechanisms may actually contribute to Dox-induced cell 
injury in some cells (Asmis et al, 2005), thereby providing a link between intracellular 
thiol-disulfide status and Dox-induced toxicity; a link that was unaccounted for by the 
model because of the qualitative nature of the findings.  
 The construction of computational models that take into account the spatial 
compartmentalization of intracellular components would go far in advancing knowledge 
of intracellular redox buffering. Aim 2 and Aim 3 of this work focused on understanding 
cellular capacity to deal with oxidative stress and how this oxidative stress could 
potentially regulate intracellular signal transduction during chemotherapy administration. 
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A limitation of the validated computational models offered in Aim 2 and Aim3 is that 
they dealt only with cytosolic, and in some instances, peroxisomal reactions. Spatially 
competent computational models could potentially provide insight into how the 
intracellular location of chemotherapy can have varying effects on chemotherapy-induced 
redox signaling and toxicity. Future experimental work could potentially focus on the 
systematic targeting of chemotherapy to particular subcellular locations and the analysis 
of how these varied targeting strategies affect degree of Dox bioactivation, ROS-
induction, and signal transduction. 
 Results of this work provide strong evidence that variations to the intracellular 
redox environment, as characterized by variations in GSH/GSSG redox balance, confers 
significant control over the extent to which chemotherapy treatment can modify NF-κB 
signaling. If NF-κB activation is a mechanism by which cancer cells elude 
chemotherapy-induced toxicity, then the systematic modulation of the glutathione redox 
balance, perhaps through the controlled administration of NAC, could potentially serve as 
a simple therapeutic measure to combat chemotherapy-induced drug resistance 
development. It has been shown in the literature that oxidative activation and inactivation 
of NF-κB itself can occur and does play a role in NF-κB signal transduction (Oliveira-
Marques et al, 2009). The work highlighted in this study did not investigate the 
mechanisms behind this possibility. Future work in this area could involve 
characterization of the extent to which variations in the redox balance of other 
intracellular redox couples, such as Trx-(SH)2/Trx-SS, affects NF-κB signal transduction 
by the direct redox modification of the NF-κB transcription factor. The Prx enzyme 
system, which is dependent on the thioredoxin redox couple, contributes approximately 
32% of the cell‟s redox buffering capacity. It would be interesting to see how variations 
in the Trx redox balance affects the ability of chemotherapy to alter cellular signaling 
pathways that control cell viability and proliferation.   
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 It was mentioned that the comprehensive description of the intracellular redox 
network may not be necessary to accurately model intracellular signaling; however, it 
would be extremely powerful if the Dox bioactivation model could be coupled to the 
mechanistic S-glutathionylation model to provide some insight into the relative 
importance of the toxicity and signaling modules of Dox bioactivation for a particular 
treatment condition. As it stands, the work provided in this study successfully 
characterized the toxicity and signaling modules of Dox bioactivation, independently, yet 
in a patient, both of these modules most likely operate simultaneously. It would be 
extremely powerful to be able to take patient-specific protein levels, input them into a 
computational model, and predict the degree to which the toxicity-generating module of 
Dox dominates over the signal-generating module. Such a model would provide an 
invaluable tool for personalized medicine.  
 This study focused on the redox-mechanisms involved in anthracycline treatment 
of ALL, and in doing so revealed some possible biomarkers that could help inform the 
efficacy of said treatment. Future work in this area could involve the development of 
comprehensive models that incorporate the redox-dependence of anthracycline treatment 
with other signaling pathways that play a role in cancer cell proliferation and growth. It 
would be interesting to develop models of chemotherapy-induced cell death that 
incorporate the redox-sensitivity of apoptotic pathways. It has been shown in the 
literature that Trx1 mediates apoptosis via its redox-dependent association with ASK1 
(Katagiri et al, 2010). Moreover, the redox-dependent translocation of thioredoxin into 
the nucleus is capable of modulating transcription factor binding (Wei et al, 2000). The 
use of the generalized model of cytosolic ROS buffering may help to inform the 
mechanisms by which these interactions and phenomena are regulated by chemotherapy-
induced ROS.   
 Lastly, the inclusion of more cancer phenotypes and more chemotherapy drug 
alternatives for characterization is essential to understanding the variability that exists 
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across cancer cells for different chemotherapy treatment regimens. The research 
presented in this thesis aims to characterize the role of redox systems in chemotherapy 
metabolism and chemotherapy-mediated cell signaling. For this endeavor, the Dox 
anthracycline was utilized in the treatment of acute lymphoblastic leukemia cell lines to 
elucidate the redox-mechanisms that control chemotherapy-induced toxicity in cancer 
cells. The sum of these results allows for further understanding of the role of redox 
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 redox couple has been implicated in the metabolic 
conversion of Dox. Previous work (Chapter 4) revealed that the dual-nature of Dox 
metabolism is highly dependent on the availability of NADPH as evidenced by in vivo 
intervention strategies using the G6PD inhibitor DHEA. Furthermore, NADPH limitation 
at low Dox concentrations was shown to alter ALL-sensitivity to Dox treatment (Fig. 4-7 
B, C) in an ROS-dependent manner. This finding suggested a role for NADPH in 
modulating not just the toxicity-generating module of Dox bioactivation, but also the 
ROS-generating module, which may be affiliated with intracellular signaling.  
It has been shown previously that the S-glutathionylation of intracellular proteins 
upon induction of oxidative stress has the potential to alter intracellular signaling 
pathways (Chapter 6). To investigate whether changes to the intracellular availability of 
NADPH, characterized by G6PD activity, can alter the protein-S glutathionylation profile 
during conditions of oxidative stress, wild-type and G6PD-knockdown EU1 cells were 
treated with exogenous H2O2 to simulate the increased oxidative conditions that result 
from Dox administration. After treatment, the degree of protein S-glutathionylation was 




Stable knockdowns were created from Jurkat cells by targeting the expression 
levels of glucose-6-phosphate dehydrogenase using MISSION Lentiviral shRNA 
Transduction Particles according to manufacturer‟s protocol with puromycin selection (4 
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µg / ml). Jurkat cells tranduced with empty pLKO.1-puro lentiviral plasmids were used as 
controls to assess the effect of lentiviral transduction on ROS-induced protein S-
glutathionylation. Lentiviral-tranduced cells were maintained in culture using the 
previously described culture conditions (Chapter 5 Materials and Methods) and Jurkat 
cell culture media supplemented with puromycin antibiotic at (4 µg / ml).  
 
Results 
Significant differences in level of protein S-glutathionylation were observed 
between WT and G6PD knockdown cells after treatment with 100 µM exogenous H2O2 
(Fig. A-1). These differences occurred at 2 min and 5 min after peroxide addition. The 
WT cells experienced increased protein S-glutathionylation at 30 min of treatment and 
values returned to baseline by 1 h of treatment. Conversely, the G6PD cells experienced 
increased protein S-glutathionylation at earlier time points with a peak in protein S-
glutathionylation exhibited at 5 min of peroxide treatment. By 10 min of treatment, Pr-
SSG levels in the G6PD cells had returned to baseline and remained there for the 
remainder of the treatment duration. PLKO controls experienced no noticeable increase 
in Pr-SSG as a result of exogenous peroxide administration.  
 
Conclusion 
This experiment indicates that changes in G6PD expression, and thereby activity, 
can alter the Pr-SSG profile of Jurkat cells under conditions of oxidative stress. This 
experiment also indicates that the lentiviral transduction process can also lead to changes 











     
  
Figure A-1. Glucose-6-phosphate dehydrogenase controls ROS-induced protein S-
glutathionylation in mammalian cells. G6PD-knockdown (G6PD), wild-type (WT), 
and empty-vector control (PLKO) Jurkat cells were treated with 100 µM H2O2 for 1 h 
and the level of ROS-induced protein S-glutathionylation was quantified by HPLC. (n = 

























 APPENDIX B 
REDOX CAPACITY CONTROLS DOX-INDUCED ROS AND DOX-
INDUCED NF-ΚB 
  
The importance of the intracellular antioxidant network in dealing with exogenous 
and endogenous sources of ROS has been shown in the literature (Adimora et al, 2010). 
Dox-induced ROS has the capacity to alter intracellular signal transduction pathways and 
has been shown to affect the NF-κB signal transduction pathway via its ability to induce 
S-glutathionylation of IKK-β (Chapter 6). This process was revealed to be highly 
dependent on the intracellular redox balance of the GSH/GSSG redox couple. However, 
this dependency of dox-induced IKK-β S-glutathionylation on the intracellular redox 
network was revealed through the modification of intracellular GSH/GSSG redox balance 
by the external administration of NAC. In order to determine if inherent differences in 
ROS buffering capacity across ALL cell lines, as evidenced by the expression levels of 
select antioxidant enzymes, were enough to result in differences in dox-induced NF-κB 
activation, a comparative study of the EU1 and EU3 ALL cell lines was carried out. The 
antioxidant capacities of the dox-resistant EU1 cells and the dox-sensitive EU3 cells were 
characterized. Following this characterization, the level of dox-induced ROS and dox-
induced NF-κB activation was assessed according to the previously described protocols 
(Chapter 6 Materials and Methods).  
 
Antioxidant Enzyme Expression 
The relative concentrations of the antioxidant proteins being investigated were 
determined via western blot (G6PD, Prx I, TR, Grx1, Trx1). Untreated EU1 and EU3 
cells were lysed according to the previously described protocol (Chapter 6 Materials and 
Methods) and cytosolic lysates were analyzed for basal protein expression levels by 
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western blot using the following primary antibodies: anti-G6PD (AbCam); anti-Prx1 
(Upstate, MA, USA); anti-TR (Upstate); anti-Grx1 (R&D Systems, MN, USA); anti-Trx1 
(BD Pharmingen, NJ, USA). Basal GSH levels were quantified by HPLC according to 
the previously described protocol (Chapter 5 Materials and Methods). Protein levels were 
normalized to the EU3 cell line and results were expressed as fold change in comparison 
to the values obtained for the EU3 cell line. 
 
Results 
Significant differences in the basal levels of the antioxidant proteins chosen for 
analysis were seen between the EU1 and EU3 cell lines (Fig. B-1 A). The protein 
expression levels for all proteins except thioredoxin reductase (TR) were significantly 
lower in the EU1 cell line compared to the EU3 cell line. Correspondingly, the 5 µM Dox 
treatment condition resulted in significantly higher levels of dox-induced ROS in the EU1 
cells compared to the EU3 cells (Fig. B-1 B). The level of dox-induced NF-κB, as 
quantified by luciferase luminescence, was significantly higher in the EU3 cells 
compared to the EU1 cells for the 5 µM Dox treatment condition (Fig. B-2).   
 
Conclusion 
This experiment indicates that inherent differences in antioxidant capacity across 
ALL cells lines can result in differential levels of Dox-induced ROS. This experiment 
also indicates that inherent differences in antioxidant capacity across ALL cells lines can 
result in differential levels of Dox-induced NF-κB activation, perhaps via the previously 
proposed mechanism of IKK-β S-glutathionylation (Chapter 6). The EU3 cells exhibit 
increased ROS buffering capacity which may help protect them from ROS-induced IKK-
β S-glutathionylation, thereby promoting increased levels of dox-induced NF-κB activity 
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Figure B-1. ALL cells with altered redox capacities experience different levels of 
dox-induced ROS. (A) Relative expressions of antioxidant enzymes in EU1 and EU3 
ALL cell lines. (B) Time-dependent Dox-induced H2O2 in EU1 and EU3 cells quantified 




























































Figure B-2. ALL cells with altered redox capacities experience different levels of 
dox-induced NF-κB activation. Dox-induced NF-κB activity, as quantified by luciferase 






























DOX BIOACTIVATION MODELS 
  
Dox Bioactivation Model – in vitro 
 
function out = Dox_Activation_in_vitro 
    % model for in vitro Dox bioactivation 
    % Solver Parameters 
    ti = 0; % start time 
    tf = 1200; % stop time  
    step = 1;  
    dt = step; 
    tspan = ti:dt:tf; 
    options=odeset('AbsTol',1E-10,'RelTol',1E-4,'maxstep',step);  
     
  
    
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%% 
        % Defining forward reaction rates () 
        % Defining the array, k, that will house reaction rates 
        k = zeros(6,1); 
  
        % CPR_reduced reacts with quinone Dox 
        k(1) = 1.2e4; 
         
        % CPR_oxidized reacts with reduced NADPH 
        k(2) = k(1); 
         
        % Molecular oxygen reacts with semi-quinone Dox 
        k(3) = 3.0e8;   
         
        % NADPH reacts with molecular oxygen 
        k(4) = 2.9e1;  
         
        % Superoxide reacts with quinone Dox 
        k(5) = 5.5e7;  
         
%         % Superoxide is removed by SOD 
%         k(6) = 6.4e9;  
  
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
       
        % Defining initial Conditions (Concentrations in M = 
Moles/Liter) 




        x0 = zeros(9,1); 
         
        x0(1) = 1.0e-6; % CPR_reduced 
        x0(2) = 0; % CPR_oxidized 
         
        x0(3) = 1e-4; % DOX quinone 
        x0(4) = 0;  % DOX semi-quinone 
         
        x0(5) = 5e-4; % NADPH 
        x0(6) = 0;     % NADP 
         
        x0(7) = 2.73e-4; % Molecular oxygen 
        x0(8) = 0; % Superoxide 
        x0(9) = 0; % Hydrogen Peroxide 
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % integration 
        tic 
        [t x]=ode15s(@crank,tspan,x0,options,k); 
        toc 
        out = [t, x]; 
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % description of derivatives 
  
            function dxdt=crank(t, x, k); 
                            
                 dxdt= x;  % setting up vector containing derivatives 
  
                 dxdt(1) = - k(1)*x(1)*x(3) + k(2)*x(2)*x(5); % 
CPR_reduced  
                  
                 dxdt(2) = k(1)*x(1)*x(3) - k(2)*x(2)*x(5); % 
CPR_oxidized      
                                         
                 dxdt(3) = - k(1)*x(1)*x(3) + k(3)*x(4)*x(7) - 
k(5)*x(3)*x(8); % DOX quinone  
                   
                 dxdt(4) = k(1)*x(1)*x(3) - k(3)*x(4)*x(7) + 
k(5)*x(3)*x(8); % DOX semi-quinone 
                  
                 dxdt(5) = - k(2)*x(2)*x(5) - k(4)*x(5)*x(7); % NADPH  
                  
                 dxdt(6) = k(2)*x(2)*x(5) + k(4)*x(5)*x(7); % NADP+  
                  
                 dxdt(7) = - k(3)*x(4)*x(7) - k(4)*x(5)*x(7) + 
k(5)*x(3)*x(8) + k(6)*x(8)*x(8); % Molecular oxygen  
                  
                 dxdt(8) = k(3)*x(4)*x(7) + k(4)*x(5)*x(7) - 
k(5)*x(3)*x(8) - k(6)*x(8)*x(8); % Superoxide  
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                 dxdt(9) = k(6)*x(8)*x(8); % Hydrogen Peroxide  
                  





Dox Bioactivation Model – EU1 cell line at 10 µM [Dox] 
 
function out = Dox_Activation_EU1_HighDox 
    % model for in vivo Dox bioactivation 
    % Solver Parameters 
    ti = 0; % start time 
    tf = 3600; % stop time  
    step = 1;  
    dt = step; 
    tspan = ti:dt:tf; 
    options=odeset('AbsTol',1E-15,'RelTol',1E-7,'maxstep',step);  
     
      
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%% 
        % Defining forward reaction rates () 
        % Defining the array, k, that will house reaction rates 
        k = zeros(10,1); 
  
        % CPR_reduced reacts with quinone Dox 
        k(1) = 1.2e4;  
         
        % CPR_oxidized reacts with reduced NADPH 
        k(2) = k(1); 
         
        % Molecular oxygen reacts with semi-quinone Dox 
        k(3) = 3.0e5;  
         
        % NADPH reacts with molecular oxygen 
        k(4) = 4.2e4;  
         
        %Superoxide reacts with quinone Dox 
        k(5) = 5.5e7;   
         
        % Superoxide is removed by SOD 
        k(6) = 6.4e9;  
         
        % Permeability constant for Dox influx (plasma membrane) 
        k(7) = 1.1e-6; % Permeability Constant value at High Dox 
Concentration 
         
        % Production of NADPH by G6PD 
        k(8) = 1.8e-6;  
  
        % Km of NADP+  
        k(9) = 5.7e-5;   
         
        % Oxygen Consumption from Environment 
        k(10) = 1e-15;   
  




       
        % Defining initial Conditions (Concentrations in M = 
Moles/Liter) 
        % Defining the array, x0, that will house initial 
concentrations 
        x0 = zeros(11,1); 
  
        x0(1) = 1.3e-6; % CPR_reduced  
        x0(2) = 0; % CPR_oxidized 
         
        x0(3) = 0; % Intracellular DOX quinone 
        x0(4) = 0;  % Intracellular DOX semi-quinone 
         
        x0(5) = 3.0e-5; % NADPH  
        x0(6) = 3.0e-7; % NADP+  
         
        x0(7) = 1.5e-9; % Molecular oxygen  
        x0(8) = 1.5e-11; % Superoxide 
        x0(9) = 1.5e-11; % Hydrogen Peroxide 
         
        x0(10) = 1e-5; % Extracellular DOX quinone 1.0e-5 = high 
         
        x0(11) = 1.1e-6; % Permeability Coefficient for Dox influx 
(Variable Parameter) 
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % integration 
        tic 
        [t x]=ode15s(@crank,tspan,x0,options,k); 
        toc 
        out = [t, x]; 
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % description of derivatives 
         
         function dxdt=crank(t, x, k); 
                            
                 dxdt= x;  % setting up vector containing derivatives 
  
                 dxdt(1) = - k(1)*x(1)*x(3) + k(2)*(x(2)-x0(2))*x(5); % 
CPR_reduced                 
                  
                 dxdt(2) = k(1)*x(1)*x(3) - k(2)*(x(2)-x0(2))*x(5); % 
CPR_oxidized     
                 
                 dxdt(3) = (x(11)*(x(10)*10e-3*6.15e-6)/(1.43e-12)) - 
k(1)*x(1)*x(3) + k(3)*x(4)*x(7) - k(5)*x(3)*x(8); % Intracellular DOX 
quinone  
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                 dxdt(4) = k(1)*x(1)*x(3) - k(3)*x(4)*x(7) + 
k(5)*x(3)*x(8); % Intracelluar DOX semi-quinone 
                      
                 dxdt(5) = - k(2)*(x(2)-x0(2))*x(5) - 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) + k(8)*(x(6) - x0(6))/(k(9) + x(6)); % 
NADPH  
                  
                 dxdt(6) = k(2)*(x(2)-x0(2))*x(5) + 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) - k(8)*(x(6) - x0(6))/(k(9) + x(6)); % 
NADP+    
  
                 dxdt(7) = - (x(4)*1e3)*k(3)*x(4)*x(7) - 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) + k(5)*x(3)*x(8) + k(6)*x(8)*x(8) + k(10); 
% Molecular oxygen 
  
                 dxdt(8) = (x(4)*1e3)*k(3)*x(4)*x(7) + 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) - k(5)*x(3)*x(8) - k(6)*x(8)*x(8); % 
Superoxide 
        
                 dxdt(9) = k(6)*x(8)*x(8); % Hydrogen Peroxide 
                  
                 dxdt(10) = - x(11)*(x(10)*10e-3*6.15e-6*(1e9)); % 
Extracellular Dox quinone   
                  
                 if (x(10)) <= (8e-6) 
                      
                     dxdt(11) = x(11)*x(10); 
                      
                 else 
                  
                     dxdt(11) = (x(11)/x(10))*(x(11))*5.5*(x(3) - 
(x(10))); % PC ((x(11)/x(10)) - 0.11)*(x(11))*3*(x(3) - (x(10))) 
                  
                 end 
                 





Dox Bioactivation Model – EU3 cell line at 10 µM [Dox] 
 
 function out = Dox_Activation_EU3_HighDox 
    % model for in vivo Dox bioactivation 
    % Solver Parameters 
    ti = 0; % start time 
    tf = 3600; % stop time  
    step = 1;  
    dt = step; 
    tspan = ti:dt:tf; 
    options=odeset('AbsTol',1E-15,'RelTol',1E-7,'maxstep',step);  
     
      
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%% 
        % Defining forward reaction rates () 
        % Defining the array, k, that will house reaction rates 
        k = zeros(10,1); 
  
        % CPR_reduced reacts with quinone Dox 
        k(1) = 1.2e4;  
         
        % CPR_oxidized reacts with reduced NADPH 
        k(2) = k(1); 
         
        % Molecular oxygen reacts with semi-quinone Dox 
        k(3) = 3.0e5;  
         
        % NADPH reacts with molecular oxygen 
        k(4) = 9.7e3;  
         
        %Superoxide reacts with quinone Dox 
        k(5) = 5.5e7;   
         
        % Superoxide is removed by SOD 
        k(6) = 6.4e9;  
         
        % Permeability constant for Dox influx (plasma membrane) 
        k(7) = 1.1e-6; % Permeability Constant value at High Dox 
Concentration 
         
        % Production of NADPH by G6PD 
        k(8) = 3.3e-6;  
  
        % Km of NADP+  
        k(9) = 5.7e-5;   
         
        % Oxygen Consumption from Environment 
        k(10) = 1e-15;   
  
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
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        % Defining initial Conditions (Concentrations in M = 
Moles/Liter) 
        % Defining the array, x0, that will house initial 
concentrations 
        x0 = zeros(11,1); 
  
        x0(1) = 8.9e-7; % CPR_reduced  
        x0(2) = 0; % CPR_oxidized 
         
        x0(3) = 0; % Intracellular DOX quinone 
        x0(4) = 0;  % Intracellular DOX semi-quinone 
         
        x0(5) = 5.4e-5; % NADPH  
        x0(6) = 5.4e-7; % NADP+  
         
        x0(7) = 1.5e-9; % Molecular oxygen  
        x0(8) = 1.5e-11; % Superoxide 
        x0(9) = 1.5e-11; % Hydrogen Peroxide 
         
        x0(10) = 1e-5; % Extracellular DOX quinone 1.0e-5 = high 
         
        x0(11) = 1.1e-6; % Permeability Coefficient for Dox influx 
(Variable Parameter) 
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % integration 
        tic 
        [t x]=ode15s(@crank,tspan,x0,options,k); 
        toc 
        out = [t, x]; 
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % description of derivatives 
         
         function dxdt=crank(t, x, k); 
                            
                 dxdt= x;  % setting up vector containing derivatives 
  
                 dxdt(1) = - k(1)*x(1)*x(3) + k(2)*(x(2)-x0(2))*x(5); % 
CPR_reduced                 
                  
                 dxdt(2) = k(1)*x(1)*x(3) - k(2)*(x(2)-x0(2))*x(5); % 
CPR_oxidized     
                 
                 dxdt(3) = (x(11)*(x(10)*10e-3*6.15e-6)/(1.43e-12)) - 
k(1)*x(1)*x(3) + k(3)*x(4)*x(7) - k(5)*x(3)*x(8); % Intracellular DOX 
quinone  
             
                 dxdt(4) = k(1)*x(1)*x(3) - k(3)*x(4)*x(7) + 
k(5)*x(3)*x(8); % Intracelluar DOX semi-quinone 
175 
 
                      
                 dxdt(5) = - k(2)*(x(2)-x0(2))*x(5) - 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) + k(8)*(x(6) - x0(6))/(k(9) + x(6)); % 
NADPH  
                  
                 dxdt(6) = k(2)*(x(2)-x0(2))*x(5) + 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) - k(8)*(x(6) - x0(6))/(k(9) + x(6)); % 
NADP+    
  
                 dxdt(7) = - (x(4)*1e3)*k(3)*x(4)*x(7) - 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) + k(5)*x(3)*x(8) + k(6)*x(8)*x(8) + k(10); 
% Molecular oxygen 
  
                 dxdt(8) = (x(4)*1e3)*k(3)*x(4)*x(7) + 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) - k(5)*x(3)*x(8) - k(6)*x(8)*x(8); % 
Superoxide 
        
                 dxdt(9) = k(6)*x(8)*x(8); % Hydrogen Peroxide 
                  
                 dxdt(10) = - x(11)*(x(10)*10e-3*6.15e-6*(1e9)); % 
Extracellular Dox quinone   
                  
                 if (x(10)) <= (8e-6) 
                      
                     dxdt(11) = x(11)*x(10); 
                      
                 else 
                  
                     dxdt(11) = (x(11)/x(10))*(x(11))*5.5*(x(3) - 
(x(10))); % PC ((x(11)/x(10)) - 0.11)*(x(11))*3*(x(3) - (x(10))) 
                  
                 end 
                 





Dox Bioactivation Model – EU1 cell line at 10 nM [Dox] 
 
function out = Dox_Activation_EU1_LowDox 
    % model for in vivo Dox bioactivation 
    % Solver Parameters 
    ti = 0; % start time 
    tf = 3600; % stop time  
    step = 1;  
    dt = step; 
    tspan = ti:dt:tf; 
    options=odeset('AbsTol',1E-15,'RelTol',1E-7,'maxstep',step);  
     
    
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%% 
        % Defining forward reaction rates () 
        % Defining the array, k, that will house reaction rates 
        k = zeros(10,1); 
  
        % CPR_reduced reacts with quinone Dox 
        k(1) = 1.2e4;  
         
        % CPR_oxidized reacts with reduced NADPH 
        k(2) = k(1); 
         
        % Molecular oxygen reacts with semi-quinone Dox 
        k(3) = 3.0e5;  
         
        % NADPH reacts with molecular oxygen 
        k(4) = 4.2e4;  
         
        %Superoxide reacts with quinone Dox 
        k(5) = 5.5e7;  
         
        % Superoxide is removed by SOD 
        k(6) = 6.4e9;  
         
        % Permeability constant for Dox influx (plasma membrane) 
        k(7) = 1.1e-5; % Permeability Constant value at Low Dox 
Concentration 
         
        % Production of NADPH by G6PD 
        k(8) = 1.8e-6;  
  
        % Km of NADP+  
        k(9) = 5.7e-5;  
         
        % Oxygen Consumption from Environment 
        k(10) = 1e-15;  
  
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
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        % Defining initial Conditions (Concentrations in M = 
Moles/Liter) 
        % Defining the array, x0, that will house initial 
concentrations 
        x0 = zeros(11,1); 
  
        x0(1) = 1.3e-6; % CPR_reduced  
        x0(2) = 0; % CPR_oxidized 
         
        x0(3) = 0; % Intracellular DOX quinone 
        x0(4) = 0;  % Intracellular DOX semi-quinone 
         
        x0(5) = 3.0e-5; % NADPH  
        x0(6) = 3.0e-7; % NADP+  
         
        x0(7) = 1.5e-9; % Molecular oxygen  
        x0(8) = 1.5e-11; % Superoxide 
        x0(9) = 1.5e-11; % Hydrogen Peroxide 
         
        x0(10) = 1e-7; % Extracellular DOX quinone 1.0e-7 = low 
  
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % integration 
        tic 
        [t x]=ode15s(@crank,tspan,x0,options,k); 
        toc 
        out = [t, x]; 
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % description of derivatives 
         
         function dxdt=crank(t, x, k); 
                            
                 dxdt= x;  % setting up vector containing derivatives 
  
                 dxdt(1) = - k(1)*x(1)*x(3) + k(2)*(x(2)-x0(2))*x(5); % 
CPR_reduced    
                  
                 dxdt(2) = k(1)*x(1)*x(3) - k(2)*(x(2)-x0(2))*x(5); % 
CPR_oxidized      
                                         
                 dxdt(3) = (k(7)*(x(10)*10e-3*6.15e-6)/(1.43e-12)) - 
k(1)*x(1)*x(3) + k(3)*x(4)*x(7) - k(5)*x(3)*x(8); % Intracellular DOX 
quinone   
                   
                 dxdt(4) = k(1)*x(1)*x(3) - k(3)*x(4)*x(7) + 
k(5)*x(3)*x(8); % Intracelluar DOX semi-quinone 
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                 dxdt(5) = - k(2)*(x(2)-x0(2))*x(5) - 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) + k(8)*(x(6) - x0(6))/(k(9) + x(6)); % 
NADPH  
                  
                 dxdt(6) = k(2)*(x(2)-x0(2))*x(5) + 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) - k(8)*(x(6) - x0(6))/(k(9) + x(6)); % 
NADP+ 
                  
                 dxdt(7) = - (x(4)*1e3)*k(3)*x(4)*x(7) - 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) + k(5)*x(3)*x(8) + k(6)*x(8)*x(8) + k(10); 
% Molecular oxygen 
                  
                 dxdt(8) = (x(4)*1e3)*k(3)*x(4)*x(7) + 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) - k(5)*x(3)*x(8) - k(6)*x(8)*x(8); % 
Superoxide 
                  
                 dxdt(9) = k(6)*x(8)*x(8); % Hydrogen Peroxide 
                  
                 dxdt(10) = - k(7)*(x(10)*10e-3*6.15e-6*(1e9)); % 
Extracellular Dox quinone    
                 






Dox Bioactivation Model – EU3 cell line at 10 nM [Dox] 
 
function out = Dox_Activation_EU3_LowDox 
    % model for in vivo Dox bioactivation 
    % Solver Parameters 
    ti = 0; % start time 
    tf = 3600; % stop time  
    step = 1;  
    dt = step; 
    tspan = ti:dt:tf; 
    options=odeset('AbsTol',1E-15,'RelTol',1E-7,'maxstep',step);  
     
    
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%% 
        % Defining forward reaction rates () 
        % Defining the array, k, that will house reaction rates 
        k = zeros(10,1); 
  
        % CPR_reduced reacts with quinone Dox 
        k(1) = 1.2e4;  
         
        % CPR_oxidized reacts with reduced NADPH 
        k(2) = k(1); 
         
        % Molecular oxygen reacts with semi-quinone Dox 
        k(3) = 3.0e5;  
         
        % NADPH reacts with molecular oxygen 
        k(4) = 9.7e3;  
         
        %Superoxide reacts with quinone Dox 
        k(5) = 5.5e7;  
         
        % Superoxide is removed by SOD 
        k(6) = 6.4e9;  
         
        % Permeability constant for Dox influx (plasma membrane) 
        k(7) = 1.1e-5; % Permeability Constant value at Low Dox 
Concentration 
         
        % Production of NADPH by G6PD 
        k(8) = 3.3e-6;  
  
        % Km of NADP+  
        k(9) = 5.7e-5;  
         
        % Oxygen Consumption from Environment 




        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
       
        % Defining initial Conditions (Concentrations in M = 
Moles/Liter) 
        % Defining the array, x0, that will house initial 
concentrations 
        x0 = zeros(11,1); 
  
        x0(1) = 8.9e-7; % CPR_reduced  
        x0(2) = 0; % CPR_oxidized 
         
        x0(3) = 0; % Intracellular DOX quinone 
        x0(4) = 0;  % Intracellular DOX semi-quinone 
         
        x0(5) = 5.4e-5; % NADPH  
        x0(6) = 5.4e-7; % NADP+  
         
        x0(7) = 1.5e-9; % Molecular oxygen  
        x0(8) = 1.5e-11; % Superoxide 
        x0(9) = 1.5e-11; % Hydrogen Peroxide 
         
        x0(10) = 1e-7; % Extracellular DOX quinone 1.0e-7 = low 
  
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % integration 
        tic 
        [t x]=ode15s(@crank,tspan,x0,options,k); 
        toc 
        out = [t, x]; 
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % description of derivatives 
         
         function dxdt=crank(t, x, k); 
                            
                 dxdt= x;  % setting up vector containing derivatives 
  
                 dxdt(1) = - k(1)*x(1)*x(3) + k(2)*(x(2)-x0(2))*x(5); % 
CPR_reduced    
                  
                 dxdt(2) = k(1)*x(1)*x(3) - k(2)*(x(2)-x0(2))*x(5); % 
CPR_oxidized      
                                         
                 dxdt(3) = (k(7)*(x(10)*10e-3*6.15e-6)/(1.43e-12)) - 
k(1)*x(1)*x(3) + k(3)*x(4)*x(7) - k(5)*x(3)*x(8); % Intracellular DOX 
quinone   
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                 dxdt(4) = k(1)*x(1)*x(3) - k(3)*x(4)*x(7) + 
k(5)*x(3)*x(8); % Intracelluar DOX semi-quinone 
                  
                 dxdt(5) = - k(2)*(x(2)-x0(2))*x(5) - 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) + k(8)*(x(6) - x0(6))/(k(9) + x(6)); % 
NADPH  
                  
                 dxdt(6) = k(2)*(x(2)-x0(2))*x(5) + 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) - k(8)*(x(6) - x0(6))/(k(9) + x(6)); % 
NADP+ 
                  
                 dxdt(7) = - (x(4)*1e3)*k(3)*x(4)*x(7) - 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) + k(5)*x(3)*x(8) + k(6)*x(8)*x(8) + k(10); 
% Molecular oxygen 
                  
                 dxdt(8) = (x(4)*1e3)*k(3)*x(4)*x(7) + 
k(4)*x(5)*x(7)*(x(3)/(1e-5)) - k(5)*x(3)*x(8) - k(6)*x(8)*x(8); % 
Superoxide 
                  
                 dxdt(9) = k(6)*x(8)*x(8); % Hydrogen Peroxide 
                  
                 dxdt(10) = - k(7)*(x(10)*10e-3*6.15e-6*(1e9)); % 
Extracellular Dox quinone    
                 







HYDROGEN PEROXIDE METABOLISM MODEL  
 
function out = Adimora_PeroxideClearanceModel_2010 
    % model for compartmentalized hydrogen peroxide consumption 
    % Solver Parameters 
    ti = 0; % start time 
    tf = 3600; % stop time  
    step = 1;  
    dt = step; 
    tspan = ti:dt:tf; 
    options=odeset('AbsTol',1E-10,'RelTol',1E-4,'maxstep',step);  
     
    
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%% 
        % Defining forward reaction rates () 
        % Defining the array, k, that will house reaction rates 
        k = zeros(28,1); 
  
 %      Rxns (Cytosolic) 
     
        % Permeability constant (plasma membrane) 
        k(1) = 1.0e-5; % cm/s  
         
        % Intracellular peroxide production 
        k(2) = 1.1e-7; % M/s  
         
        % GPx_red reacting with H2O2in 
        k(3) = 2.1e7; % M-1*s-1  
         
        % GPx_ox reacting with GSH 
        k(4) = 4e4; % M-1*s-1  
         
        % GPx-SSG reacting with GSH 
        k(5) = 1e7; % M-1*s-1  
         
        % Catalse reacts with H2O2 inside peroxisome 
        k(6) = 3.4e7; % M-1*s-1     
         
        % Km of NADP+  
        k(7) = 5.7e-5; % M  
         
        % Peroxiredoxin is oxidized by H2O2  
        k(8) = 4e7; % M-1*s-1 
         
        % Oxidized peroxiredoxin is over-oxidized by H2O2  
        k(9) = 7.2e4; % M-1*s-1   
         
        % Reduction of overoxidized Prx by Srx enzyme 
183 
 
        k(10) = 3e-3; % s-1 
         
        % Self-catalyzed disulfide formation of Prx-SS from Prx-SOH 
        k(11) = 15; % s-1   
         
        % Peroxiredoxin is reduced by Thioredoxin  
        k(12) = 2.1e6; % M-1*s-1  
         
        % Auto-oxidation of GSH  
        k(13) = 7.4e-05; % s-1  
         
        % Protein monothiol oxidized by H2O2 
        k(14) = 1e4; % M-1*s-1  
         
        % Oxidized Protein monothiol glutathionylated by GSH 
        k(15) = 1.2e5; % M-1*s-1 
         
        % Grx-SH de-glutathionylates Protein-SSG 
        k(16) = 9.1e4; % M-1*s-1  
         
        % GSH de-glutathionylates Grx-SSG 
        k(17) = 3.7e4; % M-1*s-1  
        
        % Protein dithiol oxidized by H2O2  
        k(18) = 5e5; % M-1*s-1  
            
        % Protein disulfide reduced by Trx  
        k(19) = 1e5; % M-1*s-1  
         
        % GSSG reduced by GR 
        k(20) = 3.2e6; % M-1*s-1  
         
        % Oxidized Thioredoxin reduced by TrxR   
        k(21) = 2e7; % M-1*s-1  
         
        % Production of NADPH by G6P-DH 
        k(22) = 3.75e-04; % M/s      
         
        % Permeability constant (peroxisomal membrane) 
        k(23) = 3e-3; % cm/s  
         
        % GSH synthesis 
        k(24) = 4.1e-7; % M/s  
         
        % GSSG efflux  
        k(25) = 1.2e-8; % M/s  
         
        % GSH + GSSG efflux  
        k(26) = 1.2e-7; % M/s  
         
        % Trx_SH efflux  
        k(27) = 7.45e-10; % M/s  
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        % Trx_SH synthesis 
        k(28) = 6.97e-10; % M/s  
         
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
       
        % Defining initial Conditions (Concentrations in M = 
Moles/Liter) 
        % Defining the array, x0, that will house initial 
concentrations 
        x0 = zeros(24,1); 
  
        % Cytoplasm 
         
        x0(1) = 1e-4;   % H2O2media  
        x0(2) = 1.0e-9; % H2O2cytosol 
        
        x0(3) = 5e-5;      % GPXr  
        x0(4) = 1e-14;     % GPXo  
        x0(5) = 1e-14;     % GPX-SG  
         
        x0(6) = 3.68e-4;  % GSH  
        x0(7) = 1.78e-6;  % GSSG  
         
        x0(8) = 9e-7;     % Catalase  
        x0(9) = 1.0e-10;  % H2O2peroxisome  
         
        x0(10) = 1.92e-5;             % Prx-SH  
        x0(11) = 1e-14;               % Prx-SOH  
        x0(12) = 1e-14;               % Prx-SOOH  
        x0(13) = x0(10)*(.5/100);     % Prx-SS  
         
        x0(14) = 4.27e-7;   % Trx1-SH  
        x0(15) = 7.54e-8;   % Trx1-SS  
         
        x0(16) = 1.22e-4;           % Pr-SH  
        x0(17) = x0(16)*(.5/100);  % Pr-SOH 
        x0(18) = x0(16)*(.5/100);  % Pr-SSG 
       
        x0(19) = 1.20e-6;          % Grx-SH  
        x0(20) = x0(19)*(.5/100);  % Grx-SSG  
         
        x0(21) = 1.09e-3;             % Pr-(SH)2   
        x0(22) = x0(21)*(.5/100);    % Pr-SS 
         
        x0(23) = 3.0e-5;  % NADPH  
        x0(24) = 3.0e-7;  % NADP+  
  
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % integration 
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        tic 
        [t x]=ode15s(@crank,tspan,x0,options,k); 
        toc 
        out = [t, x]; 
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % description of derivatives 
  
            function dxdt=crank(t, x, k); 
                            
                 dxdt= x;  % setting up vector containing derivatives 
  
                 %Cytosolic Dynamics 
  
                 dxdt(1) = k(1)*(x(2)- x(1))*10e-3*1.02e-5*(1e9); % 
H2O2 out    
                  
                 dxdt(2) = ((k(1)*(x(1))*10e-3*1.02e-5)/(9.16e-13)) - 
((k(1)*(x(2))*10e-3*1.02e-5)/(9.16e-13)) - 2*(k(23)*x(2)*10e-3*2.98e-
9)/(1.53e-14) + k(2) - k(3)*x(3)*(x(2)- x0(2)) - k(6)*x(8)*(x(2)- 
x0(2)) - k(8)*x(10)*(x(2)- x0(2)) - k(9)*x(11)*(x(2)- x0(2)) - 
k(14)*x(16)*(x(2)- x0(2)) - k(18)*x(21)*(x(2)- x0(2)); % H2O2 cytosol       
                                         
                 dxdt(3) = - k(3)*x(3)*(x(2)- x0(2)) + k(5)*(x(5)-
x0(5))*x(6); % GPXr  
                   
                 dxdt(4) = k(3)*x(3)*(x(2)- x0(2)) - k(4)*(x(4)-
x0(4))*x(6); % GPXo  
                  
                 dxdt(5) = k(4)*(x(4)-x0(4))*x(6) - k(5)*(x(5)-
x0(5))*x(6); % GPX-SG      
                  
                 dxdt(6) = - k(4)*(x(4)-x0(4))*x(6) - k(5)*(x(5)-
x0(5))*x(6) - 2*k(13)*x(6) - k(15)*(x(17)-x0(17))*x(6) - k(17)*(x(20)-
x0(20))*x(6) + 2*k(20)*(x(7)-x0(7))*x(23) + k(24) - k(26); % GSH 
  
                 dxdt(7) = k(5)*(x(5)-x0(5))*x(6) + k(13)*x(6) + 
k(17)*(x(20)-x0(20))*x(6) - k(20)*(x(7)-x0(7))*x(23) - k(25) - k(26); % 
GSSG  
                  
                 dxdt(8) = 0; % FeCat   
                  
                 dxdt(9) = (k(23)*x(2)*10e-3*2.98e-9)/(1.53e-14) - 
k(6)*x(8)*(x(9)-x0(9)); % H2O2 peroxisome   
                  
                 dxdt(10) = - k(8)*x(10)*(x(2)- x0(2)) + k(12)*(x(13)-
x0(13))*x(14); % Prx-SH     
                  
                 dxdt(11) = k(8)*x(10)*(x(2)- x0(2)) - 
k(9)*x(11)*(x(2)- x0(2)) + k(10)*(x(12)-x0(12)) - k(11)*x(11); % Prx-
SOH     
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                 dxdt(12) = k(9)*x(11)*(x(2)- x0(2)) - k(10)*(x(12)-
x0(12)); % Prx-SOOH   
                  
                 dxdt(13) = k(11)*x(11) - k(12)*(x(13)-x0(13))*x(14); % 
Prx-SS   
                  
                 dxdt(14) = - k(12)*(x(13)-x0(13))*x(14) - 
k(19)*(x(22)-x0(22))*x(14) + k(21)*(x(15)-x0(15))*x(23) - k(27) + 
k(28); % Trx-SH    
                  
                 dxdt(15) = k(12)*(x(13)-x0(13))*x(14) + k(19)*(x(22)-
x0(22))*x(14) - k(21)*(x(15)-x0(15))*x(23); % Trx-SS    
                  
                 dxdt(16) = - k(14)*x(16)*(x(2)- x0(2)) + 
k(16)*x(19)*(x(18)-x0(18)); % Pr-SH   
                  
                 dxdt(17) = k(14)*x(16)*(x(2)- x0(2)) - k(15)*(x(17)-
x0(17))*x(6); % Pr-SOH   
                  
                 dxdt(18) = k(15)*(x(17)-x0(17))*x(6) - 
k(16)*x(19)*(x(18)-x0(18)); % Pr-SSG   
                  
                 dxdt(19) = k(17)*(x(20)-x0(20))*x(6) - 
k(16)*x(19)*(x(18)-x0(18)); % Grx-SH    
                  
                 dxdt(20) = k(16)*x(19)*(x(18)-x0(18)) - k(17)*(x(20)-
x0(20))*x(6); % Grx-SSG    
                  
                 dxdt(21) = - k(18)*x(21)*(x(2)- x0(2)) + k(19)*(x(22)-
x0(22))*x(14); % Pr-(SH)2    
                  
                 dxdt(22) = k(18)*x(21)*(x(2)- x0(2)) - k(19)*(x(22)-
x0(22))*x(14); % Pr-SS    
                  
                 dxdt(23) = - k(20)*(x(7)-x0(7))*x(23) - k(21)*(x(15)-
x0(15))*x(23) + k(22)*(x(24)- x0(24))/(k(7) + x(24)); % NADPH     
                  
                 dxdt(24) = k(20)*(x(7)-x0(7))*x(23) + k(21)*(x(15)-
x0(15))*x(23) - k(22)*(x(24)- x0(24))/(k(7) + x(24)); % NADP+    
  
  
                  







IKK-BETA S-GLUTATHIONYLATION MODEL  
 
function out = IKK_S_Glutathionylation 
    % model for compartmentalized hydrogen peroxide consumption 
    % Solver Parameters 
    ti = 0; % start time 
    tf = 3600; % stop time  
    step = 1;  
    dt = step; 
    tspan = ti:dt:tf; 
    options=odeset('AbsTol',1E-10,'RelTol',1E-4,'maxstep',step);  
     
    
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%% 
        % Defining forward reaction rates () 
        % Defining the array, k, that will house reaction rates 
        k = zeros(9,1); 
  
 %      Rxns (Cytosolic) 
  
        % Peroxide Production Rate 
        k(1) = 60e-4;   
         
        % Peroxide Oxidation of GSH 
        k(2) = 20e-4;  
         
        % Peroxide Oxidation of IKK-SH 
        k(3) = 0.5e-4;  
         
        % Glutathionylation of IKK-SOH  
        k(4) = 60e-4;  
         
        % Radical Production Rate 
        k(5) = 12.2e-4;  
         
        % Radical-Induced GSH oxidation 
        k(6) = 50e-4; 
         
        % Radical-Induced IKK-SH oxidation 
        k(7) = 5e-4;  
         
        % GSH binds to IKK-Sdot  
        k(8) = 50e-4;  
         
        % GSH synthesis 
        k(9) = 6e-2;  
        
        % Peroxide Removal  
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        k(10) = 52e-4; 
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
       
        % Defining initial Conditions (Concentrations in M = 
Moles/Liter) 
        % Defining the array, x0, that will house initial 
concentrations 
        x0 = zeros(10,1); 
  
        % Cytoplasm 
         
        x0(1) = 6.5;  % Doxe-  
         
        x0(2) = 0;    % Perox 
        x0(3) = 0;    % RSdot 
         
        x0(4) = 500;  % GSH         
        x0(5) = 5;    % GSSG  
        x0(6) = 0;    % GSdot 
         
        x0(7) = 50;   % IKK-SH  
        x0(8) = 0;    % IKK-SOH 
        x0(9) = 0;    % IKK-Sdot 
        x0(10) = 0;    % IKK-SSG 
         
        x0(11) = 0; % NAC 
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % integration 
        tic 
        [t x]=ode15s(@crank,tspan,x0,options,k); 
        toc 
        out = [t, x]; 
         
        
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%% 
        % description of derivatives 
  
            function dxdt=crank(t, x, k); 
                            
                 dxdt= x;  % setting up vector containing derivatives 
  
                 %Cytosolic Dynamics 
                  
                 dxdt(1) = (7.14e-6*(t/60) + 22.979*(t/60) + 15)*1e-6; 
% Doxe-  
                                         
                 dxdt(2) = k(1)*x(1) - k(2)*x(4)*x(2) - k(3)*x(7)*x(2) 
- k(10)*x(2); % Perox 
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                 dxdt(3) = k(5)*x(1) - k(6)*x(4)*x(3) - k(7)*x(7)*x(3); 
% RSdot 
                  
                 dxdt(4) = - k(2)*x(4)*x(2) - k(6)*x(4)*x(3) - 
k(4)*x(4)*x(8) - k(8)*x(4)*x(9) + k(9); % GSH   
                  
                 dxdt(5) = k(2)*x(4)*x(2); % GSSG  
                  
                 dxdt(6) = k(6)*x(4)*x(3); % GSdot 
                  
                 dxdt(7) = - k(3)*x(7)*x(2) - k(7)*x(7)*x(3); % IKK-SH 
                  
                 dxdt(8) = k(3)*x(7)*x(2) - k(4)*x(4)*x(8); % IKK-SOH 
                  
                 dxdt(9) = k(7)*x(7)*x(3) - k(8)*x(4)*x(9); % IKK-Sdot 
                  
                 dxdt(10) = k(4)*x(4)*x(8) + k(8)*x(4)*x(9); % IKK-SSG        
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